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Une science, au moment où elle naît, non seulement se débarrasse d’un certain
nombre d’obstacles, mais en même temps, elle supprime un certain nombre de
savoirs et de connaissances existantes qu’elle occulte, qu’elle cache, comme si elle
appliquait une grille nouvelle qui tout en permettant de faire apparaître des
phénomènes jusque là cachés, cache des connaissances déjà acquises. Donc une
science, ce n’est pas simplement l’oubli des vieux préjugés, c’est une véritable
nouvelle grille qui cache et qui du coup fait apparaître.
— Michel Foucault
To my glipglops. . .
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Abstract
The aim of synthetic biology is to create a new discipline of engineering based on
biological parts, devices and systems. The availability of predictable, programmable
tools to sense and to control gene expression is central to our ability to engineer such
systems. Ribonucleic acid (RNA) is an attractive building material to create such
programmable tools, as RNA-RNA interactions are predictable and RNA secondary
structure prediction software has been developed. Design rules for creating such parts
using RNA can be established, based on a standardised approach or on structural
design rules into which function is implicitly encoded. In this latter case, RNA folding
software can be used to create RNA sequence which satisfy generalisable structural
characteristics, but are tailored to a specific application. In this work, new design rules
for the creation of RNA-based sensors and actuators are developed. The actuator parts
are based on riboregulators, but with a circular topology generated through splicing of
a ribozyme. The ability of these circular riboregulators to activate transcription of gene
expression in E. coli cells is demonstrated. A method for improving these actuators by
directed evolution is then tested. Finally, design rules for creating sensors of RNAs
based Clustered Regularly Interspaced Short Palindromic Repeat guide RNAs (CRISPR
gRNAs) are developed. These gRNA-based sensors can switch states and repress gene
expression through a CRISPR-Cas9 based platform, but only in the presence of an
arbitrary "trigger" RNA. The rules developed for creating sensors and actuators are
characterised in E. coli, but are based on general principles that could be used in other
organisms including eukaryotic cells.
Key words: RNA synthetic biology, computational design, riboregulator, circRNA, RNA
sensing, RNA circuits, gRNA engineering, directed evolution
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1 Introduction
The construction of synthetic biological circuits that can sense and interact with their
environment requires the availability of sensor and actuator parts. Sensors are parts
capable of sensing an input signal (e.g., the presence of a specific small molecule, or
of a gene of interest), and transforming this signal into a control signal. Actuators are
parts that can transform a control signal into an output, such as the expression of a
reporter protein (Wang et al., 2013). In this context, a control signal usually means
controlled transcription or translation of other genes.
The use of this engineering vocabulary in synthetic biology derives from a desire to
encourage – and to an extent, constrain thought into – an engineering approach to the
construction of genetic circuits, including the use of concepts such as standardisation
and abstraction hierarchy (Endy, 2005). Applying concepts from electric and software
engineering to construction of biological circuits is not straightforward, and the
creation of this new engineering discipline requires the invention of new concepts and
methods. To this end, working with ribonucleic acid (RNA) parts has some advantages
that make it a promising building material. One of the main reasons for this is the
predictable nature of RNA-RNA interactions, compared to interactions involving
proteins (Kushwaha et al., 2016). As a result of our understanding of these biochemical
interactions, the equilibrium structures of RNAs in solution can be computationally
predicted (Zuker and Stiegler, 1981; Dirks and Pierce, 2003).
1
Chapter 1. Introduction
If the structure and function of an RNA are directly linked, computational prediction
can generate desired function by creating RNA parts with a defined structure. When
two RNA species can interact with one another, such that they have different minimum
free energy (MFE) structures when folded alone or in the complexed state, and if their
functionality is dependent on one of these two alternative structures, then RNA circuits
that require both components to be active can be designed (Rodrigo et al., 2012). If
both RNAs of the circuit are synthetic parts, their sequence can be chosen so they
adopt the desired target conformations. Such parts can also be designed to interact
with natural RNAs (Green et al., 2014), but the sequence choice of the synthetic RNAs
are then constrained by the structure and sequence of the natural RNA. In this case, a
robust and flexible design architecture is needed, so that the part can interact with
a large variety of sequences. Regardless of the circuit and its use, this approach for
designing RNA parts requires one or more target structures, into which the function
of the RNA is implicitly encoded. This design goal is a set of sequence and structural
constraints chosen such that, ideally, any RNA that meets these constraints has the
desired function. The second step is the generation of the specific RNAs that meet
the general constraints. Such RNAs could be designed by hand if the constraints are
simple, but creating RNAs that respect a complex set of constraints rapidly becomes
intractable without computationally assisted design methods. The biological context
in which the RNA parts are used must also be taken into account, as other elements
such as RNA stability can also affect the behaviour of the designed circuits.
Chapter 1 introduces the basic properties of RNA, RNA structure, and the methods and
software used for computational prediction of RNA secondary structure. An overview
of RNA parts used in the literature and design rules used to create them are then
introduced, with a focus on parts that make use of RNA folding programs. Chapters 2,
3 and 4 contain more specific introductory material relevant to the strategies used to
develop RNA sensors and actuators.
2
1.0.1 RNA structure
RNA is a polymeric molecule made of a chain of nucleotides linked through a ribose-
phosphate backbone. An RNA sequence is made up of four nitrogenous bases: The
purines adenine (A) and guanine (G); and the pyrimidines cytosine (C) and uracil
(U). Each base is attached to the 1’ carbon of a ribose sugar. A phosphodiester bond
links the 3’ carbon of each ribose to the 5’ carbon of the next one, forming a polymer
of bases on a ribose-phosphate backbone (see fig. 1.1A and B). RNA can either be
single stranded, or like DNA, form a stable double helix through base pairing with a
sequence containing complementary bases, where A pairs with U and G pairs with
C. Other interactions that do not follow Watson-Crick base pairing rules, notably
G-U base pairs (also called wobble base pairs) are also possible. G-U base pairs are
relatively common in RNA structures, and for the purposes of structure prediction, are
considered as normal base pairs (Varani and McClain, 2000). A-G or A-C base pairs
also exist, but are unusual and are not considered by structure prediction software.
Double stranded helices formed by base pairing, as well as a relatively small number
of structural motifs, compose the majority of secondary structures found in RNA
(Serra and Turner, 1995, see fig. 1.1C). RNA folding, like protein folding, can be broken
down into primary, secondary and tertiary structure. The primary structure consists
of the RNA sequence. The secondary structure is determined by the RNA folding
onto itself through base pairing. Its tertiary structure consists of the higher level
folding of these structures onto themselves, through chemical interactions involving
the ribose-phosphate backbone, loops or bulges.
3
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Figure 1.1 – A. Chemical structure of the RNA backbone. B. Chemical structure of the
purines Adenine and Guanine, and of the pyrimidines Uracil and Cytosine. C. Com-
mon 2D motifs seen in RNA structures. Chemical structures adapted from Wikimedia
Commons, 2D motifs adapted from Serra and Turner (1995).
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RNA has a relatively small molecular "vocabulary". Secondary structure is the main
contributor to the free energy of an RNA structure, and base pairing effects are more
important than tertiary interactions for RNA folding (Banerjee et al., 1993; Laing and
Draper, 1994; Mathews et al., 1997). Aside from the identity of the base pairs, the most
important contributors to the stability of an RNA structure are the stacking effects
of adjacent base pairs, and loop entropies (Hofacker and Stadler, 2008). A nearest
neighbour model, where the thermodynamic properties of a base pair are assumed
to be depend on the identity of the base and its adjacent base pair, can be used to
predict the stability of a helix (Hofacker and Stadler, 2008).
To determine the rules that govern secondary folding, small model systems that fold
spontaneously can be made and their folding energies determined experimentally,
using various techniques such as calorimetry and measurement of melting curves
(Freier et al., 1986; He et al., 1991). In this way, thermodynamic properties of all
possible base pairs with all possible neighbours have been measured, as have the
stability contributions of terminal mismatches and of loops (Hickey and Turner, 1985;
Freier et al., 1986; Sugimoto et al., 1987; Serra et al., 1994). These were catalogued by
Serra and Turner (1995), with updated parameters published by Mathews et al. (1999),
then again with chemical modifications taken into account by Mathews et al. (2004).
The parameters are available for download online, along with examples on their use
(Turner and Mathews, 2010). If an RNA sequence has a known sequence and structure,
the free energy change of the structure compared to the unstructured RNA can be
calculated by adding up the contributions of all stem, loop and terminal mismatch
structures.
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1.0.3 Predicting structure of a given sequence
If the calculation of the free energy change of an RNA structure compared to its un-
folded form is possible when its sequence is known, then calculating the minimum
free energy (MFE) structure of an arbitrary sequence becomes a computational prob-
lem. Theoretically, one could calculate the free energy of every possible structure, then
pick the one with the lowest free energy, but this approach is very computationally
expensive. This problem was solved by Zuker and Stiegler (1981), who showed that
the global minimum free energy structure for an RNA sequence could be computed
relatively efficiently using a dynamic programming algorithm.
The principle of this algorithm is to divide up the sequence into smaller ones, starting
with all possible 5 nt subsequences, to calculate the energies of the subsequences,
and to use these results in a dynamic algorithm to build up the larger sequence. First,
the free energy of all subsequences in all possible permissible configurations (i.e.,
for all permissible base pairs: A-U, G-C and G-U), are computed. The first set of
subsequences would therefore be nucleotides 1-5, 2-6, 3-7, and so on. The length
of 5 bp is chosen because 3 bp is considered to be the smallest possible loop, so a
5 nucleotide subsequence has two possible configurations: 5 unpaired bases, or a
structure with 2 paired bases and a 3 nt loop.
For a longer subsequence that goes from two arbitrary nucleotides i to j, there are
two possibilities: either nucleotide j is unpaired or it is paired. If j is unpaired, the
free energy for the sequence is that of the sequence i – j-1, plus the energy of the 3’
overhang j. As smaller subsequences are calculated before larger ones, the previously
calculated value for the subsequence i – j-1 is used and adjusted for the 1 bp overhang.
If j is paired, it can be paired to i or to i’, where the order of the nucleotides is i < i ′ < j .
When paired to i, the free energy of the base i-j is added to that of the substructure
i+1 – j−1, which has already been calculated. When paired to i’, the same process is
applied to the substructure i’ – j, and added to the free energy of i – i’-1 which has
6
already been computed.
This process is repeated for all subsequences one base longer, until the last one which
is the whole sequence. This yields the free energy of the final sequence, but also
that of all the substructures that compose it. The final structure is then built up by
backtracing through the matrix of previously calculated values. This process uses
experimentally measured free energy values for the small subsequences, with larger
ones calculated by adding up the calculations for subsequences.
The method was adapted to permit the calculation of suboptimal structures within a
certain percentage the MFE structure (Zuker, 1989), and a comparison of these subop-
timal structures with the MFE structure allows an assessment of the probability that a
given base pair will be present in the real structure. For example, a base pair present
in the MFE and all suboptimal structures within 10% of MFE would be assigned a high
score, and a base pair only present in the MFE structure would be assigned a low one.
When tested against a variety of RNA sequences up to 800 nt long, models that use
this type of dynamic programming algorithm have a sensitivity of about 74%, and a
positive predictive value (PPV) of 64%, that is, they identify 74% of the base pairs that
form in reality, and 64% of base pairs that are identified really form (Mathews et al.,
1999). Generally, the prediction tends to get worse for longer RNAs.
Sensitivity= True positive pairs
True positive pairs+False negative pairs
PPV= True positive pairs
True positive pairs+False positive pairs
The predictions of such models can be strengthened by the use of a partition function
that calculates the probability that a base will be paired at equilibrium, taking into ac-
count suboptimal structures (McCaskill, 1990; Mathews, 2004). 91% of bases that pair
with a probability of 99% in the predicted minimum free energy structure also exist
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in the known structures derived from comparative sequence analysis. Overall, such
energy minimisation algorithms can be used to predict the structure of short RNAs
quite well, as well as provide an assessment of the quality of the prediction. The longer
the RNA gets, the less accurate these predictions become. One important drawback of
the dynamic programming algorithm presented above is that it explicitly excludes the
presence of pseudoknots in the sequence (Lorenz et al., 2011). A pseudoknot is formed
if any base pairs a-b and a’-b’ form such that a<a’<b<b’ in the sequence. Pseudoknots
are known to exist in longer RNA sequences and are important in many catalytic
RNAs such as ribozymes. Finally, with all its advantages and drawbacks, this method
aims to calculate the minimum free energy structure, which would be expected to
be the dominant structure at equilibrium. Whether this is a physiologically relevant
structure will depend on the kinetics of RNA folding, as well as on interactions with
other cellular components.
1.1 The sequence-structure-function relationship in RNA
circuits
RNA circuits are based on a certain number of basic RNA "parts". With regard to a
computational design strategy, these parts can be broadly separated into two groups:
those whose function can be predicted from their secondary structure – i.e., which
function by base pairing to themselves or their target –, and those whose correct
function requires tertiary structure folding. The first group are particularly interesting
for automatic design or RNA circuits, as their secondary structure can be predicted
from their sequence. If design rules can be devised such that their function can be
predicted from their structure, then we should be able to predict their function from
their sequence when provided with accurate structural predictions, and therefore
design new ones (Kushwaha et al., 2016). This approach has notably been used for
the de novo design of riboregulators (Rodrigo et al., 2012; Green et al., 2014). The
second group of RNA parts, that depend on specific tertiary structure, are harder
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to use as tertiary structure cannot be predicted accurately based on our current
knowledge. They nonetheless often contain secondary structure and some attempts
can be made at incorporating within computational design pipelines, by ensuring
that their predicted secondary structure is not disrupted (Shen et al., 2015), or by
incorporating additional constraints into the folding calculation (Borujeni et al., 2015).
1.1.1 RNA design through abstraction of secondary structure
The correct function of riboregulators and other antisense RNAs can often be pre-
dicted based on the secondary structure calculations of their target messenger RNA
(mRNA) when folded alone, or in presence of a small RNA (sRNA) regulator. This
approach is based on the assumption that ribosome binding sites (RBS) are functional
if unstructured, but inactive when occluded by secondary structure formation. Other
constraints can also be incorporated into riboregulators, such as structural elements
that enhance stability, or chaperone binding sites. Clustered Regularly Interspaced
Short Palindromic Repeats (CRISPR) are composed of a protein (Cas9) and guide RNAs
(gRNAs), and the latter falls into this category. The gRNAs contain a region that binds
to DNA through base pairing, and a stem-loop motif that specifically binds the Cas9
protein. This system is described in more detail in sections 1.2.1 and 4.1.3.
Riboregulator and antisense RNA engineering
Riboregulators are a class of RNA based regulators of gene expression. The term is a
catchall used to describe small RNAs that interact with an RNA target through base
pairing, whether they are found in nature or engineered. The first bacterial riboreg-
ulator to be discovered in Escherichia coli (E. coli) was an antisense RNA (asRNA),
MicF, that directly pairs with the ribosome binding site of its target, the OmpF mRNA
(Andersen et al., 1987). MicF hinders access of the ribosome binding site and inhibits
translation, as well as encouraging degradation of the mRNA (Delihas and Forst, 2001).
Positive antisense riboregulation was first discovered in S. aureus by Morfeldt et al.
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(1995). Expressed alone, the hla gene has a self-repressing 5’ untranslated region
(UTR) that blocks access to the ribosome binding site. The authors showed that
RNAIII could interact with the 5’ of the hla mRNA, unfolding it and exposing the RBS.
RNAIII also codes for the hld gene, so it is an mRNA that also acts as a riboregulator.
Both positive and negative riboregulators can be engineered. The first artificial an-
tisense RNAs were based on the MicF RNA, redirected to pair with lpp, ompC and
ompA mRNAs (Coleman et al., 1984). The synthetic riboregulators were targeted to
the RBS of the mRNAs, allowing downregulation of these genes by manually changing
the sRNA binding site. This approach has been shown to work in various bacterial
species (Desai and Papoutsakis, 1999; Darsonval et al., 2015) and has been used to
regulate natural metabolic pathways to optimise the production of chemicals of in-
terest (Yoo et al., 2013; Na et al., 2013; Yang et al., 2015). Positive riboregulators have
also been engineered (Isaacs et al., 2004; Rodrigo et al., 2012; Green et al., 2014). In
the case of positive regulators, the cis-repressing 5’ UTR of the mRNA also needs to
be designed. These circuits were at first derived from natural riboregulator circuits
(Isaacs et al., 2004). Following structural design rules from natural regulators, Rodrigo
et al. (2012) created completely artificial regulators, showing that computationally
encoded design rules could be used to automatically design biological parts. These
first design rules focused on a 5’ UTR which folded to occlude the RBS when in the
off state. Green et al. (2014) devised a new set of design rules, focusing on blocking
the start codon and surrounding region rather than the ribosome binding site. This
allowed an improvement of the dynamic range of such circuits.
CRISPR gRNA engineering
CRISPR is a type of adaptive immune response system in prokaryotes (Barrangou
et al., 2007). In type II CRISPR systems, the Cas9 protein acts as an RNA guided DNA
endonuclease (Jinek et al., 2012), where 20 to 25 bases of RNA direct the nuclease to
the target site on the DNA. The S. pyogenes CRISPR system has the advantage of using
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a single Cas9 protein which uses two small RNAs – crRNA and tracrRNA – to target
and cleave double stranded DNA. The crRNA contains 20 to 25 nt of complementarity
to the DNA target, and requires the tracrRNA to mature and bind to the Cas9 protein.
The complex then cleaves both strands of the dsDNA target. A single synthetic guide
RNA can also be used, by fusing the crRNA and the tracrRNA into one short synthetic
guide RNA (sgRNA, or just gRNA). The CRISPR gRNA is formed of three domains: The
20 to 25 bp of targeting region, the Cas9 handle which binds the Cas9 protein, and the
S. pyogenes terminator at the RNA 3’. In the crystal structure, the targeting region is
single stranded, with the "seed" region maintained in A-form conformation by the
Cas9 protein, ready for pairing with its target DNA (Jinek et al., 2014). The Cas9 handle
is formed of two stems. The first is where the crRNA and the tracrRNA are paired,
and a single sgRNA can be made by linking them with a small loop. A second shorter
stem loop is present further in the tracrRNA. The terminator sticks out of the Cas9
protein, with some contact with the protein in the crystal structure. The secondary
structure of CRISPR gRNAs has been shown to be important for their proper function,
and structured targeting regions can inhibit them (Thyme et al., 2016). CRISPR gRNAs
can be incorporated within RNA circuits, by inhibiting them with antisense RNAs (Lee
et al., 2016). They can also be combined with riboswitches to create small molecule
responsive gRNAs (Liu et al., 2016). Additional elements such as MS2 and PP7 binding
regions can also be added onto gRNAs. Zalatan et al. (2015) showed that protein
effectors fused to MS2 or PP7 could be targeted to specific DNA sequences this way.
1.1.2 RNA parts which require tertiary structure interaction
RNA aptamers and riboswitches
Aptamers are short nucleic acid sequences that can specifically bind a target molecule,
through interactions involving both the nucleotides and the ribose-phosphate back-
bone. Natural RNA aptamers that bind small molecules have been identified as part of
riboswitches (Nahvi et al., 2002; Serganov and Nudler, 2013), where they serve as RNA
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based small molecule sensors. Riboswitches are usually part of RNA 5’ UTRs, and con-
trol mRNA translation by a conformational change upon binding, which modifies the
accessibility of the RBS. Interestingly, the creation of artificial aptamers by Systematic
Evolution of Ligands by Exponential Enrichement (SELEX – Ellington and Szostak,
1990; Tuerk and Gold, 1990) predates the discovery of natural ones. SELEX starts from
a random library of DNA or RNA sequences, and selects for new aptamers through
rounds of ligand binding in a column, followed by error-prone PCR amplification of
the best binders. This technique has allowed the development of hundreds of artificial
aptamers (Cruz-Toledo et al., 2012) that target small molecules, proteins or whole
cells, leading to the idea that these could be used to engineer artificial riboswitches.
However, the steps for transforming an aptamer into an artificial regulator have proven
challenging to implement (Berens and Suess, 2015), although recent developments
have shown promising results (Borujeni et al., 2015; Liu et al., 2016).
Ribozymes
Catalytically active RNAs were first discovered in the 1980s, revealing their role in com-
plex cellular processes, beyond that of mere carriers of information (Cech et al., 1981;
Guerrier-Takada et al., 1983). Many ribozymes cleave RNAs in trans, such as RNase P
which processes transfer RNAs (tRNAs), or self-cleave, such as the Hammerhead or
Hepatitis D virus (HDV) ribozymes (Serganov and Patel, 2007). Group I introns are
ribozymes that autocatalytically remove themselves and ligate exons together (Cech
et al., 1981; Banerjee et al., 1993). They all require tertiary interactions between the dif-
ferent elements of the ribozyme to be active. However, secondary structure still plays
a major role in their folding, and double mutants that preserve secondary structure
can often remain active even when single mutants are not (Kobori and Yokobayashi,
2016). Ribozymes can be combined with aptamers, to produce small molecule re-
sponsive ribozymes, also called aptazymes (Soukup and Breaker, 1999). They are
produced by including an aptamer into one of the ribozyme loops, in such a way that
the ribozyme is destabilised and rendered inactive. Upon small molecule binding, the
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stem is stabilised and the ribozyme activity is restored. Similar systems that turn off
upon small molecule binding can also be engineered. Aptazymes that self-cleave to
release an mRNA allow small molecule dependent gene expression, by engineering a
structure where ribosome access is hindered by the ribozyme, and cleavage releases
the mRNA, allowing translation. Such small molecule sensors have been used in cell
free extract, bacteria and eukaryotes (Ogawa and Maeda, 2007; Wieland et al., 2009;
Win and Smolke, 2007). Aptazymes have also been combined with riboregulators,
creating "1.5 component" signal transduction. Such systems, termed "regazymes",
release a riboregulator after cleavage upon small molecule binding. The riboregulator
then goes on to activate a cis-repressed mRNA, demonstrating the use of aptazymes
and riboregulators in layered circuits (Shen et al., 2015).
1.2 Design rules for RNA parts
As natural RNA parts were discovered and synthetic ones created, design rules for
different parts have been developed. The main rules used for creating new parts are
outlined below.
1.2.1 Riboregulators, gRNAs, asRNAs, riboswitches
Positive riboregulators
Positive riboregulator design strategies are based on three main assumptions. The
first is that the secondary structures of RNA strands at equilibrium can be predicted
computationally, for both single strand and multistranded complexes, using programs
described in section 1.0.3. The second is that initiation of translation cannot take
place if the RBS and/or the start codon are obstructed by the secondary structure
of the mRNA 5’ region, forming the cis-repressed mRNA (cr-mRNA). The third is
that the trans-activating RNA (taRNA) can interact with a cr-mRNA through solvent
exposed regions, either in a linear or in a loop region. This exposed region is called
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the "toehold". The design rules then aim to create a cr-mRNA / taRNA couple such
that translation is obstructed when the cr-mRNA is expressed alone, but unhindered
when both RNAs are expressed together. The interaction is presumed to be initiated
through the toehold region, and followed by a strand displacement that leads to the
new configuration. The design rules thus focus on the creation of structures which
aim to maximise repression of translation in the OFF state, minimise repression in the
ON state, and favour interaction between the cr-mRNA and the taRNA.
The first design rules for riboregulators were inspired by the natural hok/sok toxin-
antitoxin system (Isaacs et al., 2004). The cr-mRNA contained a stem which occludes
the RBS, and a YUNR motif (for pyrimidine-uracil-nucleotide-purine) in the loop of
the stem, which creates a sharp bend in the loop and exposes its bases to the solvent
(Franch et al., 1999). The cognate riboregulators initially had a similar secondary
structure to the Sok RNA, with a single stranded toehold region complementary to the
YUNR loop sequence. Rodrigo et al. (2012) built on this design, showing that other
sRNA structures could be used, and targeting cr-mRNAs without YUNR motifs. More
importantly, they abstracted the rules into secondary structure requirements that
allowed unsupervised de novo design of taRNA/cr-mRNA pairs (see fig. 1.2).
An alternative "modular" approach that incorporated key structural changes was
developed by Green et al. (2014). The authors moved away from nature-inspired
structures, and created completely artificial architectures. The taRNAs, which they
called "trigger RNAs", were designed to have low secondary structure, apart from
a 5’ stem loop for enhanced stability. The cr-mRNAs, renamed "toehold switches",
contain a longer 15 nt linear toehold, at the 5’ region rather than in a loop. The RBS is
left unpaired in a loop, while the secondary structure formed by the stem obstructs
the ATG start codon (see fig. 1.2). To allow this structure to be engineered past the
start codon, the encoded protein is preceded by a linker peptide, whose sequence is
determined by the bases in the second part of the stem. This means the output protein
is fused to this short peptide. The toehold switches were automatically designed using
14
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the NUPACK suite which includes an RNA design package (Zadeh et al., 2011).
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1.2.2 Negative riboregulators
Negative riboregulators, also called simply antisense RNAs (asRNAs) were initially
inspired by natural RNAs (Coleman et al., 1984). Since, different design rules have
been proposed. Nakashima et al. (2006) added stem-loops at either end, creating
"paired-termini asRNAs" which they found had enhanced gene repression abilities.
Others added Hfq chaperone binding sites on the RNAs to improve their function (Na
et al., 2013). The most thorough study was probably carried out by Lee et al. (2016),
who designed and tested 96 asRNA against different targets. The authors varied target
location, number of mismatches, dsRNA length, thermodynamic parameters and the
presence of a YUNR motif, in E. coli. They found that asRNAs with dsRNA lengths over
15 nt, with a Gibbs free difference between the single species and complex species of
−40 or less, and less than 15% mismatches, performed best. They also found that the
presence of YUNR motifs did not result in stronger repression, and that all regions
of the 5’ UTR and the first 30 nucleotides of coding sequence were valid target sites.
Overall their study highlighted the challenge of establishing design rules for RNAs
with several important, overlapping factors, and uncovered the important factors for
future asRNA design.
1.2.3 Aims of this work
This work addresses the development of design rules that allow the creation of sensors
of RNA and of RNA-based actuators, using both computational and rational design.
Chapter 2 presents the development of a method for creating riboregulators with a
circular topology, using a Permuted Intron Exon (PIE) ribozyme. These riboregulators
were first developed with computational methods. To improve their function in vivo, a
new method for directed evolution of biological parts was tested, presented in chapter
3. Chapter 4 presents the development of sensor RNAs that use computationally
designed strand-dispacement reactions that control the activity of guide RNAs from
the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) system, using
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the CRISPR-Cas9 system as an output. Each chapter contains relevant introductory
materials, as well as a discussion and methods section. General methods are presented
in chapter 5. Finally, chapter 6 discusses how the results fit into the context of RNA
synthetic biology, and the potential uses of this work.
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2 Circular Riboregulators
2.1 Introduction
2.1.1 Circular RNA in nature
Most studied RNAs are linear molecules, but circular RNAs (circRNAs) have been
found in all domains of life (Guo et al., 2014; Danan et al., 2012; Lasda and Parker,
2014). Although they were previously considered oddities, experimental artefacts or
products of spurious splicing, circRNAs have now been shown to be common (Jeck
et al., 2013) and to play important regulatory roles (Memczak et al., 2013; Hansen
et al., 2013; Ye et al., 2015). However, they remain relatively understudied and the
reasons for their circularity remain unclear. circRNAs are found in viroids, small virus
like particles composed of a single infectious non-coding circular RNA genome, and
that have been suggested to be relics of pre-cellular life forms (Diener, 1989; Flores
et al., 2014). Hepatitis delta virus, a satellite virus of hepatitis B virus, also has a
circular genome (Macnaughton et al., 2002). In both cases, the circular RNA serves
as a template for rolling circle replication, resulting in a concatamer that undergoes
enzyme-mediated or autocatalytic cleavage. This process produces monomers which
are then circularised to produce more virus or viroid genomes. circRNAs have also
been found in some bacteria (Molina-Sánchez et al., 2006) and in many archaea
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(Danan et al., 2012), where they exist as by-products of intron splicing, or in certain
species as circular versions of snoRNAs and of the ribozyme RNase P (Lasda and Parker,
2014). In human cells, circular RNAs were recently shown to be more common than
previously thought (Jeck et al., 2013). This has spurred much interest, especially due
to the role they may play in disease (Chen, 2016a; Guarnerio et al., 2016). In humans,
some circRNAs have been shown to function as miRNA ’sponges’ that can suppress
the activity of miRNAs, by binding to them whilst being resistant to miRNA mediated
degradation (Hansen et al., 2013). However, this role as a regulator of miRNAs may be
not be generalisable to other expressed circular RNAs (Guo et al., 2014), and whether
many circular products have an important function or whether most are merely by-
products of spurious splicing reactions remains unclear. How circularity affects RNA
behaviour in general remains unexplained (Barrett and Salzman, 2016), and what
roles circRNAs can play as well as the reasons for their unusual topology remains an
open question.
2.1.2 Advantages of circularisation
One major change brought by circularity is the absence of free ends, which render
circRNAs resistant to exonuclease degradation (Jeck et al., 2013). As some endonucle-
ases are known to cleave close to RNA ends, they are also affected by circularisation.
For example, in E. coli, the rapid RNA turnover – the average RNA half-life is about
5 minutes (Selinger et al., 2003; Chen et al., 2015) – is mostly due to degradation
by RNase E (Mackie, 2000). Although an endonuclease, it has higher affinity for
RNAs with monophosphorylated 5’ ends. Dephosphorylation of newly transcribed
tri-phosphorylated RNA is undertaken by the RppH protein, which tags it for subse-
quent degradation by RNase E (Deana et al., 2008). As a result, RNA circularisation
can result in stabilisation (Mackie, 2000). circRNA transcripts have also been found
to have an increased half-life compared to their corresponding linear transcripts in
human cells (Enuka et al., 2015). Aside from increased resistance to nucleases, the
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increased thermal stability that results from the joining of the ends has also been put
forward as a possible advantage of having circular RNA. This might be important in
thermophilic archaea, where several types of circular RNAs have been found (Danan
et al., 2012).
2.1.3 RNA circularisation
RNA circles can be generated either through RNA back-splicing, when the acceptor
splice site is situated upstream of the donor splice site (Zhang et al., 2016), or by liga-
tion of RNA ends by an RNA ligase (Petkovic and Müller, 2015). A relatively simple way
of generating artificial circular RNAs is to use self-splicing group I intron ribozymes,
through the reorganisation of their sequence by a circular permutation (Puttaraju and
Been, 1992). In this case the dispensable P6 loop of a T4 bacteriophage td gene, which
contains a self-splicing group 1 intron, is removed, and the exons are joined together
(see fig. 2.3). This results in a back-splicing reaction and the circularisation of the
exons. Additional sequences can be inserted between the two exons of the permuted
intron-exon (PIE) ribozyme, which results in their inclusion within the processed
circRNA (Perriman and Ares, 1998; Umekage and Kikuchi, 2009).
2.1.4 Methods for detection of circularity
There are a number of methods used to detect circular RNA, reviewed by Jeck and
Sharpless (2014, also see fig. 2.1). Divergent primer RT-PCR can detect circRNAs, as
the splicing reaction reorders the primer binding sites into convergent orientations
(see fig.2.1A). 2D gel electrophoresis and gel trapping are biochemical methods for
detection of circular topology. The former separates the RNA in denaturing conditions,
with different acrylamide concentration in each dimension. The migration speed
changes linearly with acrylamide concentration, but the slope of this linear change is
different for linear and circular RNAs. Linear RNAs thus appear along a diagonal on
the 2D gel, whereas circular RNAs appear outside of it (fig. 2.1B). Gel trapping relies
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on the mixing of RNA with melted agarose, which traps circular molecules during
polymerisation. Linear molecules migrate normally, but circular molecules stay in
the trap (fig. 2.1C). Exonucleases such as RNase R can also be used to degrade linear
RNA, and have been used in combination with deep sequencing for high throughput
circRNA detection (Jeck et al., 2013, see fig. 2.1D.).
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5’ 3’
PCR with divergent primers
Product if sequences reordered
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5%
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AM
5% PAM
Linear RNAs 
along diagonal
Circular RNA
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RNA loaded in 
melted agarose 
Cross-linking 
traps nonlinear 
RNA
Circular RNA 
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Linear RNA 
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Exonuclease 
digestion
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Figure 2.1 – Methods for detecting circRNA. A: Divergent primer PCR. Reorganisation
of exons after ligation replaces primers in convergent orientation, allowing PCR am-
plification. B. 2D polyacrylamide (PAM) gel electrophoresis. Linear RNAs migrate
along a diagonal. CircRNAs appear outside as they migrate more slowly in highly
cross linked gels. C. Gel trap elecrophoresis. Non-linear RNAs are trapped by cross
linking. D. Exonuclease such as RNase R selectively degrade linear RNA. They can be
combined with next generation sequencing for high throughput circRNA detection.
Figure adapted from Jeck and Sharpless (2014).
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2.2 Results
2.2.1 Design of a circular riboregulator
The prevalence of circular RNAs in nature suggests that this topology may be ad-
vantageous in certain conditions. Several natural circular RNAs function as cellular
regulators. Artificial circular RNAs have been produced before (Been, 1996), some-
times with a cargo included (Umekage and Kikuchi, 2009), but never as functional
parts in vivo. Since circularisation may bring advantages such as increased thermal
stability and resistance to nucleases, or simply cause different behaviour than lin-
ear RNAs within cells, it may be interesting to make use of circularised RNAs within
synthetic circuits. To determine whether circular RNAs can be used as components
of riboregulatory circuits, a group I self-splicing ribozyme from bacteriophage T4
with permuted introns and exons (PIE ribozyme) was used to produce circular ri-
boregulators. The ability of the PIE ribozyme to produce circular RNAs was tested,
and the effectiveness of the resulting circular RNA at activating translation from two
cis-repressed mRNAs was assayed. To determine whether this is a generalisable pro-
cedure, a series of circular riboregulators were also constructed, and their ability to
activate cis-repressed mRNAs compared with their linear counterparts.
To test the feasibility of using PIE ribozymes to create circular riboregulators, a previ-
ously described small RNA, taRAJ31, was used as a starting point. taRAJ31 interacts
with its target through a loop-loop interaction (Rodrigo et al., 2012, see fig. 2.2), as its
hybridisation region is contained in a large loop at the end of a stem. The scaffold
stem of taRAJ31, which is 37 bp long, was shortened to 9 bp, yielding taRAJ31min,
which was inserted within a PIE ribozyme derived from the t4 bacteriophage td gene
self-splicing intron (Puttaraju and Been, 1992; Umekage et al., 2012).
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Figure 2.2 – Secondary structure of the computationally designed taRAJ31 system
(Rodrigo et al., 2012), folded in NUPACK with energy parameters from Serra and
Turner (1995) A: Structure of taRAJ31. Green bases indicate the stem that serves as
scaffold. Cyan: Hybridisation region with the cis-repressed mRNA. Blue: Toehold.
Red: RrnC terminator. B: Secondary structure of cisRAJ31 5’UTR and first 30 bases
of sfGFP. Cyan: Hybridisation region. Blue: Toehold. Violet: RBS. Orange: Coding
sequence.
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Figure 2.3 – Wild type and PIE Group 1 self-splicing ribozymes derived from the T4 td
gene. A: Arrangement of the WT ribozyme at the DNA level.
B. RNA 2D structure of the WT intron, with the dispensable P6 loop in green. The
splicing reaction takes place through two sequential trans-esterifications, starting
with a nucleophillic attack on the indicated U. The C873U mutation greatly reduces
splicing efficiency. C: Arrangement of PIE ribozyme at the DNA level. The gene starts
with intron 2, exon 2, then exon 1 and intron 1. Cargo (here, taRAJ31min) can be
inserted between the exons. D: Structure of the PIE intron, with the taRAJ31min
riboregulator inserted as a cargo (dark blue). As the RNA splices and ligates at the
same place despite the circular permutation, the taRAJ31min riboregulator becomes
circularised. 2D structures were adapted from Been (1996).
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The resulting sequence, circRAJ31, was inserted downstream of a PL-tet promoter for in-
ducible control of expression with anhydrotetracycline (aTc). It was synthesised, and
co-transformed into E. coli MG1655-Z1 cells, along with cisRAJ31-GFP, the cognate
cis-repressed GFP (Rodrigo et al., 2012). The transcription of cisRAJ31 is controlled
by a PL-Lac promoter, which is inducible by IPTG. MG1655-Z1 cells contain a Z1 cas-
sette integrated onto their chromosome (Lutz and Bujard, 1997), which overexpresses
the LacI and TetR repressors, thus allowing a tight control of transcription of genes
expressed from PL-Lac and PL-tet using IPTG and aTc, respectively. To test whether
co-expression of the circularising version of taRAJ31 could regulate translation of
cisRAJ31-GFP, the cells containing both plasmids were grown with different inducer
combinations, and their ODλ= 600 and green fluorescence was measured during ex-
ponential growth in a plate reading fluorometer. Cells grown with both IPTG and
aTc, which induce cisRAJ31-GFP and circRAJ31, respectively, showed a ~2 fold in-
crease in fluorescence than cells grown in IPTG alone (see fig. 2.4), indicating that
circRAJ31 could activate translation of the cis-repressed mRNA. Although the cells
showed low fluorescence in the absence of inducers or in the presence of aTc alone,
cells induced with IPTG also showed an increase in fluorescence, about 7 times that of
uninduced cells. This fluorescence increase in presence of cr-mRNA alone suggests
leakiness of the cis-repressing 5’ UTR, whereas the further increase in fluorescence
when both cisRAJ31-GFP and circRAJ31 are transcribed indicated that circRAJ31 may
be a functional riboregulator in vivo.
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Figure 2.4 – Activation of cisRAJ31-GFP by circRAJ31. A. Circuit used. aTc (100 µg/mL)
induces circRAJ31 transcription. IPTG (1 mM) induces cr-mRNA transcription. B. GFP
fluorescence of E. coli MG1655-Z1 cells containing both cisRAJ31-GFP and circRAJ31,
with different inducer combinations. Error bars represent standard deviation of three
biological replicates.
2.2.2 In vitro RNA circularisation
RT-PCR and sequencing in vitro produced RNA
The ability of circRAJ31 to produce circular RNA despite the addition of the cargo was
then tested. As a splicing deficient control, a C873U mutant (Belfort et al., 1987), which
has very low splicing splicing efficiency (1.5% of wild type according to Brion et al.
(1999)) was constructed, referred to as circRAJ31C873U. Initially, both circRAJ31 and
circRAJ31C873U were cloned downstream of a pT7 promoter, yielding pT7-circRAJ31
pT7-circRAJ31C873U, and used to produce RNA in vitro. After RNA extraction, an RT-
PCR using divergent primers was run. Divergent primers only lead to amplification
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if a splicing event changes the orientation of the target sites (Jeck and Sharpless,
2014). The products were run on a 2% agarose gel (see fig. 2.5). The PCR products
from circRAJ31 separated into a fragment of the expected size (111 bp), as well as
a ~222 bp band. A very faint ~333 bp band was also present on the gel. Samples
from circRAJ31C873U separated into a faint 111 bp band and an approximately 300
bp band. No RT controls did not lead to any amplification, a faint primer dimer
band is visible on the gel. The 111 bp band confirmed the splicing of the RNA was
taking place, changing the direction of the primer binding regions to a convergent
orientation. The 222 bp and 333 bp bands correspond to concatamers generated
during the RT step, as the reverse transcriptase repeatedly transcribes around the
circular RNA template, until its RNase H domain eventually cleaves the RNA. The lanes
from the circRAJ31C873U also contain a 111 bp band, suggesting that some splicing
takes place despite the C873U mutation, and this sample also generates circular RNA.
It also contains a ~300 bp band that does not fit the size of a concatamer, and is due to
a mis-splicing event (see section 2.2.2 and fig. 2.7).
100bp 
600bp 
222bp concatamer 
111bp 
RT: + + - + + - 
circRAJ31 circRAJ31C873U
LL
Figure 2.5 – 2% agarose gel of RT-PCR product of circRAJ31 or splicing-deficient
mutant. L: Invitrogen 100 bp ladder. +: RT-PCR products of labelled samples (two
repeats of RT-PCR in same conditions). -: no RT control.
Sequencing of RT-PCR products
To confirm that the splicing reaction ligated the exons at the expected site, and to
investigate the nature of the unexpected bands, the obtained PCR products were
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sequenced (see fig. 2.6). The sequencing of the circRAJ31 RT-PCR product confirmed
the ligation site of the splicing reaction, as well as the presence of concatamers that
result from the RT reaction on a circular template.
Chomatogram
Annotation
Sequence
Base reads
Ligation site
Figure 2.6 – Theoretical sequence of circularised circRAJ31, showing the ligation site
between the two exons, aligned with the Sanger sequencing chromatogram of the
RT-PCR products shown in Figure 2.5. The first bases are too close to the sequencing
primer to be readable.
The sequencing chromatogram of the unexpected 300 bp RT-PCR product did not align
with the theoretical sequence of the 111 bp circular RNA, nor with the circRAJ31 DNA.
Further analysis revealed that the sequences that correspond to both exons, as well as
the reverse complement of intron 1, were present. The intron 1 is located at the 5’ of
the exons, which normally adjacent to intro 2 in the PIE configuration. 5 out of 6 bases
of the XbaI restriction site that is present just after the promoter of the PIE ribozyme
are also present on the mis-spliced, just before exon td 5’. A putative 283 bp long
sequence, starting with taRAJ31min, followed by the 3’ exon and 3’ intron, followed
by the 5’ exon and the rest of taRAJ31min, finishing with the circRT-fw primer, aligns
well with the chromatogram trace after 90 bases (see fig. 2.7). This fragment could be
generated by a mis-splicing event, where the second step of the group I intron ligation
reaction attacks the wrong part of the sequence, resulting in the ligation of the exon
with a part of the intron at the 5’ of the RNA. Mis-splicing events are known to happen
at low frequencies when the ribozyme structure is destabilised, causing cryptic splice
sites to be activated and the generation of alternative splice products (Chandry and
Belfort, 1987). A cryptic splice site was found to be present in intron 2, at the 5’ of the
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PIE ribozyme, with the spurious splice product only present with the C873U mutation.
This sequencing result suggests that the C873U mutation destabilised the ribozyme,
but without disrupting it entirely – with some splicing still detectable – and whilst also
causing some mis-splicing reactions due to the destabilised ribozyme structure.
A
Dispensable!
P6 loop!
5’!
3’!
A!
C873U mutation!
Site of initial cleavage !
5’! 3’!
RAJ31!
D!
trans-activation and 
protein translation!
Ribosome!
Loop-loop interaction!
circular riboregulator!
cis-repressed mRNA!
B!
PIE ribozyme! Split introns! Circular exons with 
riboregulator!
Group 1 ribozyme!
Ligated exons!
Linear introns!
C!
Ex. 1! Ex. 2!Int. 1! Int. 2!
Int. 2! Ex. 2!
Riboregulator!
Ex. 1! Int. 1!
RBS!
Self-splicing!
Self-splicing!
C873U mutation
Original splice site
Exon 2
Exon 1
Intron 2
Intron 1
Primer binding site
Correct splicing
Mis-splicing
B
Figure 2.7 – A: Alignment of the sequencing chromatogram of the RT-PCR with the
putative sequence that would result from the mis-splicing. B: Mis-splicing event
where intron 2 attacks the splice site.
2.2.3 In vivo RNA circularisation
With the confirmation that the introduction of the taRAJ31min riboregulator between
the two exons of a PIE ribozyme led to the generation of a circular RNA containing the
riboregulator, and the establishment of a method to detect the circular RNA, total RNA
was extracted from E. coli expressing either circRAJ31 or circRAJ31C873U. The RT-PCR
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was repeated with both convergent PCR primers (to detect the unspliced RNA) and
divergent primers (to detect the circular RNA, see fig. 2.8). A band of ~111 bp is seen in
both cases with primers designed to amplify the linear RNA, but only in samples from
circRAJ31 when divergent primers were used. The approximately 300 bp band from
the mis-splicing event detected from in vitro transcribed samples was not visible. PCR
products were sequenced, confirming the reorientation of exons and the correct splice
site in circRAJ31 samples, as in fig. 2.6. Amplicons from the linear samples showed the
presence of the introns. The PCR product from circRAJ31C873U after amplification with
divergent primers was sequenced, even though no product was visible on the gel, and
did not yield a readable chromatogram. Neither the circular RNA or the mis-spliced
RNA that were detected after in vitro expression were detectable when the procedure
was carried out with RNA produced in E. coli.
circRAJ31 circRAJ31C873U
circRAJ31
1
100bp
500bp
Linear 
isoform
Circular
isoform 
100bp
500bp
100bp
500bp
100bp
500bp
2 3 4 1 2 3 4
1 2 3 4 1 2 3 4
circRAJ31C873U
Figure 2.8 – Agarose gels of RT-PCR of E. coli total RNA, expressing either circRAJ31
or circRAJ31C873U. RNA was extracted from E. coli expressing either circRAJ31 (left
column) or circRAJ31C873U (right column), and the PCR was carried out using either
convergent primers specific to the unspliced product (top row) or divergent primers
specific to the circular product (bottom row).
2.2.4 Splicing is required for circRAJ31 activation of translation
To reduce the background of GFP that is visible with untagged GFP, an LAA degradation
tag (Keiler et al., 1996) was added to its C terminus. The LAA peptide tags the protein
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for degradation by the ClpX protease machinery, significantly shortening its half-
life (Andersen et al., 1998). The ability of circRAJ31 and circRAJ31C873U to activate
translation of cisRAJ31-GFP-LAA was then compared. As the unspliced RNA also
contains the taRAJ31min sequence, unspliced RNA products may also activate cis-
repressed mRNAs if the hybridisation sequence is solvent exposed and able to bind
the cr-mRNA target. DH5α cells containing cisRAJ31-GFP-LAA and either circRAJ31 or
circRAJ31C873U were grown in a fluorometer in the presence or absence of IPTG and
aTc for induction of cis-repressed mRNA and of the riboregulator, respectively, and
their fluorescence during exponential phase measured (see fig. 2.9A). In the absence
of inducers, or in the presence of a single inducer, fluorescence was low for both
constructs. In the presence of both aTc and IPTG, the fluorescence of cells containing
the circular riboregulator and cr-mRNA was about 22 times that of cells induced
with IPTG alone, whereas expression of circRAJ31C873U only increased fluorescence
by about 2 fold. This suggests that the splicing is required for efficient activation
of cisRAJ13, and therefore that translational regulation by a circular riboregulator is
possible (see fig. 2.9B). To confirm that circRAJ31 was activating translation through a
toehold-initiated base pairing mechanism, a mutant with 4 mutations in the toehold
binding region of circRAJ31 was constructed, called circRAJ31Toe. These mutations
completely abolished GFP activation (see fig. 2.9C), confirming the importance of the
toehold region.
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Figure 2.9 – Activation of cis-repressed GFP by circRAJ31. A. Circuit used. B: Flu-
orescence of E. coli DH5α containing cisRAJ31-GFP-LAA and either circRAJ31 or
circRAJ31C873U, with different inducer combinations indicated on the x axis. C. Fluo-
rescence of cells containing cisRAJ31-GFP-LAA and either circRAJ31 or circRAJ31Toe,
with different inducer combinations indicated on the x axis. circRAJ31, circRAJ31C873U,
circRAJ31Toe are under the control of an aTc inducible promoter, cisRAJ31-GFP-LAA is
under the control of an IPTG inducible promoter. Error bars represent the standard de-
viation of three biological replicates. IPTG concentration: 250 µM, aTc concentration:
100 ng/mL.
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2.2.5 Circular riboregulator can control antibiotic resistance gene
expression
To test the possibility of using an antibiotic resistance marker to select improved
versions of the circular riboregulator, or to create new ones, the cat gene was cloned
downstream of the cisRAJ31 5’ UTR, generating cisRAJ31-cat. cisRAJ31-cat and either
circRAJ31 or circRAJ31C873U were co-transformed in E. coli DH5α cells, then plated on
agar plates prepared with different combinations of inducers and antibiotics. Control
plates did not contain any chloramphenicol, whereas others contained chlorampheni-
col and either no inducers, aTc, IPTG, or aTc and IPTG. At IPTG concentrations of
250 µM and/or aTc concentrations of 100 ng/mL, cells containing circRAJ31 and
cisRAJ31-cat only grew on plates containing both IPTG and aTc (see fig. 2.10). At
higher concentrations of IPTG or with longer growth times, colonies also grew on
IPTG-containing plates, which suggests leakiness of the cis-repressing UTR when
controlling the cat gene.
No 
chlor
No 
inducers
aTc IPTG aTc
+
IPTG
Figure 2.10 – CFU per mL of E. coli DH5α cells transformed with circRAJ31 and
cisRAJ31-cat on agar plates containing chlorampenicol (chlor) and different inducers.
IPTG and aTc control induction of cisRAJ31-cat and circRAJ31, respectively. IPTG:
250 µM, aTc: 100 ng/mL.
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The cis-repressed cat gene can also be controlled by circRAJ31 in liquid culture. E. coli
DH5α cells containing this circuit grow faster in LB containing chloramphenicol if
IPTG and aTc are also present (see fig. 2.11). However, this is only the case at certain
concentrations of chloramphenicol. In LB containing 35 µg/mL of chloramphenicol,
samples containing IPTG grow at the same speed as samples containing both IPTG
and aTc. At high concentrations (70 µg/mL), samples where circRAJ31 is induced by
aTc grow faster than uninduced samples (see fig. 2.11).
A
B
35 µg/mL chlor.
70 µg/mL chlor.
0
0.2
0.4
0.6
0.8
1
0 5 10 15 20 25
OD
60
0
Time (hours)
0
0.2
0.4
0.6
0.8
1
0 5 10 15 20 25
OD
60
0
Time (hours)
Legend:
Shapes:
circRAJ31
circRAJ31C873U
Colours:
No Chlor
Chlor, No inducers
Chlor, IPTG
Chlor, aTc
Chlor, IPTG + aTc
Figure 2.11 – Liquid cultures of E. coli DH5α in M9 containing different concentrations
of chloramphenicol and inducers. A: 35 µg/mL chloramphenicol. B: 70 µg/mL chlo-
ramphenicol. Triangles show circRAJ31 samples, rectangles circRAJ31C873U samples.
Colour codes show inducer combinations (IPTG, 250 µM, and aTc, 100 ng/µL). Error
bars represent standard deviation of three biological replicates.
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2.2.6 Comparison of circRAJ31 with a linear version
To investigate how the circular riboregulator compared to a linear one for trans-
activation, the linear equivalent of circRAJ31 (taRAJ31min) was synthesised and cloned
into the same plasmid as circRAJ31. taRAJ31min was found to be a better activator of
cisRAJ31-GFP-LAA, with a 65% higher level of fluorescence over ODλ= 600(see fig.2.12).
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Figure 2.12 – Fluorescence of E. coli DH5α cells with cisRAJ31 under the control of an
IPTG inducible promoter, and either circRAJ31, circRAJ31C873U or taRAJ31min, under
the control of an aTc inducible promoter. IPTG: 250 µM, aTc: 100 ng/ µL . Error bars
represent standard deviation of three biological replicates.
2.2.7 Engineering new cis-repressed mRNAs
Although circRAJ31 and taRAJ31min could activate translation of the cisRAJ31 mRNA,
the relative difference between samples expressing mRNA alone and those co-expressing
the mRNA and circRNA activator remained lower than some published RNA regu-
lators (Green et al., 2014). Growth of samples expressing cis-repressed cat without
any RNA activator suggested that the cis31 cr-mRNA structure was leaky. To improve
this, new cis-repressed RNAs were constructed according to new design rules (Green
et al., 2014). New cis-repressed messenger RNAs that can be activated by circRAJ31
according to new secondary structure rules were first designed using a custom NU-
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Figure 2.13 – Design of reverse engineered cis-repressed mRNAs using a design goal
based on (Green et al., 2014) and evaluated using the sRNA calculator (Borujeni and
Salis, 2011).
PACK script (Dirks et al., 2004; Zadeh et al., 2011; Wolfe and Pierce, 2014). The new
design goal included a long single stranded toehold at the 5’, an exposed RBS in a loop,
but with strong secondary structure around the start codon (see fig. 2.13 for exact
structural constraints). As the RAJ31min hybridisation sequence is longer than that of
the trigger RNAs (31 vs 25), two alternative designs were made: One with an extended
21 nt toehold, and one with a 15 nt toehold, the same as normal toehold switches. The
10 best design sequences were curated to remove those that contained stop codons
in the coding sequence, then were evaluated using the alpha version of the Salis lab
sRNA calculator available on the Salis lab website (Borujeni and Salis, 2011). The sRNA
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calculator is a variant of the RBS calculator (Salis et al., 2009), and predicts changes in
translation initiation rate of an mRNA 5’ UTR after sRNA binding. The highest scoring
sequence for each design were named Nusl_3 (with a 21 nt toehold) and Nusl_6 (15 nt
toehold). They were synthesised, co-transformed into E. coli cells and characterised in
the presence of circRAJ31, circRAJ31C873U and the linear taRAJ31min. The newly RAJ31
activated cr-mRNAs showed no significant activation in the presence of circRAJ31.
However, the increase in fluorescence in the presence of both Nusl_3 and Nusl_6
by taRAJ31min was high (approximately 10 fold and 32 fold, for Nusl_3 and Nusl_6,
respectively – see fig. 2.14).
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Figure 2.14 – Fluorescence of E. coli DH5α cells expressing a circRAJ31, or taRAJ31min,
and 2 variants of cis-repressing 5’ UTRs reverse-engineered to be activated by RAJ31,
according to the Green et al. (2014) design rules. A: Nusl3 and B: Nusl6. Error bars
represent standard deviation of three biological replicates.
2.2.8 New circular riboregulators
The circRAJ31 riboregulator was found to be effectively circularised by the PIE ri-
bozyme, although it had a marginally lower activation fold than taRAJ31min. To
find out whether PIE circularisation is a generalisable strategy for circularising ri-
boregulators, and to further investigate the differences of circular riboregulators with
their linear counterparts, 5 more variants of circular riboregulators were designed
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and synthesised, and tested against their corresponding cis-repressed mRNAs. The
new circular riboregulators were engineered to activate previously described ’toe-
hold switch’ cr-mRNAs (Green et al., 2014). They all contain the same circularising
ribozyme sequence as circRAJ31, but each has a different hybridisation region inserted
between the exons (the hybridisation region corresponds to the "cargo" in figure 2.3D,
sequences are given in appendix B). For each regulator, a C873U splicing mutant and
a linear riboregulator was generated to compare their activity (see fig. 2.15). Riboregu-
lators circRAG1v1, circRAG1v2, circRAG2v2 and circRAG4v1 were found to increase
fluorescence of their cognate cis-repressed mRNAs.
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Figure 2.15 – Fluorescence of E. coli DH5 α cells expressing cis-repressing 5’ UTRs, and
their cognate riboregulators. UTRs used are indicated in the title of each graph. Blue:
circRAJ31, Red: Non-splicing C873U mutants. Yellow: linear versions from (Green
et al., 2014). Error bars represent standard deviation of three biological replicates.
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However, the circular regulators never activated translation better than their linear
counterparts. The fluorescence of cells expressing the riboregulators circRAG1v1,
circRAG1v2 and circRAG2v2 was much lower than that of cells expressing their linear
counterparts. Like circRAJ31 and taRAJ31min, circRAG4v1 and RAG4 have similar
activation folds. In the case of RAG5v1 regulators, the circular regulator was not found
to activate translation and the linear regulator had a marginal activation fold of ~2
fold. The calculated activation folds for all parts are shown in figure 2.16.
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Figure 2.16 – Apparent activation folds of cis-repressed GFP mRNAs (indicated on the
x axis) by linear versions (yellow) or circular versions (blue) of riboregulators. Two
different versions of circRAG1 were tested. Values were calculated by dividing fluores-
cence values when both activator and cis-repressed mRNA are induced, compared
those when the cr-mRNA is alone. Error bars represent standard deviation of three
biological replicates.
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2.3 Discussion
2.3.1 PIE ribozymes for synthetic regulatory circRNA production
The incorporation of riboregulators within PIE group I ribozymes enabled the genera-
tion of circular sRNA regulators. The ribozymes splice correctly despite the addition
of a sRNA cargo between the exon sequences, and can be used to produce circular
sRNAs in vivo as well as in vitro. In 4 out of the 5 cases tested, the introduction of the
cargo did not impede circularisation, which was either observed directly, or indirectly
through the introduction of the C873U mutation, which disrupts ribozyme functional-
ity. This mutation reduced or abolished riboregulator activity. RNA-RNA interactions,
including those involving natural circular RNAs, are known to interact through base
pairing. However, for riboregulators to be effective, they need to be present in suffi-
cient quantities to activate their cognate 5’ UTR targets. The low splicing efficiency
of some ribozymes had been noted (Olson and Müller, 2012), but our results show
that PIE group I intron ribozymes can produce enough circRNAs to be used as in vivo
regulators of gene expression. Circular riboregulators were able to regulate translation
from various cis-repressed 5’ UTRs, for two different cis-repressed mRNAs coding for
a fluorescent protein and for an antibiotic resistance gene. Mutations in the ’toehold’
loop region of circRAJ31 abolished riboregulator activity, suggesting that like natural
riboregulators, our circular riboregulator initially interacts with its target through
base pairing of solvent exposed regions. Circular riboregulators, like linear ones, then
modify the 2D structure of their target cis-repressed mRNA 5’ UTRs in vivo, and can be
incorporated as actuator parts in synthetic RNA circuits. PIE ribozyme circularisation
is easy to achieve and is an effective method to produce circular riboregulators in vivo.
To our knowledge, this is the first example of a synthetic circular sRNA regulator being
used to regulate gene expression in living cells.
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2.3.2 Advantages and drawbacks of PIE circularisation
Generation of PIE-ribozyme circularised RNAs is extremely straightforward as it sim-
ply requires inclusion of the desired sequence between the two exons of the sequence.
Out of 6 PIE ribozyme encased riboregulators tested, 5 were more active than the
non-splicing mutant used as a control, supporting the case that PIE effectively cir-
cularises these riboregulators and allows them to interact with their targets. The 6th
(circRAG5v1) was not more active than its non-splicing control. However, its linear
equivalent linRAG5 only had a marginal activation fold of 2.3, compared to ~450 when
tested by Green et al. (2014), albeit in a different genetic context. This suggests that
cisRAG5 is not a good target for riboregulators in this genetic context, and does not
give us any information on whether circRAG5 is circularised or not. The PIE ribozyme
method has also been used by others for producing various kinds of circular RNAs.
Perriman and Ares (1998) used it to create circularised mRNA in vivo, and Umekage
and Kikuchi (2009) to create large amounts of circular aptamers for purification. The
production of synthetic circular riboregulators extends this list, and suggests that PIE
ribozyme circularisation is a robust method for producing many different synthetic
circular RNA in vivo, despite the addition of various ’cargo’ between the two exons.
It is possible however that certain sequences would disrupt ribozyme activity and thus
RNA circularisation. For example, a cargo which has strong homology to the ribozyme
sequence may disrupt its secondary structure, and thus the formation of the catalytic
core, blocking circRNA production. In these cases, a simple potential solution would
be to circularise said sequences using a PIE ribozyme from another organism, such as
Tetrahymena. Many group I self-splicing introns have been identified, and they show
little conservation at the sequence level (Nielsen and Johansen, 2009), even though
they have conserved secondary structure. It should therefore be possible to find a
group I intron without homology to the cargo and circularise such sequences in this
way. Other methods for circularising RNA, such as via an RNA ligase (Englert and
Beier, 2005; Petkovic and Müller, 2015), could also be used, although it is unknown
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whether they will produce sufficient quantities of circRNA for them to be used as
regulators.
2.3.3 Activation of translation by unspliced RNA
It is noteworthy that several C873U mutants also activated translation of cis-repressed
mRNA. Circularisation is therefore not required for activity of these parts, which is to
be expected as previously published riboregulators are linear. Rather, low activation
by non-splicing mutants may be due to inaccessibility of the hybridisation region of
the unspliced PIE-riboregulator RNA, as can be the case when cis-repressed UTRs
interact with mRNAs (Green et al., 2014). The ribozyme is a large molecule (383 bp)
compared to the the spliced riboregulator (111 bp), and has strong secondary and
tertiary structure, which could interfere with RNA-RNA interactions unless removed.
The fact that circRAG1v2 had a higher activation fold than circRAG1v1, for both
the circularising version and the C873U mutant, tends to support this hypothesis.
The hybridisation regions of both riboregulators are identical, but circRAG1v2 has
a longer stem region than circRAG1v1. This may allow the taRAG1 cargo to extend
out of the ribozyme structure and activate its target even when uncleaved. This is
also supported by the strong activation of both Nusl_3/Nusl_6, and of ’RAG’ toehold
switches, by linear RNAs. The mis-splicing event that is detected in the in vitro
produced samples (but not in vivo) also adds some complexity to using ribozymes
for circular sRNA production. Mis-splicing events are known to occur in destabilised
ribozymes (Chandry and Belfort, 1987), and in this case, a cryptic splice site seems
to have been reactivated by the C873U mutation. The mis-spliced RNA was not
detected in vivo, and mutant had lower activation levels than the functional ribozymes.
However, this mis-splicing event also raises the possibility of other spurious splicing
products being generated at very low levels. Although these rare products would
not be an issue for our assay, they may be for other applications of circular RNA.
Interestingly, it is also through mis-splicing that many natural circRNAs are thought
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to be created, although how many of these are accidental, spurious products and how
many actually play a useful role remains a point of debate (Guo et al., 2014). Another
possibility for higher activity of circRAJ31 versus circRAJ31C873U is that the circular
products accumulate to higher levels in the cells than the linear, splicing deficient
mutant. Circular RNA is known to have high stability in E. coli cells (Mackie, 2000).
Even if this is not an advantage in this context of fast growing E. coli cells, which are
characterised during exponential growth phase, it may be interesting in other cases,
discussed further on.
2.3.4 Differences between linear and circular RNA
In all cases, the circular versions of the riboregulators had similar or lower activation
folds than their linear counterparts, and inclusion within a PIE ribozyme for circulari-
sation did not increase the activation fold of the riboregulators tested. This could be
due to a relatively low splicing efficiency of the riboregulators in this context, leading
to most RNA remaining unspliced, or to the circular RNA being less effective in regulat-
ing cis-repressed mRNA. Although the goal of this project was to determine whether
circular RNAs could be used in bacteria, testing purified circular riboregulators in
vitro, for example in a transcription-translation cell free system (Sun et al., 2013),
would help our understanding of the differences when using circular rather than
linear RNA parts. Lower activation folds in vitro at identical activating riboregulator
concentrations would suggest that the constraints brought by circularisation impede
interaction with cr-mRNAs. Similar or higher activation by circRNAs would suggest
that the lower in vivo levels seen might be due to low splicing efficiency or differences
in stability, which were not determined in this work.
2.3.5 Design rules for synthetic circRNAs
Regardless of the lower activation fold by circular RNAs, it is clear from these results
that the design rules used to produce linear taRNA/cr-mRNA couples cannot be
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used directly with circular regulators. The Nusl3 and Nusl6 cr-mRNAs (fig. 2.14),
that were reverse-engineered to be activated by taRAJ31min according to the design
rules of Green et al. (2014), showed a large increase in fluorescence in the presence
of taRAJ31min, but none by circRAJ31, even though both RNAs contain the same
hybridisation sequence. The originally tested cisRAJ31 cr-mRNA, designed by Rodrigo
et al. (2012), has the same hybridisation region but a different 2D structure, and is
activated by both the linear and circular versions of RAJ31. The circRAG4 regulator
also had a similar activation fold as linRAG4, whereas linRAG2 and linRAG1 had much
higher activation folds than circRAG2 and circRAG1, respectively. Although these
experiments are too few to determine what structure of cr-mRNA would interact
better with circRNAs, new rules could be determined if a larger number of cr-mRNA
structures were tested. Nonetheless, some the rules for riboregulator design remain
valid. The mutation in the toehold totally abolished circRAJ31 activation of cisRAJ31,
despite 34 bases of complete homology between the taRNA and the cr-mRNA target,
showing that the solvent exposed toehold loop of the cr-mRNA is an important region
for the interaction between RNAs and comforting the hypothesis that hybridisation is
established through solvent exposed regions of the RNAs. In the case of RAJ31, this
is through a kissing loop interaction, whereas for the RAG series of regulators, the
toehold of the cr-mRNA is in the solvent exposed 5’ linear region.
2.3.6 circRNA containing circuits and RNA structure prediction
All of the linear versions of these riboregulators were computationally designed using
2D RNA folding models. The circular RNAs on the other hand were simply made
by incorporating the hybridisation region of the previously designed riboregulators
within the PIE ribozyme. One major disadvantage of circular RNA parts is that they
cannot be easily incorporated within these computational design pipelines using
current RNA folding algorithms. This is due to two related reasons. The first is that RNA
co-folding software actually calculates the MFE structure of a single strand of RNA,
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made by concatenating the two RNA sequences, and removing some of the constraints
at the junction of the two RNAs. This is in turn due to the second reason, which is
that RNA folding software assumes the absence of pseudoknots (see section 1.0.3). As
circularity of one of the RNAs implies the formation of some kind of pseudoknot for
interaction, they cannot be handled by current software.
2.3.7 Advantages of circRNA for synthetic Biology
One interesting point is that circular RNA causes a constraint on folding (Lasda and
Parker, 2014). Forcing the 5’ and 3’ ends to be close to each other could force proper
folding of an RNA structure that would not fold on a linear strand. This circular-
ity constraint may be responsible for the reduced activity of some of the circular
riboregulators described here, as it may interfere with the formation of a stable taRNA-
cr-mRNA complex. It could nonetheless be beneficial in other contexts, and further
work is required to understand how these constraints influence the interaction of
circRNA regulators with their targets. Asides from the introduction of topological
constraints, the most notable difference between linear and circular RNAs that could
be of use for synthetic biologists is a difference in stability. Circular RNAs have been
shown to be more stable than linear ones in bacteria like E. coli (Mackie, 2000), as well
as in humans (Enuka et al., 2015), presumably due to their resistance to exonucleolytic
degradation (Jeck and Sharpless, 2014; Chen, 2016b). This may not be so advanta-
geous for riboregulator circuits in this context of fast growing cells, were the RNAs are
expressed from strong promoters, which could allow both linear and circular RNAs
to saturate the system. It could however be useful in other contexts. For example, if
circRNAs are indeed more stable, they might be used as slow responding regulators, to
dampen transcriptional outbursts from other regulators, similarly to their presumed
role as ’RNA sponges’ in human cells. The increased thermal stability of at least some
circRNAs (Abe et al., 2007) may also be useful for using RNA circuits in vitro at high
temperature, or in thermophilic organisms (Danan et al., 2012), provided a ribozyme
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that can function at high temperatures is used.
2.3.8 Using circRNA in other organisms
Whether PIE circularisation would work in thermophiles remains to be seen. However,
the autocatalytic nature of group I introns is propitious to their portability across
organisms. PIE ribozymes have been shown to work in yeast (Ford and Ares, 1994),
and group I introns exist in many other organisms. The possibility that they work in
humans would allow potential medical uses. Although PIE ribozymes have rarely been
used and have not been shown to work in organisms other than E. coli and S. cerevisiae,
other group I self-splicing introns derived from T. thermophila are functional in
human cells (Watanabe and Sullenger, 2000; Fiskaa and Birgisdottir, 2010a), which is
an encouraging sign that perhaps PIE-circularised synthetic circRNAs could also be
made.
2.3.9 Conclusion
Overall, we found that circular riboregulators can be produced by the PIE group I
ribozyme method. This method is generalisable to many regulators, and can be used
to control fluorescence or antibiotic resistance genes. Toehold accessibility remains
an important factor for circular riboregulator design, but other design rules for cr-
mRNA design are not valid when using circular rather than linear regulators. The
use of circular molecules did not result in increased activation folds compared to
when using linear riboregulators. An added layer of complexity is also brought by the
self-splicing step, and by the incompatibility of current RNA folding and RNA design
software with the circular topology of these molecules. However, PIE ribozymes are
simple to design and allow easy in vivo circRNA generation. As our understanding of
circRNAs improve, and the contexts in which circularisation is an advantage become
clear, circular riboregulator production via PIE ribozyme circularisation could become
a useful tool for synthetic biologists.
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2.4 Materials and Methods
2.4.1 Sequence design and construction
circRAJ31 was designed based on the the principles described in section 2.2.1, using a
T4 bacteriphage td gene derived group I PIE ribozyme (Sequence supplied by Umekage
and Kikuchi, 2009), and synthesised by Integrated Dna Technologies, Inc (Coralville,
USA). It was supplied in the pIDT-Amp vector, and the BsaI site present in the AmpR
gene was removed by Quikchange mutagenesis. CircRAJ31C873U was generated by
Quikchange site directed mutagenesis PCR according to manufacturer’s instructions,
using primers tdC873U_sense and tdC873U_antisense, whereas circRAJ31Toe was
generated by amplifying the whole vector with primers CircRaj_toe_sense and Cir-
cRaj_toe_asense and re-ligating the PCR product by goldengate. taRAJ31min was con-
structed by amplifying circRAJ31 with wr_cr83 and wr_cr84 and cloning the resulting
product in the EcoRI site and PstI sites of the pIDT-Amp plasmid. pT7-circRAJ31 and
pT7-circRAJ31C873U were expressed from pSB1C3. The cisRAJ31-GFP plasmid was ob-
tained from Rodrigo et al. (2012). It was amplified with GFP_AddLAA_fw/rv and cisR31-
Fw/Rv. The former was goldengate ligated with the annealed LAA_anneal_Fw/Rv and
construct cisRAJ31-GFP-LAA. The latter was goldengate ligated with the cat amplified
from pSB1C3 with GG-CAT-Fw/Rv.
Nusl3, Nusl6 and cisRAG parts were synthesised as Gblocks by IDT and cloned
into pSC101-sfGFP-DB by goldengate. circRAG parts were bought as primers (cir-
cRAG#S and AS) and annealed, then cloned into the PIE ribozyme present in circu-
lar_generic_RFP via goldengate (see appendix A.1).
All riboregulators were produced from high copy plasmids (pMB1 origin of replication).
All cis-repressed genes were expressed from the medium copy plasmid pSB4K5, which
has a pSC101-E93K origin of replication (Peterson and Phillips, 2008).
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2.4.2 RNA production
In vitro
pT7-circRAJ31 and pT7-circRAJ31C873U were used as templates to transcribe RNA
in vitro using the Transcriptaid T7 high yield transcription kit (Life Tech), accord-
ing to manufacturer’s instructions. Briefly, the plasmid containing circRAJ31 and
circRAJ31C873U under control of a T7 promoter were cut with PstI to linearise the plas-
mid, and incubated in the presence of T7 RNA polymerase for 30 minutes to produce
RNA. The RNA was then extracted using acidic (ph 4.5) phenol-chloroform (Ambion)
according to manufacturer’s instructions and precipitated in ethanol in the presence
of 50 µg/mL glycogen (Ambion) and 0.3 M sodium acetate. RNA was treated with
DNAse I (NEB), then phenol chloroform extraction repeated.
In vivo
pT7-circRAJ31 and pT7-circRAJ31C873U were transformed into E. coli BL21(DE3) cells.
Three colonies were grown overnight in LB medium, refreshed by diluting them 1:200
in fresh medium in the presence of 125 µM IPTG and 35 µg/mL chloramphenicol for 4
hours before total RNA extraction. For RNA extraction, 20 mL of cells were spun down,
resuspended in 400 µL TE buffer, disrupted with 0.1 µm glass beads in a cell disrupter
for 5 minutes, then RNA was extracted using acidic phenol-chlorophorm as described
above. Extracted samples were run on a 30% polyacrylamide, 6% urea gel to check for
RNA integrity before the next steps.
2.4.3 RT-PCR
Primer-specific RT was used to reverse transcribe RNA using circRT-Rv, using M-MuLV
reverse transcriptase (Life tech), according to manufacturer’s instructions. RNA was
then degraded by adding 1 µL of 4M NaOH to the 20 µL RT reaction, heating to 95°C
for 3 minutes, then neutralised with 1 µL of 1M HCl. 1 µL of this reaction was used
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as a template for the PCR reaction, which was carried out with GoTaq Green Master
mix (Promega), using primers CircRT-Fw and CircRT-Rv (for detecting the circularised
product), or CircRT-Lin and CircRT-Rv (for detecting the unspliced product). Products
were then run on a 2% agarose gel (2h, 85V) and imaged in a Biometra BioDocAnalyze.
The rest of the PCR product was purified with a PCR cleanup kit (Thermo Scientific),
and sent for sequencing using circRT-Rv as a primer. The chromatograms shown in
figures 2.6 and 2.7 were aligned using SnapGene (GSL Biotech LLC).
2.4.4 Fluorescence measurements
For population fluorescence measurements, single colonies of freshly transformed
cells were grown overnight in LB medium. The next morning, cells were refreshed in
enriched M9 medium (recipe in appendix A, table A.1) by diluting 5µL of culture in
1 mL M9 (1:200 dilution), grown for 6 hours at 37ºC with shaking, then refreshed a
second time by inoculating 5µL in 200µL of M9 in a 96 well plate (Greiner Bio-One 96
well plates, black, transparent bottom), and grown in a TECAN Infinite F-500 plate
reader fluorometer with shaking (2mm, orbital) at 37ºC, with measurements taken
every 15 minutes. Measurements taken were OD600 and GFP (excitation: 465nm,
bandwidth 35nm; emission: 535nm, bandwidth 25nm; gain setting 35). Other TECAN
settings: Z-position height (manual): 22000µM; lag time: 0 µs; multiple reads per well
type: FilledSquare, 2x2, with Well border: 1450µM(for ODλ= 600) and 900µM(for GFP).
For analysis, technical replicates were averaged, values of background substracted,
then points closest to O.D. 0.3 were picked for each biological replicate. Bar charts
show the average GFP/ODλ= 600of biological replicates, error bars represent standard
deviation between biological replicates. For activation fold calculations in figure 2.16,
values of GFP/OD600 with both inducers was divided by GFP/OD600 values with IPTG
alone, for each biological replicate. Standard deviation between biological replicates
shown as error bars in all cases.
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2.4.5 Antibiotic resistance assays
For assays on plates, appropriate plasmids were co-transformed into E. coli DH5α cells
and three single colonies were picked and grown overnight in LB. The next morning,
samples were diluted 1:1000, grown for 2 hours, serially diluted and plated on agar
plates containing ampicillin (100 µg/mL), kanamycin (35 µg/mL), spectinomycin
(100 µg/mL), was well as, if appropriate, chloramphenicol (35 µg/mL), IPTG (250 µM)
and/or aTc (100 ng/mL). Plates were then incubated for 20 hours at 37 °C, colonies
were counted and photos taken. For tests in plates, cells were grown overnight, re-
freshed in M9 medium without inducers, then inoculated into 96 well plates with
inducers and chloramphenicol, as appropriate.
2.4.6 Computational design of parts
Nusl3 and Nusl6 cis-repressed UTRs were designed using the NUPACK design web-
page (Zadeh et al., 2011). The structural specifications described in figure 2.13 were
converted into DU+ notation and automatically designed by the NUPACK webserver.
Options used were: Material : RNA; Temperature : 37°C; 10 trials, sodium: 1M, dan-
gles: some. Prevented patterns: AAAA, CCCC, GGGG, UUUU, KKKKKK, MMMMMM,
RRRRRR, SSSSSS, WWWWWW, YYYYYY. The resulting sequences were manually cu-
rated, and sequences with stop codons in the fusion protein coding region were
discarded. The NUPACK code used for design is given in appendix E.1.
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3 Directed evolution of RNA parts with
bacteriophage
3.1 Introduction
3.1.1 Directed evolution of biological parts
Directed evolution is another method for the engineering of biological parts. In
contrast to rational or computational design, directed evolution relies on the random
modification of DNA or RNA sequences, followed by screening or selection of the
best parts or organisms, through a user-defined process that aims to imitate natural
selection (Lutz, 2011; Packer and Liu, 2015). As this screening or selection process
picks the best-working parts amongst a library, there is usually a need to have a
working part as a starting point, as non-working parts cannot be selected for. If this
is not the case, a working part needs to be created de novo during the first round of
library generation. Computational design, on the other hand, can be used to create
simple working parts de novo. However the models used in computational design are
necessarily simplified and fail to take into account biological complexity. The parts
created may therefore not be optimised for in vivo use. Computational design and
directed evolution can therefore be seen as complementary techniques. The former
can be used for de novo design of parts, whereas the latter use these as a starting
point for further improvement. As directed evolution aims to blindly select the best
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working parts, it can be used for improving parts whose mechanism is not completely
understood, or whose activity cannot be predicted computationally. In the realm of
RNA part engineering, this is the case for ribozymes or other RNAs where tertiary
structure plays an important role. The major disadvantage of directed evolution
is the difficulty in designing a selection process that will favour mutants with the
desired characteristics, rather than "cheaters" that can outcompete other mutants in
an unexpected or undesired way (Raman et al., 2014).
3.1.2 Diversity generation and selection or screening
Directed evolution requires two stages, outlined below: a diversity generation step,
and screening or selection step.
Diversity generation
During the first step, a library of sequences has to be generated. There are many
methods for generating diversity, and this can be done in vitro or in vivo. This can be
done through imprecise replication of a DNA or RNA template, or through the direct
cloning of a synthetic library (Tee and Wong, 2013). Errors could be introduced during
replication by the DNA polymerase, but natural mutation rates are often too low to be
useful in an artificial setting (Badran et al., 2016), so chemical or physical mutagens
are often used to increase this rate. N-methyl-N9-nitro-N-nitrosoguanidine (NG) or
ultraviolet light are common examples (Wong et al., 2006; Labrou, 2010).
Due to the risk involved with the manipulation of these chemicals, biological methods
have been developed to replace them. Again, methods exist for use both in vitro and in
vivo. The use of error-prone DNA polymerases (Söte et al., 2011), or error-prone PCR
conditions if used in vitro, can generate diversity during DNA replication. Another
method is to decrease replication fidelity by using hypermutator strains (Greener et al.,
1997), or mutagenesis-increasing plasmids (Badran and Liu, 2015).
Rather than causing errors during DNA replication, a library of DNA parts can be
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prepared synthetically and introduced through cloning and transformation (Tee and
Wong, 2013) or in vivo recombination with the target (Swers et al., 2004). These library
approaches allow targeted mutagenesis, concentrating diversity generation in one or
a few "mutational hotspots" that are known (or presumed) to be important for part
functionality. This approach has been termed ’semi-rational’ engineering (Lutz, 2011).
Screening or selection
During the second step, the mutagenised library is subjected to a custom selection or
screening process that picks the best performing members of the library. A screening
process consists in analysing each member of the library for functionality, and pick-
ing the best performing members. The details of the process used depends on the
objectives of the directed evolution. The most straightforward screening approaches
directly assay for part functionality, such as product yield in the case of an enzyme
(Coelho et al., 2013). Such an approach is limited by its throughput. To permit the
faster screening of libraries, one solution is to link part functionality with fluorescence.
This can be done by using a surrogate molecule whose reaction with the evolved
gene results in the production of fluorescence (Ostafe et al., 2014), or by using genetic
reporters which produce a fluorescence output that correlates with desired part func-
tionality (Swe et al., 2012). Combining fluorescence or luminescence outputs with
Fluorescence-Activated cell sorting (FACS) can allow rapid screening of cultures at the
single cell level, up to 108 per day (Packer and Liu, 2015).
By definition, any screening method requires the interrogation of individual colonies
or cells, which limits throughput and constrains the methodology used. Selection
methods are designed to bypass the necessity to test each phenotype individually and
instead links the activity of the part of interest to the reproduction or reproduction
rate of the genotype that encodes it. Again, selection can take on different forms
depending on the specifics of the activity that is being selected for. One approach
consists in selecting good phenotypes based on binding affinity for a target. Proteins
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are displayed at the surface of a cell (bacterial display – Bessette et al., 2004), or of
a bacteriophage capsid (phage display – McCafferty et al., 1990). Weak binders are
washed away, whereas strong binders can be recovered and reused in other rounds
of diversification and selection. Binding selection methods have given good results,
notably for antibody production, but remain limited in scope. Another selection
strategy is to link the survival of the organism to a desired protein function. A simple
example is the evolution of expanded spectrum antibiotic resistance proteins, where
the evolving sequence directly leads to better growth (Orencia et al., 2001). If the
correct function of the part can be linked to gene expression, growth on antibiotics
can be used as a proxy to select better parts. For example, Desai and Gallivan (2004)
could select riboswitches for their ability to grow in chloramphenicol, and Olson and
Müller (2012) selected better trans-splicing ribozymes for their ability to reconstitute
a chloramphenicol resistance mRNA. Similar strategies can be devised with auxotroph
complementation (Young et al., 2014). In all cases, in order to select for useful parts,
the selection methodology must link higher growth rates or survival with activity of
the evolved protein, either directly or indirectly through a genetic circuit.
Screening methodologies are usually limited by the throughput of the screening
process, with the fastest methods allowing 108 test per day. Selection procedures are
often limited by the transformation efficiency, which can reach 1010 transformants
per experiment with E. coli. In both cases, the replication and selection rounds are
usually iterated until parts with the desired qualities are obtained.
3.1.3 Iterative and continuous directed evolution
Iterative evolution
Traditional directed evolution techniques rely on discrete rounds of genetic variation
generation, and rounds of selection. Diversity can be generated by various methods
described in section 3.1.2, and by Packer and Liu (2015). This diversity generation
allows the creation of a library of parts. It takes place independently in time or space
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of the selection process that follows it, during which the best parts are selected for.
Continuous evolution and PACE
Continuous evolution, on the other hand, is the evolution of organisms in continuous
culture, where the diversity generation and the selection procedures are taking place
concurrently, without any spacial or temporal separation. Evolution experiments in
batch culture have been used for long term evolution of bacteria, most notably in
the E. coli long-term evolution experiment (Travisano et al., 1995; Tenaillon et al.,
2016). In this case, cultures of E. coli are grown in batch and have been rediluted
every day, since 1988. Phage can also be evolved by serial transfer, but as this involves
co-culture of bacteria and phage, both organisms tend to co-evolve. Mutations that
render the bacteria resistant to the phage can be selected for after a single challenge
by bacteriophage (Qimron et al., 2006; Moons et al., 2013). To study phage evolution
independently of its host, Husimi et al. (1982) invented the ’cellstat’. A cellstat is a
continuously diluted bioreactor which always contains the same number of cells – as
opposed to a chemostat or a turbidostat, which maintain at a constant level either
the concentration of chemicals (usually nutrients), or the turbidity of the culture (via
a feedback between an OD sensor and the dilution rate). The cellstat is maintained
by using two interconnected bioreactors. The first is a turbidostat that maintains a
constant culture of bacterial cells, at a constant OD. It is connected to the second
reactor (the cellstat), where the bacteriophage is grown and which is supplied with a
constant influx of bacterial cells. The system is set up such that the average time spent
in the cellstat is inferior to the generation time of the bacteria. This ensures that the
bacteria do not grow in the cellstat, and therefore not evolve resistance to the phage.
As the phage growth rate is much higher than that of the bacteria, phage can sustain
their population in the cellstat without any co-evolution of the bacteria.
One recent improvement in continuous directed evolution technology is the develop-
ment of Phage Assisted Continuous Evolution (PACE) (Esvelt et al., 2011). The PACE
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methodology reused this ’evolution machine’ devised by Husimi et al. (1982) to evolve
bacteriophage, bringing in a key change: One of the bacteriophage genes is removed
from its genome, and placed on a plasmid in the bacterial cells (see fig. 3.1). Then, a
gene of interest is placed on the bacteriophage genome, in such a way that it controls
the expression of the bacterial gene from the plasmid. This way, the gene on the
bacteriophage genome evolves to increase expression of the selection gene placed on
the plasmid. PACE was initially used to evolve variants of the T7 RNA polymerase that
recognise different promoter sequences (Esvelt et al., 2011). The technique has been
used to evolve proteases (Dickinson et al., 2014), nucleases (Hubbard et al., 2015) and
protein-protein interactions (Badran et al., 2016). PACE has also been expanded to in-
corporate negative selection, by using a truncated selection gene which is deleterious
to the phage when expressed (Carlson et al., 2014), and the authors have worked to
increase the mutation rate of the phage by using an inducible mutagenesis plasmid
(Badran and Liu, 2015).
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Figure 3.1 – PACE uses a turbodistat to supply exponential phage bacteria to a cellstat
which contains continuously replicating bacteriophage. An evolving gene is expressed
from the Phage genome (Ph). This gene controls expression of the selection gene from
the accessory plasmid (AP). Expression of the selection gene increases production of
infectious phage. Mutants that increase expression of the selection gene are therefore
selected for. Mutagenesis is continuously provided by the mutagenesis plasmid (MP).
Figure adapted from Esvelt et al. (2011).
3.1.4 T7 bacteriophage
T7 bacteriophage is an efficient bacterial killing machine. It is fast-replicating (~17
minutes), lytic, and carries its own transcription and replication systems, making it
largely independent from the host machinery (Molineux, 2006). For these reasons,
it could be an attractive chassis for Phage Assisted Continuous Evolution (PACE) or
PACE-inspired techniques that involve continuous phage growth. Fast replication
mean more rounds per time unit, its lytic nature reduce or eliminate biofilm which
complicate bioreactor operation, and the independent replication machinery might
allow the use of T7 in other hosts. Unfortunately a major drawback to its use is the
absence of an easy, robust cloning method for engineering the T7 genome. However,
homologous recombination followed by selection has been used to delete portions
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of the T7 genome. Selection for mutants is achieved by incorporating the E. coli
genes cmk or trxA, that are important for T7 replication, between homology arms.
Recombinant phage is then selected by plating on E. coli deficient in such genes
(Qimron et al., 2006; Tridgett, 2015).
T7 bacteriophage life cycle
The T7 genome is 39,937 bp long, coding for 56 genes (Dunn et al., 1983), encapsulated
in a 60 nm icosahedral capsid, with a 23 nm tail (Rontó et al., 1983; Molineux, 2006). T7
can infect E. coli as well as some Salmonella and Shigella strains, and some mutants
can infect Y. pestis strains (Molineux, 2006). T7 infection starts when the tail fibre
interacts with the outer membrane lipopolysaccharide (LPS), the first step of phage
adsorption. After binding, the inner core of the phage is ejected from the virion
capsid into the outer membrane and periplasm, where it degrades the peptidoglycan
layer, presumably forming a channel for DNA translocation, although this has not
been well characterised (Molineux, 2006). The first ~850 bp of the genome then
enter the cell, allowing initiation of transcription by the E. coli RNA polymerase that
recognises the promoters present at the start of the genome. Transcription of the
genome by the endogenous polymerases pull the rest of the phage genome into the
cell (Garcia and Molineux, 1995). This gradual entry of the genome into the host
cell forms a first layer of gene regulation. Genes transcribed from the phage can
be divided into three classes (see fig. 3.2). Class I genes are expressed early in the
infection stage – up to 8 minutes – from three strong E. coli promoters (Moak and
Molineux, 2000) situated at the start of the genome. They consist of 9 genes, from
gene 0.3 to 1.3, expressed from mRNAs transcribed from different promoters but that
terminate at the TE terminator that follows gp1.3. Two important proteins are gene 0.7
and gene 1. The product of gp0.7 inactivates host transcription and phosphorylates
many host proteins, including ribosomal subunits, RNase III and RNase E, and E.
coli polymerase subunits (McAllister and Barrett, 1977; Molineux, 2006). Gene 1
codes for T7 RNA polymerase, which goes on to initiate transcription of late genes
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from T7 promoters. Late genes are divided into class II and class III. Class II genes
are expressed from 6 to 15 minutes after infection at 30°C, and consist of enzymes
required for T7 replication. gp2 also inhibits the E. coli RNA polymerase (Nechaev
and Severinov, 1999), switching off transcription of early genes. gp3 and gp6 are
responsible for degrading the host chromosome. These nucleotides are then recycled
by endogenous E. coli proteins, and make up 80% of the progeny phage DNA. The Cmk
protein is responsible for the recycling of cytidine monophosphate (CMP) nucleotides.
Its deletion greatly reduces phage replication, allowing its use as a selection gene.
gp5 is the T7 DNA polymerase which replicates the phage chromosome, in complex
with the E. coli protein thioredoxin (TrxA). TrxA acts as a processivity factor for the
phage DNA polymerase, increasing the speed of DNA polymerization 1000 fold, and is
essential for T7 replication. Class III genes are responsible for DNA packaging, viron
assembly and the eventual lysis of the host which releases the virons (Molineux, 2006).
Class III gene mRNAs are highly expressed, which may reduce class II gene expression
by ribosome sequestering.
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Figure 3.2 – The life cycle of T7. Adsorption starts with attachment of phage legs to LPS.
The inner core enters the cell membrane, 850 bp of the genome enter the cytoplasm,
where the E. coli RNAP expresses Class I genes, simultaneously pulling in the rest of
the genome. T7 RNAP expresses Class II then III genes. The T7 genome is replicated
by the Gp5-TrxA complex. Nucleases degrade the E. coli genome, and nucleotides are
recycled.
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3.1.5 Engineering T7
Even though bacteriophage have recently attracted much attention as a potential
alternative to antibiotics, engineering of lytic phage like T7 remains relatively rare.
Modifications are complicated by the fact that T7 is a lytic phage with a dsDNA linear
genome. Unlike M13 or other lysogenic DNA phages with circular genomes, it cannot
be transformed into a phagemid – a hybrid that contains both a phage and a plasmid
origin of replication. There are nonetheless a few methods to engineer T7. One
approach uses homologous recombination, either in combination with a T7 selection
marker, or by targeting and destroying non-recombinant phage with CRISPR (Qimron
et al., 2006; Kiro et al., 2014). In both cases, the exogenous gene is placed between
homology arms on a plasmid in E. coli cells, which are then killed with wild type T7.
If the homologous recombination cassette includes a selection marker, the lysate
is plated on E. coli cells where this gene is deleted. Two previously used selection
markers are thioredoxin (trxA) and cytidine monophosphate kinase (cmk), which can
be inserted onto the T7 genome and selected for using ΔtrxA or Δcmk E. coli cells
(Qimron et al., 2006). Both genes are non-essential for E. coli but essential (in the
case of trxA) or very important (for cmk, without which efficiency of plating of T7 is
reduced by 95%).
Instead of using a selection gene, nucleases can be targeted to the wild type sequence,
favouring recombinant bacteriophage. CRISPR-Cas9 has been used in this way to
engineer T7 (Kiro et al., 2014). Alternatively, the whole T7 genome can also be trans-
ferred into a Yeast Artificial Chromosome (YAC), in one piece or as PCR fragments
assembled through gap-repair cloning (Jaschke et al., 2012; Lu et al., 2013). The phage
genome can then be modified, before ’rebooting’ the phage by transformation into
E. coli. This method has been used to engineer T7 with modified host ranges (Ando
et al., 2015).
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3.1.6 Continuous evolution of T7 bacteriophage
Directed evolution could be a good complement to computational or rational design
strategies for creating new genetic parts. Amongst directed evolution techniques,
continuous evolution is a promising method for the improvement of biological parts.
However, it has so far only been carried out with M13, even though other organisms
such as T7 could bring advantages, as they are lytic and can replicate in other hosts.
This chapter presents an investigation of whether T7 can be used in continuous evolu-
tion experiments to optimise previously designed parts. First, methods for creating
engineered T7 containing exogeneous cargo genes are tested using two previously
used selection markers. The validity of these recombination techniques is tested in
batch culture, but also in continuous culture within continuously diluted bioreactors.
The effectivity of two potential selection genes, the T7 DNA polymerase gp5 and the E.
coli gene cmk, are tested. A recombinant T7 phage containing the circRAJ31 riboreg-
ulator was then grown in a cellstat in continuous culture, and the accumulation of
mutations in the phage in presence of an error prone DNA polymerase measured.
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3.2 Results
3.2.1 Construction of recombinant T7 bacteriophage
To construct recombinant T7 bacteriophage, initially, both the cmk and trxA genes
were used as selection markers, to increase the chances that any cargo carried between
them was transferred to the phage genome (although one selection gene was later
found to be sufficient). The selection cassette containing both genes between 100
bp homology arms was transferred into pLitmus-chlor-RFP, generating PR100-cmk-
trxA. The homology arms contain the last 100 bp of the T7 gene 4.7 and the first 100
bp of the T7 gene 5.3. This targets the recombination cassette to the gene 5 locus
(T7 DNA polymerase), removing it in the process. E. coli MG1655 cells carrying the
recombination plasmid were infected with wild type T7 phage (MOI 0.01), which
resulted in bacterial lysis. Dilutions of filter sterilised lysate (containing 200 µL , 20
µL and 2 µL of lysate) were used to challenge Δcmk ΔtrxA E. coli cells containing
pT7-G5. The 200 µL dilution killed all bacterial cells, and the 2 µL dilution resulted in a
bacterial lawn with no visible plaques. The intermediate 20 µL dilution resulted in an
uneven lawn of small colonies spread throughout the plates, interspersed with a few T7
plaque-sized clearings. To confirm that these clearings were recombinant T7 plaques,
the gp5 region was amplified by PCR with phage specific primers located outside the
target site. A product of the expected size (3000 bp) was detected and sequenced,
confirming the insertion of the recombination cassette containing cmk and trxA into
the T7 genome, and the removal of gp5. This validated this method for recombinant
phage generation, and the recombinant phage was named T7:Δg5::cmk-trxA. The
cI gene from phage λ (λcI) was then inserted between the selection genes on PR100-
cmk-trxA, generating PR100-cmk-λ-trxA, and the recombination process repeated.
Initially, no recombinant phage were detectable, as the undiluted sample (200 µL of
lysate) killed all cells whereas diluted samples (20 µL and 2 µL dilutions), a lawn or
interspersed colonies grew, with no visible plaques. The killing of bacterial cells is
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due to the presence of wild type phage in the lysate. Wild type T7 is non-replicative
in Δcmk ΔtrxA cells, but can still cause abortive infection and cell death. As a result,
there is a theoretical limit to recombinant phage detection which corresponds to the
concentration where all cells get killed by wild type T7, preventing the growth of a
cell lawn and therefore the detection of recombinant T7 plaques. To detect whether
recombinant phage was present at lower levels, an amplification stem was carried
out. 150 mL of liquid culture of Δcmk ΔtrxA E. coli cells was inoculated with 1 mL of
lysate, and the new lysate recovered and filtered. Plaque assays were repeated with
this ’post-selection’ lysate, and recombinant T7:Δg5::cmk-λcI-trxA were picked after
subsequent plaque assays on Δcmk ΔtrxA cells. The presence of the λcI containing
selection cassette on the phage was confirmed by PCR and sequencing, validating this
method for generating recombinant T7 bacteriophage.
3.2.2 ’On the fly’ recombineering with phage co-infection
With the confirmation that exogenous cargo could be inserted onto the T7 genome
to create recombinant bacteriophage, the possibility of carrying out recombination
during continuous culture of bacteriophage was investigated. The ability to supply
exogenous sequences during continuous culture of bacteriophage would allow the
integration of library based screening techniques with continuous directed evolution
techniques like PACE, as arbitrary sequences could be supplied for recombination
during continuous evolution. To test whether such ’on the fly’ recombineering is
possible, a system where both M13 and T7 can co-infect a cell was tested.
In wild type strains, superinfection by these two phages does not occur. M13 can
only infect F+ E. coli, but F plasmids confer resistance to T7 through the pifA gene
(Morrison and Malamy, 1971). To permit co-infection of T7 and M13 phages, an F+
ΔpifA E. coli strain was obtained, and its susceptibility to co-infection was tested.
The strain was grown and infected with either M13KO7, wild type T7, both or neither.
M13KO7 contains a kanamycin resistance gene, allowing detection of M13 infected
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Kanamycin M13 T7 Result
No No No Uniform lawn
No Yes Lawn with plaques
Yes No Uniform lawn
Yes Yes Lawn with plaques
Yes No No No lawn growth
No Yes No lawn growth
Yes No Uniform lawn
Yes Yes Lawn with plaques
Table 3.1 – Growth of ΔpifA cells after infection with or without M13 phagemid (with
MOI À 1) and/or T7 phage (10 PFU per plate). All plates contained Ampicillin and
Tetracycline.
cells as they grow on kanamycin containing plates, whereas T7 infection creates
characteristic plaques. Only samples infected with M13 grew on kanamycin plates.
T7 plaques grew on all bacterial lawns that were inoculated with T7, including M13
infected bacterial lawns grown on kanamycin plates (see table 3.1). These results
confirm that F+ ΔpifA E. coli can be co-infected by both M13 and T7 bacteriophage.
M13 phagemid particles containing the PR100-cmk-trxA recombination cassette
(M13::PR100-cmk-trxA) were then generated. As a negative control, phagemids con-
taining an RFP gene (M13::RFP) were made. ΔpifA cells containing pT7-G5 were
co-infected with M13::PR100-cmk-trxA or M13::RFP, and with wild type T7. T7 in-
fection of cells previously transduced and selected for PR100-cmk-trxA uptake was
carried out alongside as a positive control. The infected cultures cleared after two
hours. To assay the presence of recombinant T7 phages containing the cassette pro-
vided by M13 phagemids, the filtered lysates were used to perform plaque assays on E.
coli Δcmk ΔtrxA , with or without an amplification step. In non-amplified samples,
recombinant phage were detected in pre-transduced E. coli lysates, but not in lysates
resulting from co-infection. After amplification, recombinant phage was detected in
lysates from co-infection with PR100-cmk-trxA phagemid, but not co-infection with
RFP phagemid (see fig. 3.4). This confirmed that recombination between co-infecting
M13 phagemid and T7 can take place in vivo. The inability to detect recombinant
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phage in non-amplified samples shows that recombination after co-infection occurs
at a lower level than in previously transformed or transduced cells.
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Figure 3.3 – A. Schematic of homologous recombination for engineering of T7 bac-
teriophage. The recombination cassette is brought by an M13 phagemid. trxA is
essential for phage growth, and recombinant phage are selected for on ΔtrxA cells. B.
Diagram of co-infection experiment. T7 and M13 phagemid are used to co-infect E.
coli cells. C. Table of results after co-infection. Recombination after co-infection with
M13 phagemids is detectable after sample enrichment. D. E. coli lawn infected with
enriched lysates from co-infections with wild type T7 and M13:PR100cmk-trxA (left,
plaques visible) or M13:RFP (right, no plaques).
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To test the validity of this method alongside continuous evolution, the process of in-
fection was repeated in a continuous T7 culture using interconnected chemostats and
cellstats. Two cultures, one containing ΔpifA -g5 cells (the recombination strain), and
the other aΔcmk ΔtrxA culture (the selection strain), were grown in chemostats. Both
chemostats were connected to a single continuously diluted cellstat in a 50/50 ratio
(see fig. 3.4), creating an environment where phage could grow in a mixed bacterial
culture. The cellstat was first inoculated with wild type T7, then with M13::PR100-
cmk-trxA, with samples taken from the cellstat output every hour. The last sample
was taken after infection of the chemostats with the M13 phagemids. The presence
of recombinant phage in the cellstat samples was then assessed by lysis assays on
Δcmk ΔtrxA cells. In samples 1 (before phage addition), 2 (before M13 phagemid
addition), 3 and 4 (after M13 addition in cellstat), no recombinant phage was detected.
Sample 5 (after M13 phagemid addition in chemostat) contained recombinant phage.
Recombination did not occur if co-infection took place in the cellstat, but did work
effectively if M13 was added to the cells in the chemostat, which gives more time for
phagemid entry into the cells.
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Figure 3.4 – A. Bioreactor setup, with recombination strain cells grown in one chemo-
stat, selection strain cells grown in another. Both chemostats feed a cellstat where T7
is grown continuously, and M13 is injected intermittently. B. Timeline of experiment.
C. Characterisation of cellstat output. Lysis of ΔpifA cells indicates T7 presence, lysis
of Δcmk ΔtrxA cells indicates recombinant T7 presence. Co-infection in cellstat does
not permit recombination (Samples 2-5), but M13 addition in chemostat does (sample
6).
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3.2.3 Accessory plasmid testing for T7 PACE
Conducting PACE experiments using T7 bacteriophage requires a selection gene
whose expression is correlated with higher and faster production of infective offspring.
Two genes, gp5 (T7 DNA polymerase) and cmk (cytidilate monophosphate kinase),
were tested for their ability to be used as selection genes.
Testing gp5 as a potential selection gene
To determine whether gp5 can be used as a selection gene, the ability of two phages,
T7ΔG5::cmk-trxA and T7ΔG5::cmk-λcI-trxA (described in section 3.2.1), to infect
E. coli cells containing gp5 on accessory plasmids (AP) was assayed. Two phages
(with or without a cargo) were used to determine whether the presence of the cargo
influenced phage infectivity, and three APs were used to determine whether the
promoter controlling gp5 transcription influenced phage infectivity. Both phages
were diluted to identical concentrations, then used to perform plaque assays on E.
coli MG1655 cells containing the APs. The phage gene 1 (T7 RNApol), the cargo (λcI)
and the gene 5 present on the APs form genetic circuits that all lead to the production
of Gp5 (T7 DNA pol) and therefore phage replication (see fig. 3.5A). The three APs all
contain gp5, downstream of either a pT7 promoter, a pRM promoter with the wild
type RBS, or pRM with a weak RBS (B0031). The T7 polymerase (gene 1) is initially
transcribed by an endogenous E. coli polymerase. T7 RNAP can then transcribe the
synthetic unit which is inserted in the gene 5 locus. In the control phage 1, this
contains cmk and trxA, whereas in phage 2, it also contains λcI. In cells containing
AP1, T7RNApol directly transcribes G5, whereas in cells containing AP2 and AP3, G5 is
under the control of the λcI activated pRM promoter.
The presence of cI on the phage did not lead to higher plaque numbers when cells
contained a pRM promoter upstream of Gp5. Infection by both phages was similar,
regardless of the accessory plasmid used. The presence of the cI activator gene on the
phage DNA in combination with its target pRM promoter on the AP did not lead to
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Figure 3.5 – A: Recombinant phage containing either cmk or cmk-λcI-trxA inserted
into the gene 5 locus. B. Accessory plasmids (AP) used. AP1 contains pT7-g5. AP2
and AP3 contain pRM-g5, with the wild type RBS from AP1 or B0031, respectively. C.
Results of the plaque assays. Both phage were diluted to identical concentrations
beforehand (measured on cells containing AP1), then against MG1655 cells containing
each AP.
changes in phage infectivity compared to infection of the same cells with a control
phage which does not contain the cI gene. Although we cannot discard the possibility
that cI is not expressed from the phage, plaque forming unit (PFU) measurements
performed with the control phage were similar when plaque assays are performed on
cells expressing gp5 from a pRM promoter and on cells expressing gp5 from a strong T7
promoter. This showed that pRM is a leaky promoter which that does not require the
presence of cI to be expressed. Varying the AP did cause small differences in plaque
numbers. In cells containing AP3, the PFU titres of both phages were slightly higher
than in cells containing either AP1 and AP2. This difference was visible regardless of
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the phage used. The B0031 RBS was chosen for AP3 because it had a small predicted
Translation Initiation Rate (TIR) of 972.90 according to the Sallis lab RBS calculator
(Salis et al., 2009; Espah Borujeni et al., 2014). This is much weaker than the wild
type RBS used in AP1 and AP2, which has a predicted TIR of 38695.20. Even if the
increase in PFU is small on cells containing AP3, these results suggest that gp5 is not a
suitable selection gene for conducting directed evolution with T7. A good selection
gene would cause clear differences in infectivity and plaque morphology, which were
not detectable when varying the promoter in front of gp5. Rather, the leakiness of
the pRM promoter without cI presence was sufficient to give the same results as the
positive control with a pT7 promoter, and a predicted lower expressing RBS had higher
levels, suggesting that lower levels of GP5 could in fact be advantageous.
Testing cmk as a selection gene
Cytidine monophosphte kinase (cmk) catalyses the phosphorylation of CMP and
dCMP to CDP and dCDP, respectively, and is a key part of the salvage pathway that
recycles pyrimidine bases (see fig. 3.6A). cmk has been shown to be important for T7
growth (Qimron et al., 2006). When T7 enters its host, nucleases are expressed and
degrade the E. coli genome. The nucleotides that result from this degradation are
reused for T7 genome replication. cmk deletion results in a 95% reduction in efficiency
of plating, and it can be used as a selection marker for T7 recombineering (Qimron
et al., 2006). If restoring its activity results in an increase in phage fitness, cmk could be
used for selection during directed evolution (see fig. 3.6B). To test whether cmk could
be used as a suitable selection gene on an accessory plasmid, a new recombinant T7
phage containing trxA (but not cmk) in the gene 5 locus was constructed (see fig 3.7A).
The trxA gene was found to be sufficient for recombinant phage selection, and
T7Δg5::trxA was generated by homologous recombination as previously described.
To determine the effect of cmk on the phage, phage challenges of E. coli cells were per-
formed on plates then in liquid culture. First plaque assays of T7Δg5::trxA on either
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Figure 3.6 – A. Pathway to dCTP production and effect of cmk deletion. cmk is essen-
tial for efficient T7 replication. B. Putative pathway for phage production via cmk
production circuit. The phage contains the cargo added using trxA as a selection gene.
The cargo controls the gene circuit of interest, that leads to cmk production.
E. coliΔtrxA or E. coliΔcmk ΔtrxA cells expressing gp5 were performed. T7Δg5::trxA
plaques were found on both E. coli strains, but plaques on Δcmk ΔtrxA cells were
much smaller than plaques on the ΔtrxA control strain (see fig. 3.7). This shows
that cmk is not essential, but that cmk expression does have a large effect on the
phage. As PFUs of Δg5 phage on cells containing or not containing the cmk gene were
similar, but with plaque size differences, it was hypothesised that an equal amount of
T7Δg5::trxA should kill a population of E. coli cells slower when cmk levels are lower.
A kill curve assay was then devised for comparing the effects of cmk expression on
phage killing speeds. If cells were equally susceptible to infection but phage replica-
tion was slower, or burst size smaller, we would expect a similar PFU measurement,
but a slower overall time to kill a population of cells. To test this, 4 new accessory
plasmids were constructed. They all contain an error prone version of gp5, a T7 DNA
polymerase engineered to have a decreased replication fidelity (Söte et al., 2011). They
also contain the cmk gene, but with varying promoters and cis-repressing 5’ UTRs
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upstream of cmk (see fig. 3.8). APcmk-1 contains a pT7 promoter, and was used as
a positive control. APcmk-2 contains no promoter or RBS, but a 14 bp spacer, and
was used as a negative control. APcmk-3 and APcmk-4 contain a pT7 promoter and a
cis-repressed cmk gene where the RBS and ATG are repressed by a 5’UTR that block
initiation via base pairing. These 5’ UTRs were designed to be activated by the RAJ31
riboregulator described in chapter 2, therefore permitting its improvement by evolu-
tion. They were designed using NUPACK, with the same design goals as in figure 2.13
(chapter 2).
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Figure 3.7 – A. Contructions used. B. Plaque assays with T7ΔG5::trxA in ΔtrxA and
Δcmk ΔtrxA E. coli cells.
The 4 new APs were transformed into E. coli Δcmk ΔtrxA. The cells were grown
to ODλ= 600 0.15, challenged with an equal amount of phage and grown in a plate
reader to follow growth and death of the cells. Cells containing pT7-cmk reached peak
ODλ= 600 after 79 minutes, whereas cells containing no promoter upstream of cmk
reached peak ODλ= 600 after 102 minutes. Presence of a cis-repressing UTR upstream
of the RBS caused slower killing. Cells expressing UTR1 or UTR2 reached peak OD after
94 and 102 minutes, respectively, which is between the peak times for AP cmk-1 and
AP cmk-2. All strains had similar growth rates until they reached their peak ODλ= 600,
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apart from cells containing UT2 (AP cmk-4) which grew slightly slower. The difference
in killing time between the cells expressing APcmk-1 and APcmk-2 indicates that a pT7
controlled cmk gene can reduce phage killing times of cells. pT7 is induced by the
T7 gene 1 (T7 RNAP), so control of cmk expression by another phage gene, whether
natural or synthetic, could potentially control cmk expression, and therefore phage
fitness. The cmk gene seemed to be a suitable choice as an accessory selection gene
for conducting PACE with T7 bacteriophage, as lower expression increases killing time.
The cis-repressing UTRs also slowed the killing of cultures relative to the positive
control with only a pT7 promoter.
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Figure 3.8 – A: Accessory plasmids used. pT7-cmk and SL-cmk (Short linker, no
promoter) were used as positive and negative controls. Two cr-mRNA UTRS (UTR1 and
UTR2) were tested.B: Kill curves of E. coli cells containing the different APs described
in A, challenged with T7ΔG5::trxA. Cultures prepared from three independent colonies
were used, and standard deviation of OD measurements is shown as error bars. C.
Average time to peak ODλ= 600 of cells when infected with equal amounts of phage.
Phage fitness inversely correlates with time. Time to peak ODλ= 600 did not vary
between replicates, so no error bars are plotted.
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3.2.4 Continuous evolution of recombinant T7 bacteriophage
The circular riboregulator RAJ31 (see chapter 2) was then recombineered into T7,
producing T7Δg5::pT7-circRAJ31-trxA, referred to as T7-circ31 henceforth. A setup
of continuously diluted bioreactors were assembled, such that one bioreactor, the
chemostat, would continuously maintain a culture of growing, uninfected E. coli cells;
and be connected to a second bioreactor, the cellstat, inoculated with T7-circ31 (see
fig. 3.9 A). The phage can replicate within the continuous supply of cells, maintaining
a continuous culture of bacteriophage. The setup is similar to the PACE technique
(Esvelt et al., 2011), although it uses T7 phage intead of M13, and cmk as a selection
gene (instead of M13 gene 3). 4 independent bioreactor setups were run in parallel.
The chemostats contained Δcmk ΔtrxA cells transformed with either pT7-cmk, pT7-
UTR1-cmk or pT7-UTR2-cmk, and the cellstats were inoculated at time 0 with T7-
circRAJ31 (see fig 3.9 B). The bioreactors were then run for 14 days, starting with
a dilution rate of 28 minutes (ie a renewal of volume every 28 minutes). The flow
rate was increased gradually, to reach a final flow rate of 14 minutes. Samples were
taken every 24 hours, and the region containing circRAJ31 was amplified by PCR and
sequenced (see fig. 3.9C and D).
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Figure 3.9 – A. Specifications of bioreactors used for evolution of T7-circRAJ31. B.
Overview of bioreactor setup, with 4 parallel chemostats and cellstats. C. Schematics
of experiments. 2 replicates of pT7, and 3 replicates of both UTR1 and UTR2 were run
for 6 days. 1 replicate of pT7 and all replicates of UTR2 were run for an additional 6
days (total 12 days), before sequencing. D. The cellstats were inoculated with T7 on
day 0 and the dilution rate was increased gradually during the experiment.
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3.2.5 Phage sequencing
Testing for presence of the phage by PCR and/or by plating showed that T7 phage
was present in all four cellstats throughout the experiment. Despite the increasing
dilution rate, T7 was never washed out. Daily samples were sequenced around the
region of the inserted circRAJ31 gene (see fig. 3.10) using Sanger sequencing after PCR
of the relevant region. This revealed that all phage populations accumulated different
mutations in the bioreactor, in all three genes sequenced (gp4.7, circRAJ31 and trxA).
Most of the mutations were fixed in the bioreactor after 12 days, with the original
genotype undetectable. For some positions, both mutated and non-mutated phage
were detectable, showing that some diversity still existed within the phage population
in the bioreactor.
3.2.6 Mutations in protein coding genes
Mutations in gene 4.7 were common, with 2.75 mutations in gp 4.7 on average. There
was no apparent pattern, with synonymous, non-synonymous and non-sense mu-
tations appearing in the phage genome (see fig. 3.10B). Several non-synonymous
mutations were fixed in samples pT7(2), UTR2(2) and UTR2(3), and a nonsense muta-
tion was fixed in sample UTR2(3). Although it is not known what effect the mis-sense
mutations have, the non-sense mutation in sample UTR2(3) truncates Gp4.7 to 42%
of its original length. The accumulation of non-synonymous mutations as well as the
subsistence of the genotype containing a non-sense mutation in the bioreactor does
not show any evidence of selection pressure operating on gp4.7, and suggests that
deletion of this gene is not deleterious.
13 different mutations appeared in the trxA coding sequence in the four bioreactors,
an average of 3.25 mutations per sequence in a 333 bp long coding region, although
with uneven numbers of mutations in each bioreactor. Three samples contained 1 or
2 mutations, whereas UTR2(1) had 8 mutations after 2 weeks of continuous growth
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(see fig. 3.10C). Out of 13 mutations that appeared in the trxA gene, 7 were silent
mutations (61%), whereas the probability that a random mutation in trxA is silent is
24%, assuming an equal probability of any mutation happening. Out of the 6 non-
silent mutations, 4 mutated the same amino acid Arg74. These 4 mutations led to 3
amino acid changes: Arg74Cys in Nu2_1 and in Nu2_2, and Arg74Leu in Nu2_3 (the
other mutations caused Asp3Asn and Ala57Thr in Nu2_1 and Nu2_2, respectively).
The high amount of synonymous mutations within the body of the coding sequence
relative to non-synonymous mutations suggests positive selection on the trxA gene.
The convergent evolution of Arg74 to Cysteine or Leucine in 3 out of 4 bioreactors
further points towards a strong selection pressure on this gene. These signs of positive
selection on the trxA gene prove that the continuous culture conditions the phage are
subjected to are suited to directed evolution. The mutation rate is high enough for
mutations to accumulate in the phage genome, and beneficial ones are selected for.
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Figure 3.10 – Dominant mutations in T7-circRAJ31 after 12 days of continuous evo-
lution in pT7-cmk or UTR2-cmk cells. A. Fragment of T7 genome sequenced. B.
Mutations found in coding regions. 4.7 shows no evidence of selection and both silent
and non-silent mutations appear. C. trxA shows evidence of strong selection, with 7
out of 13 mutations being silent and 4 of the 6 non-silent mutations affecting a single
amino acid. Asterisks indicate a detectable mixed population (mutant + original) in
the final sample.
3.2.7 Mutations in circRAJ31 sequence
Mutations appeared in the circRAJ31 sequence in all 4 bioreactor runs, shown in fig.
3.10C. An average of 7.5 mutations appeared in circRAJ31 when evolved in Nu2_UTR
cells, a similar number to when evolved in the negative control cells containing pT7-
cmk (8 mutations). The mutations were spread throughout the promoter, ribozyme
and RAJ31 riboregulatory region sequences. To determine whether these mutations
conferred any advantage to the riboregulator sequence, they were re-synthesised and
cloned in the same context as the original circRAJ31 riboregulator, removed from the
T7 phage sequence. The evolved circRAJ31 sequences were co-transformed with cis-
repressed GFP plasmids used in chapter 2, which are activated by rationally designed
linear and circular versions of the RAJ31 riboregulator (see figs. 2.13 and 2.14). The
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ability of the evolved riboregulators to activate translation of cis-repressed GFP was
then evaluated using the same setup.
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Figure 3.11 – Dominant mutations in the circRAJ31 region of the T7-circRAJ31 phage
after 12 days of continuous evolution in pT7-cmk or UTR2-cmk cells. Asterisks indicate
a detectable mixed population (mutant + original) in the final sample.
3.2.8 Characterisation of evolved circRAJ31 sequences
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Figure 3.12 – A. circRAJ31 sequences obtained after 12 days of continuous T7 growth
in the cellstats were re-synthesised and cloned downstream of
The sequences evolved in samples pT7-cmk(2) and pT7-UTR2-cmk(1), (2) and (3) were
resynthesised in new plasmids, named Evo_circRAJ31_0, Evo_circRAJ31_1, Evo_circRAJ31_2
and Evo_circRAJ31_3 respectively (see fig. 3.12A). They were cloned on the same high-
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copy plasmid as circRAJ31, downstream of a PL-tet promoter, and co-transformed with
3 different versions of cis-repressed GFPs: cisRAJ31, Nusl3 and Nusl6/ This permitted
the testing of the circuit with inducers aTc and IPTG controlling the riboregulator and
the cis-repressed mRNA (See fig. 3.12B), to determine whether the mutated sequences
can control the translation of GFP from a cis-repressed mRNA. The evolved RNAs
were found to have lost their activity against all three cis-repressed RNAs tested. When
expressed alongside cisRAJ31 (see fig. 3.13A), the evolved RNAs show much lower
activation of GFP translation than the unmutated circRAJ31, showing that the muta-
tions only block circRAJ31 activity. This could happen if the mutations inactivated
the self-circularisation of the ribozyme region. When co-transformed with Nusl3
or Nusl6 cis-repressed mRNAs, which have a more similar secondary structure to
the cmk repressing UTRs that were used during the evolution, the evolved circRAJ31
sequences also did not have any activity. These results show that although there was
selective pressure for beneficial mutations in the recombinant phage, the mutations
that accumulated in the circRAJ31 sequence are most likely random neutral mutations
that are unlikely to have been the result of artificial selection for riboregulation of the
cmk gene.
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Figure 3.13 – Characterisation of evolved circRAJ31 sequences. A. Summary of the
sequences obtained from evolution experiments. B. Diagram of the circuit used
for characterisation. C. Fluorescence of the circuits with and without riboregulator
expression, using 2 different cis-repressed mRNAs. Evolved riboregulators do not
cause an increase in fluorescence when compared to the non-evolved versions.
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3.3 Discussion
3.3.1 Recombineering with T7 bacteriophage
We found that recombineering with T7 bacteriophage using trxA and cmk as selection
markers was a viable strategy which allows the production of recombinant T7. Exo-
geneous genes could be recombined onto the bacteriophage genome by including
them within 100 base pair homology arms along with the selection gene, permitting
the easy generation of T7 phage carrying foreign DNA. Initially, two selection genes
(trxA and cmk) were used, with the "cargo" in the middle. This was then found to be
superfluous and the trxA gene was used alone. Homologous recombination was used
to insert various genes onto the T7 genome. The longest was cmk-λcI-trxA, which is
1839 bp long. As the cassette is inserted in place of T7 gp5, which is 2133 bp long with
the RBS region included, this modification actually reduced the phage genome size.
However, any extra sequence added onto the T7 must fit into the capsid. According to
Molineux (2006), the upper limit to this is about 103% of the phage genome size, which
means about 1200 bp of genetic material can be added onto the 39937 bp genome,
plus whatever is removed in the recombination process. When inserting genes into
this locus, the removal of gp5 provides some extra space, allowing the insertion of
2.9 kbp of foreign DNA, plus the 353 bp required for the trxA selection marker. To
insert longer fragments of DNA, further elements of the T7 genome would need to be
removed. In our case, gene 4.7 (408 bp long) was left on the genome. However, it has
been claimed to be non-essential, an assertion that is supported by the accumulation
of non-synonymous mutations in our experiments. In fact, all genes from 4.1 to 5.9
(included) are non-essential according to Studier (1981) and Molineux (2006). The
first and last ones overlap with essential genes, but removing the non-essential regions
would free about 4100 bp, and allow 5 kbp of exogenous DNA sequence to be carried
by a recombinant T7 bacteriophage. Further size increases could result from the
deletion of other non-essential regions of the T7 genome, which would add up to
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about 3500 bp when counting all regions labelled as non-essential by Molineux (2006).
Such a phage could carry about 8.5 kbp of foreign sequence.
If carrying out PACE-like directed evolution experiments, this can be compared with
the size limit of M13 based phage or phagemids which was used by Esvelt et al. (2011).
The size limit for DNA insertion into an M13 phage is about 3 kbp (Brown, 2010), which
might be slightly increased due to the deletion of gene 3 (1275 bp). If an M13 phagemid
were used for evolution instead, this would free up some space and allow bigger cargo
to be evolved. The size limit in this case would be about 10 kbp (Brown, 2010), but
with 2.5 kbp taken by the inevitable presence of antibiotic resistance markers, the M13
packaging signal and the plasmid origin of replication, the limit would be about 7.5
kbp. In both cases it seems like slightly bigger sequences could be evolved using T7 as
a host rather than M13.
3.3.2 Co-infection and "on the fly" recombineering
The recombination protocol required to engineer T7 is slightly more fastidious than
the plasmid-like cloning used for M13. However, we show that this recombination
takes place between two phage particles in co-infected E. coli cells. We show that this
can take place in test tubes, which offers little advantage compared to using a plasmid,
but also in continuously cultured phage within a cellstat, in the same conditions used
for PACE-like experiments with T7.
The main advantages of using a phagemid carried cassette for recombination lies in
the fact that no special procedure is required to make the DNA enter into the cell, as
the phagemid capsid contains all the machinery to inject the DNA into the host. In
this case, a simple cassette (containing cmk and trxA) recombines onto the phage
genome. This provides an immediate advantage to recombinants, the ability to target
a new host population (Δcmk ΔtrxA E. coli cells).
M13 phagemid can also be used to prepare libraries (e.g., Kay et al., 1993). Therefore,
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the same recombination method could be used to recombine libraries with an en-
gineered gene during directed evolution. Continuous evolution such as PACE relies
on mutations that appear randomly during phage replication. The sequence space
accessed is large, estimated to include all possible double mutants in a 1000 bp gene
(Esvelt et al., 2011). However, this could be greatly improved if combined with semi-
rational engineering techniques that can target libraries to "mutational hotspots"
that are known to be important for part function. Such combination of continuous
evolution with recombination of libraries could allow big jumps in the sequence space.
This would reduce the probability of selecting for a local fitness optimum if more than
1 or 2 mutations are required to improve the part.
Recombineering based methods that allow targeted mutations exist, such as Multiplex
Automated Genome Engineering (MAGE, Wang et al., 2009). However MAGE requires
the preparation of the cells for electroporation between each round, increasing time
and rendering these methods incompatible with continuous evolution techniques.
The ability to bring recombination alongside directed evolution, which itself is a result
of the non-disruptive nature of using phagemids to make DNA enter a cell, solves
this problem and allows simultaneous continuous evolution and recombination. The
advantages of both methods could be combined, continuous evolution of a gene with
occasional pulses of diversity generation brought by recombination.
We showed that this type of technology is possible, in this case using cells that are
modified to accept co-infection by both M13 and T7. Other phagemids may be also
suited, for example phage λ, which can be packaged in vitro. M13, λ phage and
others can be used to make libraries and could target a continuously evolving gene to
increase the search of the sequence space.
The biggest challenge for this to be integrated into continuous evolution experiments
is that of the recombination efficiency. Our experiments in non-continuous culture
required a "selection" step where non-recombinant phage were eliminated in order to
be able to see the recombinant phage. This suggests that recombination is happening
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at less than 1 in 107, which may be too low to be useful. The recombination efficiency
could be increased by adding homology based recombinases into the host cells.
We also found that although co-infection could occur after simultaneous inoculation
of cells with both phages in test tubes, no recombinant phage were observed when
the M13 phagemid was added into a continuously diluted culture of T7. The larger
numbers of T7 in the running cellstat compared to that in test tubes may reduce the
chances of M13 from successfully entering the cells and recombining, either because
there are less cells or because T7 nucleases are expressed in the cells that the M13
phagemid can infect. In any case, this is not a major issue as infection of the cells in
the chemostat permitted recombinant T7 generation. This method could be improved
with the use of a delay chamber where the phagemid library is added. This could
consist of another bioreactor between the chemostat and the cellstat, or simply of
longer tubing between the two reactors. This delay chamber would provide enough
time for M13 to enter the cell before the culture is fed to the T7 in the cellstat. As the
stock culture of cells in the chemostat would be free of both M13 and T7, successive
rounds of infection with different libraries could be achieved.
3.3.3 Picking a selection gene for PACE with T7 bacteriophage
Two potential selection genes for Phage-Assisted Continuous Evolution (PACE) were
tested. The first, gp5, is the bacteriophage DNA polymerase, whereas the second, cmk,
plays an important role in nucleotide recycling which allows more phage genome
synthesis. gp5 was found to have little or no effect on phage numbers, despite the fact
that DNA polymerase is an essential gene for T7 (Molineux, 2006). The cells containing
gp5 under the control of different promoters and ribosome binding sites were infected
with phage containing or not containing the λcI transcription factor DNA. Varying
the conditions from which it is expressed, or the presence of the transcription factor
had no substantial effect on plaque numbers or appearance. On the contrary, phage
infectivity was slightly higher on cells containing the plasmid AP3, which contains
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gp5 under the control of a RBS with a very weak predicted translation initiation rate.
Although gp5 expression levels with different RBS and promoters were not directly
measured, we can expect that there should be some differences in expression when
varying these sequences. The lack of visible differences when changing the promoter
and RBS sequences disqualified gp5 as a useable selection gene for PACE experiments.
The initial reasoning behind the choice of gp5 was that DNA replication would be a
key element for production of new infective phage. The lack of decrease in infectivity
on cells containing AP3 (predicted weak RBS) compared to AP2 (predicted strong RBS)
shows that varying levels of gp5 did not have the required characteristics, instead
leaving to a slight increase in infectivity. The leakiness of the pRM promoter may be
sufficient to reach the required levels of gp5 protein and explain why we do not see
any difference.
The testing of cmk as a selection gene showed a clear effect on bacteriophage. Plaque
morphology was significantly altered, with small plaques on Δcmk cells. Phage
killing speeds were affected when cmk was placed on accessory plasmids with varying
promoter and RBS strengths. This showed that increasing cmk levels upon phage
entry increased killing speeds, and therefore that cmk is a potential good selection
gene for T7.
3.3.4 Evolution of gp4.7 and trxA
The random set of mutations with no clear pattern that was found in the various
gp4.7 genes sequenced contrast with the high frequency of synonymous mutations
and the convergent mutations that were found in trxA. The absence of a significant
pattern in the mutations in gene 4.7 suggests a lack of selection pressure on the
sequence, with the sequence drifting away in a neutral fashion from the starting
sequence. The function of gene 4.7 is not known but it has been reported to be non-
essential (Studier, 1981; Molineux, 2006) and that its deletion has no effect upon
phage behaviour. Our observation that gp4.7 accumulates mis-sense mutations in the
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bioreactor is consistent with these reports, as there is no apparent selection pressure
to maintain the sequence.
On the other hand, an unexpectedly high amount of mutations in trxA are synonymous
mutations. Furthermore, non-synonymous mutations are clustered in amino acid 74,
with two of the four phage populations gaining a Arg74Cys and one gaining a Arg74Leu
mutation. Only one in four samples did not finish the 12 day run with a mutation at
this site. A high rate of synonymous mutations, as well as the high frequency of this
specific mutation at amino acid 74, are both signs of adaptive evolution (Springman
et al., 2010). These signs of adaptive evolution in the sequence of the trxA gene
suggest that the conditions in the bioreactors were favourable for directed evolution
experiments. A relatively high number of mutations became fixed and there was
convergent evolution of the same mutation in several replicates.
3.3.5 Mutations in circRAJ31 in evolving phage
circRAJ31 accumulated many mutations in the different bioreactors. As it does not
contain a protein coding sequence, the comparison of the frequency of synonymous
mutations with non-synonymous mutations done for gp4.7 and trxA cannot be re-
peated. One noted factor was that there were no convergent mutations of circRAJ31
sequences evolved in different bioreactors. Furthermore, the sample evolved in the
host containing a pT7-cmk accessory plasmid, designed as a negative control where
circRAJ31 would not play a role, also had a number of mutations. These mutations
were found in all parts of the circRAJ31 sequence: The promoter, the ribozyme introns
and exons, and the actual riboregulator sequence that was complementary to the
cis-repressed cmk UTR targets. After characterisation, the circRAJ31 sequences were
found to have all lost their ability to activate cisRAJ31-GFP. The evolution run therefore
only led to the accumulation of deleterious mutations in the sequence. This could be
because circRAJ31 activation of cis-repressed cmk did not lead to a substantial benefit,
or because this benefit was lower than the disadvantages conferred by the presence of
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a self-splicing sequence within the T7 genome.
3.3.6 PACE with T7 bacteriophage
One of the potential advantages of T7 as a phage for use in PACE-like directed evolution
is the fact it is a lytic phage, which avoids clogging and biofilm formation in the cellstat.
With M13 phages used by Esvelt et al. (2011), biofilm formation by cells infected with
M13 leads to continuous production of phage without any selection pressure, as the
cells are no longer continuously diluted, and can lead to cheaters. It was apparent in
our bioreactor setting which was easy to run for 6 days without any biofilm growth or
clogging. T7 may also have a slightly higher capacity for carrying exogenous cargo,
which could be useful when trying to evolve longer sequences. On the other hand, the
recombineering with T7 is not as straightforward as M13 cloning, which essentially
behaves as a plasmid inside cells. Circuits can be easily cloned onto M13 by standard
techniques, treating the phage as a plasmid, before replicating it (Brown, 2010). With
T7, the linear and lytic nature of the phage leads to the requirement for engineering
by recombination.
Co-infection of T7 with M13 was demonstrated to be possible as a means for ’on the
fly’ recombineering. This could allow the combination of library based techniques,
where an important functional site of a biological part is randomised, and of PACE,
where continuous evolution is used to apply selection pressure on the part.
The efficiency of recombination in our setting was however too low to allow this
method to work without further work to increase the recombination rate. Recom-
binant phage was produced at levels that were undetectable without selection and
amplification, which corresponds to a ratio lower than 1 in 107 recombinant phage to
wild type phage. An increase in the recombination rate by using recombination-prone
strains could improve this.
Our experiments show that gp5 is not a suitable gene for use as a selection gene, but
that cmk seems a better choice. However, it could not be used to evolve the circRAJ31
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riboregulator. Other genes might be useable as selection genes with T7 and be better
candidates. One possibility is to use gene 17, which codes for the T7 tail fibre that
interacts with the target host (Kato et al., 1986). Deletion of gene 17 results in phages
that lack tail fibres and cannot infect their target (Springman et al., 2010). This is simi-
lar to the strategy used by Esvelt et al. (2011) with the M13 gene 3. Other essential class
III genes (genes 6.5+), especially the ones that code for part of the virion capsid (genes
6.7, 8 and 10) and tail (genes 9, 11 and 12) might also be suitable as they are expressed
at high levels and are essential for the production of progeny. The disadvantage with
these choices is that being class III genes, they are all expressed from pT7 promoters
by T7 RNA polymerase. Thus, evolution of parts that interact with the endogenous E.
coli polymerase might not be possible if the evolved "cargo" is expressed as a class III
gene.
This problem highlights a more general disadvantage of using T7 as a host for PACE-
style directed evolution experiments, which is that a number of T7 proteins highjack
or deactivate the normal E. coli machinery. This includes the endogenous RNA poly-
merase, along with E. coli proteins degraded by the T7 proteases. Furthermore, E. coli
is killed by the process of infection, so evolution of toxic proteins could be advanta-
geous in these conditions, but would be a problem if the evolved parts were used in a
different setting.
3.3.7 Conclusion
We found that T7 could be engineered by recombination using trxA as a selection
marker, allowing the production of phage carrying exogenous genes. The process
could also work after co-infection of an engineered bacterial strain with an M13
phagemid carrying the recombination cassette, including in a continuously diluted
bioreactor. This could permit the combination of library based selection techniques
with continuous evolution as it allows recombination to take place during continuous
culture of bacteriophage. Such a system would combine the advantages of semi-
94
3.3. Discussion
rational mutagenesis approaches such as MAGE, where rationally chosen portions of
the genome are randomly mutagenised, and the advantages of continuous evolution
carried out with PACE. This might permit the evolution of parts which require a local
increase in mutagenesis rate that PACE alone cannot achieve.
Two genes, gp5 and cmk were evaluated as selection genes. While the former did not
seem useable, the latter showed desirable characteristics. However, the use of cmk to
evolve the circRAJ31 riboregulator did not lead to an improved riboregulator. Muta-
tions did accumulate in all genes of the T7 genome, with signs of positive selection
in the trxA coding sequence. This confirmed that despite the lack of improvement
of circRAJ31, the constructed system of continuous culture with T7 bacteriophage
was subject to evolutionary selection pressures, and that T7 based PACE experiments
should be possible. While the compact genome and lytic life cycle of T7 phage might
complicate the directed evolution of single proteins, the evolution of whole phage in
continuous culture, for example targeted to different bacterial receptors or strains,
could also be a possibility.
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3.4 Materials and methods
3.4.1 Cloning
All cloning methods were carried out as described in section 5.3. The plasmid pLitmus-
chlor-RFP was built for generic cloning using goldengate and used as a starting point
for other pLit-chlor derived plasmids using red/white selection. The cmk-trxA cassette
was amplified from pRec (Tridgett, 2015) with primers PR1 and PR2 then goldengate
ligated into pLitmus-chlor-RFP to generate PR100-cmk-trxA. λcI and pT7-circRAJ31
were inserted into the BamHI site of PR100-cmk-trxA, which generated PR100-cmk-
λcI-trxA and PR100-cmk-λpT7-circRAJ31. cmk was removed from the latter as well
as from PR100-cmk-trxA by cutting both plasmids with BglII and BamHI then self-
ligating them, generating PR100-pT7-circRAJ31-trxA and PR100-trxA.
pSEVA631_RFPcmk_gp5EP was built for generic cloning of parts upstream of cmk,
for accessory plasmid constructions using red/white selection. Accessory plasmids
were then constructed by annealing primers (pT7-cmk and SL-cmk by annealing
pT7_anneal and SL_anneal, respectively) or buying synthetic gblocks from IDT DNA
(for UTR1-cmk and UTR2-cmk and using goldengate to insert them upstream of cmk.
All products were checked by restriction analysis and sequencing.
3.4.2 Bacterial strains used
Recombination experiments were carried out in MG1655 cells (see section 5.1). ΔtrxA cells
were used for all experiments involving recombinant bacteriophage, unless oth-
erwise specified. They are BWBW25113 E. coli and were obtained from the Keio
collection (Baba et al., 2006). Their genotype is: LacI+ rrnBT14 ΔlacZWJ16 hsdR514
ΔaraBADAH33 ΔrhaBADLD78 rph-1, ΔtrxA ::KanR), and were transformed with pT7-
GP5. Δcmk ΔtrxA cells are derived from the same strain but with a knockout of cmk by
tetR insertion, and is tetracycline resistant, and were also transformed with pT7-GP5
unless otherwise specified. Co-infection was carried out using a modified MG1655
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cells containing an F sure (TetR) plasmid with pifA::AmpR deletion, and further dele-
tions to biofilm formation genes (Δfim, Δflu, ΔmatB::P2LUX). This ’co-infectable’
strain is Ampicillin and Tetracycline resistant.
3.4.3 Bacteriophage strains used
The wild type T7 used was identical to NCBI reference sequence NC_001604.1 for
the portions sequenced. It was propagated in MG1655 cells and stored at 4°C in 0.2
µm filtered lysate after centrifugation (7000 rcf, 10 minutes). Recombinant phage
were produced as described in section 3.4.7, propagated in ΔtrxA cells and stored
in the same conditions as wild type phage. Wild type phage contamination after
recombination was checked by plaque assays on MG1655 and by PCR, and removed
by serial dilution and repeating plaque assays on ΔtrxA -G5 cells until wild type
phage was undetectable by both methods. T7 phages were sequenced after PCR of
the plaques or filtered supernatant with G5F_new and G5R_new, and sequencing the
purified PCR products (Sanger sequencing, GATC biotech) using the same primers.
3.4.4 M13 phagemid preparation
M13 phagemids were prepared by co-transforming the appropriate pLitmus derived
plasmids (pLitchlor-PR100 or pLitchlor-RFP) with the M13KO7 helper phage. The
co-transformed cells were grown overnight then refreshed 50 fold in LB medium and
grown at 30°C for 6 hours with chloramphenicol (17.5 µg/mL) and Kanamycin (25
µg/mL). Cells were centrifugated (7000 rpm, 3 minutes) and the phagemids were
recovered by filtering the supernatant with a 0.2 µm filter (Sartorius). Phage concen-
tration was measured by serial dilutions of the filtrate, incubation with TG1 E. coli
cells (10 minutes at 30°C without shaking, 10 minutes with shaking), plating serial
dilutions on LB plates with chloramphenicol (17.5 µg/mL), and counting colonies.
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3.4.5 Plaque assays
Plaque assays were conducted with the appropriate cells, grown to O.D. 0.2 after
refreshing an overnight culture in LB (1:100 dilution). Cells were placed on ice until
use if necessary. 100 µL of phage dilutions were added to 300 µL of cells, then plated
in 3 mL of soft LB agar (0.75 % agar) onto LB agar plates containing appropriate
antibiotics. Plaques were counted after overnight growth at 37°C. To recover phage,
the centre of the plaque was picked with a pipette tip, diluted in 0.5 mL LB and filter
sterilised.
3.4.6 Co-infection with M13 and ’on the fly’ recombineering
Co-infection of ΔpifA cells
E. coli F+ ΔpifA biofilm deficient cells were grown overnight, then refreshed 1:100 in
20 mL culture and grown to ODλ= 600 0.2. This was then split into two, with 150 µL of
LB or of M13KO7 phagemid added (MOIÀ 1), incubated at 37°C for 15 min (10 min
without shaking, 5 min with shaking at 200 rpm). 100 µL of wild type T7 dilutions (100
PFU per mL), or LB, was added and plaque assays were performed as described in
section 3.4.5, on LB plates with or without Kanamycin (50 µg/mL). Plaque assays were
incubated overnight and lawns and plaques counted the next day.
Recombination in batch culture
E. coli F+ ΔpifA cells were transformed with pT7-G5[Kan]. E. coli F+ ΔpifA , PR100-
cmk-trxA were then infected with M13::PR100-cmk-trxA phagemid with tranduced
colonies selected for on chloramphenicol LB plates (35 µg/mL), providing a positive
control for cells tranformed with the plasmid. Both strains were grown overnight
and refreshed (1:100 dilution) in LB. At ODλ= 600 0.5, the strains were placed at 30°C.
E. coli F+ ΔpifA were inoculated with M13::PR100-cmk-trxA or M13::RFP (MOI=20),
and both strains were inoculated with wild type T7 (MOI=0.01). When the cultures
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cleared, they were centrifugated (7500 rcf, 10 minutes), and filter sterilised, yielding
the non-enriched lysate. Enriched samples were obtained by inoculating a 100 mL
culture of T7 ΔtrxA -G5 (at ODλ= 6000.2) with 0.75 mL of non-enriched lysate (MOI =
0.5), then centrifugating and filtering the cleared lysate as above. Plaque assays were
then performed on T7 ΔtrxA -G5 E. coli cells as described in section 3.4.5.
Recombination in continuous culture
Co-infection and recombination in continuous culture was carried out in a continu-
ously diluted cellstat that was fed by two chemostats in a 50/50 ratio. Tubing and other
hardware are described in section 3.4.10 and on the Evoprog constortium website
(Polesel et al., 2016). The system was setup to maintain the ODλ= 600 in the chemostats
close to 0.6, and allow a dilution rate of 20 minutes in the 2 mL cellstat, as described in
figure 3.4. The system was cleaned with 1 M NaOH overnight, rinsed and primed with
media before use. Cell cultures of the recombination strain (E. coli F+ ΔpifA ) and
the selection strain (E. coli ΔtrxA -G5) were grown overnight, refreshed (1:50 dilution)
grown to ODλ= 600=0.4, then placed in the chemostats. Cultures were grown in the
bioreactors for 4 hours during which the stability of the ODλ= 600 in both chemostats
was verified from waste outputs. Samples were taken just before T7 addition (t=30min),
just before PR100-cmk-trxA addition (t=60min) then every 30 minutes. After sample
5, phage was added in the chemostat containing the recombination strain, and the
final sample taken after 16 hours. The cellstat was inoculated by rapidly opening the
cap and inoculating it with 105 PFU of T7 phage, or 2×109 cfu of M13 phage. Samples
were taken from the cellstat waste output, centrifugated and filtered. Lysis assays used
10 µL of filtered lysate and 10 mL of recombination or selection strain.
3.4.7 T7 recombineering
All homologous recombination onto the T7 genome was targeted to the gp5 locus.
Homologous recombination plasmids containing the gene to be incorporated onto
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T7 was cloned between two 100 bp recombination arms homologous to T7 genes 4.7
and 5.3, on the plasmid pLitmus-chlor (Chloramphenicol resistant, pMB1 origin of
replication). The recombination leads to the deletion of base 14336, the first base after
the gp4.7 stop codon, through to base 16468, the last base of the gp5 stop codon. cmk
and trxA were used as selection markers in initial constructs, with trxA used alone
in later constructs, as described. Unless otherwise specified, MG1655 cells (recA+)
E. coli cells containing the HR plasmid were grown to O.D.600 0.2 and infected with
wild type T7 (M.O.I. 0.1). After ~2 hours, the lysate was filter sterilised and 0.75 mL
added into 150 mL of selection strain cells (either Δcmk ΔtrxA cells or ΔtrxA only
cells, transformed with pT7-G5). The resulting lysate was diluted and used for plaque
assays on selection strain cells. Single plaques were PCRed used primers G5F_new
and G5R_new to check for a correct sized insert and sequenced using G5F_new. Wild
type phage contamination, which is carried over from the recombination procedure,
was removed by serially diluting the plaque extract in LB and replating on selection
strain cells. Absence of wild type contamination was checked by PCR (using primers
CIE20 and G5F_new), then confirmed by plaque assay on cells without a G5 plasmid.
All recombinant T7 sequences were confirmed by sequencing the gene 5 region PCR
fragment.
3.4.8 UTR design
Cis-repressing cmk 5’UTRs were designed using a custom NUPACK script (Zadeh et al.,
2011). The code was identical to that described in appendix E but using the first 30
bases of the cmk sequence 5’ instead of the domain gfp variable (see cmk_5’_30bp in
appendix C). Stuctures were checked in NUPACK for prediction of correct structure
alone and for hybridisation with the RAJ31 sequence in complex.
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3.4.9 Kill curve assays
Kill curves were run with refreshed cultures of appropriate cells growth to O.D. 0.15,
then kept on ice until ready. 96 well plates were prepared in a cold room, by mixing
180 µL of cells and 20 µL of diluted phage (MOI 10-6). Plates were incubated at
4°C for 5 minutes, 37°C for 2 minutes, then transferred to a TECAN Infinite F-500
plate reader. Measurement cycles consisted of shaking (2 mm, orbital, 3 min), with
ODλ= 600 measured every 4 minutes. ODλ= 600 of 3 replicates is averaged with standard
deviations shown as error bars. For time to peak O.D., the time at highest ODλ= 600 is
shown. The first time points are ignored as the high apparent ODλ= 600 is an artefact
due to condensation on the plate lid.
3.4.10 Bioreactor construction
Interconnected bioreactors were constructed using silicone 2-stop tubing (Tygon
SI 3350, 1.42mm internal diameter), customised glass bottles (see appendix C), and
peristaltic pumps (Watson Marlow 403U). A 1602N Hova-Bator Incubator (G.Q.F.
Manufacturing Co, Savanah, GA, USA) was used to maintain a temperature of 37°C.
Small parts such as bottle holders were 3D printed with PLA using an Ultimaker 2 3D
printer (Ultimaker). 80 mm computer cooling fans with magnets attached were used
as magnetic stirrers. The system was maintained under pressure generated by the
peristaltic pumps and stirred with a magnet. Detailed construction information can
be obtained on the Evoprog.eu consortium website (Polesel et al., 2016).
3.4.11 Continuous culture of T7-circRAJ31 in bioreactors
For continuous culture of T7-circRAJ31, 4 cultures of Δcmk ΔtrxA cells were grown
overnight and refreshed, then grown to O.D. of 0.5 to 0.7. Chemostats were then loaded
with 32 mL of culture, and grown in continuous culture for 24 hours before phage
addition. Phage was added by loading the cellstats with 20 µL of diluted T7-circRAJ31
101
Chapter 3. Directed evolution of RNA parts with bacteriophage
phage (M.O.I. = 0.01), left unstirred for 10 minutes before restarting. Bioreactors
were run at various dilution rates, which are indicated in figure 3.9. Dilution rate
was adjusted during the run on the appropriate day, by adjusting the flow rate on
peristaltic pumps. Sampling was taken from the cellstat waste output. 2 mL were filter
sterilised and kept at 4°C, and 0.5 mL (unfiltered) used to make a glycerol stock (25%)
and stored at -80°C. 1 µL from phage sample each day were PCRed using primers
G5F_new and G5R_new, PCR purified and sent for sequencing using G5F_new and
G5R_new and PR2, and analysed for mutations.
3.4.12 Calculations of probabilities of mutation in trxA
To calculate the probability of a random mutation appearing in the trxA gene, a python
script was written. The script takes a DNA sequence as an input and goes through it
base by base, creating every possible single base mutation and evaluating whether it
is silent. The number of possible silent and non-silent mutations are then counted
and used to calculate the probability that a random mutation is silent.
3.4.13 Characterisation of mutated riboregulators
The sequences obtained after 12 days of continuous culture of the T7::circRAJ31 bac-
teriophage in pT7-cmk and UTR2-cmk samples were resynthesised as minigenes by
IDT DNA, and characterised with cisRAJ31, Nusl3 and Nusl6, three cis-repressed GFP
genes (see chapter 2). The TECAN fluorescence assays were conducted as described
in section 2.4.4, with ODλ= 600 and GFP fluorescence measurements taken during
exponential growth and plotted as GFP/ODλ= 600 during exponential phase.
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4.1 Introduction
Many RNA sensors exist in nature, and serve to regulate the transcriptome or to defend
against foreign sequences that are synonymous with infection (Filipowicz et al., 2008;
Jensen and Thomsen, 2012). Some sense generic patterns of RNA, such as dsRNA or
A/U rich RNA, while others are specific to a particular sequence. Unsurprisingly, many
sensors are protein based, for example Toll-Like Receptors (TLRs) or RNA binding
proteins. Others are only RNA based (many bacterial sRNAs) or include an RNA
component (e.g. chaperoned sRNAs, microRNAs). Because RNAs naturally base-pair
with complementary sequences, their structure offers an evident way of interacting
with other sequences specifically. Both RNA only sensors and ribonucleoproteins
(RNPs) use this mechanism to interact with their targets. In the case of RNPs, the
protein based component often carries out the function of the sensor, after an RNA-
based recognition.
Several natural RNA based sensors use a modular architecture, where a generic RNP
complex carries out a task after target recognition by an interchangeable, modular
sRNA (Meister and Tuschi, 2004; Barrangou et al., 2007). From a synthetic biology
point of view, modifying such a system to create sequence-specific sensors would be
of great interest. Such a device, if it could be programmed to respond to any RNA and
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result in targeted gene expression, could be used in synthetic systems that sense RNA
viruses, or the transcriptional state of natural systems. The base pairing properties of
RNA is an attractive way of providing programmability, as it can be used alongside
computational predictors of folding, as well as RNA design software, to create RNAs
with specific structures (Zadeh et al., 2011). However, to use these properties to create
programmable RNA sensors, a generalisable architecture of RNA sensors that relies
on base pairing must be designed.
One exciting new development in biological research has come from the study of
Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) (Barrangou et al.,
2007; Haurwitz et al., 2010). The CRISPR system is a mechanism of acquired immune
response found in bacteria and archaea. After viral invasion, the Cas system integrates
parts of the infecting phage DNA into the bacterial genome, between "protospacer"
motifs. These then get transcribed from the bacterial genome, and after processing,
are used as RNA guides that base pair with their phage targets, followed by interference
through cleavage of phage DNA or RNA. In CRISPR type II systems, the interference
complex is composed of a two-part sRNA guide which base pairs with its target,
and a single protein effector, Cas9, which cleaves the phage DNA. Using the Cas9
protein from Streptococcus pyogenes, this system has recently been engineered beyond
its natural capacity to cleave DNA targets, allowing the use of CRISPR to control a
number of biological reactions including activation and repression of arbitrary genes.
Furthermore, CRISPR targets are programmed by its guide RNA sequence (gRNA)
through base pairing, which make them an ideal molecule for integration within RNA
circuits.
4.1.1 Natural sensors of RNA
Sensors of specific RNAs are needed to accompany the many regulatory roles played
by RNA in all domains of biology. The existence of RNA viruses provides a second
incentive for the evolution of sensors of RNA, and many pattern specific RNA sensors
104
4.1. Introduction
are part of the innate immune response in humans. Broadly, both regulatory and im-
mune sensors of RNA, whether they detect endogenous or exogenous RNA sequence,
can be split into two groups: pattern sensors, and sequence sensors. Pattern sensors
recognise a particular two-dimensional or three-dimensional shape, or a chemical
pattern, regardless of the nucleotide sequence. Sequence sensors detect a specific
RNA sequence. Many RNA binding domains sense a specific sequence both through
the structure it folds into and the bases that compose it, and therefore belong to both
groups.
Sensors of specific sequences
Many natural RNA regulators are RNA sequences themselves, and interact with other
RNAs through base pairing (see fig. 4.1A). This is, by nature, sequence specific, even
if absolute complementarity is not always required and some sensors can tolerate
mismatches. In eukaryotes, siRNAs and miRNAs (Meister and Tuschi, 2004; Filipowicz
et al., 2008) are two large classes of regulatory sRNA. Their mature forms are generated
through different pathways, but once processed, both miRNAs and siRNAs base pair
with complementary sequences, then downregulate their targets through repression
of translation or degradation, in association with cellular proteins. Many prokaryotic
antisense RNAs work in similar ways. In E. coli, MicF is expressed as part of the stress
response pathway. It downregulates its target, ompF mRNA, by binding to its 5’ UTR
and blocking translation, then encourages its degradation by other factors (Delihas
and Forst, 2001). Similar RNAs exist in Gram-positive bacteria and in archaea (Durand
et al., 2012; Bernick et al., 2012). These bacterial sRNAs bind to complementary targets
through base pairing, but are often found in association with chaperones like Hfq,
although some work alone (Repoila and Darfeuille, 2009). Other cellular processes,
such as recognition of Shine-Dalgarno sequences by ribosomes, or of codons by
transfer RNA (tRNA) anti-codon loops, also function through RNA base pairing, and
could therefore be seen as sequence specific RNA sensors in this respect.
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Sensors of shapes
Other sensors detect specific patterns of RNA, rather than specific sequences. These
are common within innate immune response to RNA viruses, and bind to RNA patterns
that are typical of viral infection (see fig. 4.1B). For example, Toll-Like receptor 3
(TLR3) recognises double stranded RNA (dsRNA), whereas TLR7 binds to uridine-
and guanosine-rich single stranded RNA (ssRNA) (Jensen and Thomsen, 2012). Upon
sensing of their targets, TLRs activate downstream pathways of inflammation and
antiviral immune response. Other proteins, such as RIG-I (retinoic acid-inducible
gene I product), or MDA5 (melanoma differentiation-associated antigen 5), are also
involved in the recognition of viral-associated RNA patterns (Jensen and Thomsen,
2012). Both are activated by dsRNA, with the former also activated by triphosphate
ssRNA – an indicator of foreign RNA, as human transcripts are usually capped.
Many RNases are also specific to certain patterns, often as part of endogenous RNA
processing pathways. In bacteria, RNase III cleaves dsRNA, RNase H cleaves DNA-RNA
duplexes, whereas RNase E has a preference for A and U rich single stranded regions
(Deutscher, 2006; Majorek et al., 2014).
Sensors of both sequence and shape
Finally, many proteins recognise specific sequences, but through recognition of both
the structure of RNA and of its specific sequence, without any base pairing mechanism
(see see fig. 4.1C). Usually, they bind to the specific stem-loop structures of their
targets. MS2 coat protein (MCP) and PP7 coat proteins (PCP) are phage proteins that
bind to the RNA genomes of the phages that code for them, serving as the basis of
the viral capsids as well as acting as translational repressors (Fouts et al., 1997; Lim
and Peabody, 2002). MCP interacts with the MS2 stem-loop structure, making contact
with the phosphate backbone of the stem, as well as with exposed bases in the loop
and in a bulge within the stem (Valegard et al., 1997). Similar proteins exist on other
phages of the same family, each with its own target RNA sequence, usually a stem-loop.
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These RNA binding proteins can be fused with others to create chimeric proteins that
target specific RNA sequences (e.g. Lange et al., 2008; Delebecque et al., 2011).
Other bacterial proteins also interact with their targets through stem loop motifs. The
Hfq chaperone, which binds E. coli sRNAs, interacts with its targets through conserved
motifs (Updegrove et al., 2016). The Cas9 protein of the CRISPR system recognises the
Cas9 handle, formed by the crRNA and tracrRNA, with CRISPR family nucleases from
different species recognising different sequences (Esvelt et al., 2013).
Some sequence specific RNases are also specific to a sequence and the structure it
folds into. One example is Csy4, which is responsible for processing the pre-crRNA of
the E. coli CRISPR system. It recognises a 16 nucleotide stem loop, making contact
with nucleotides and the phosphate backbone before cleaving, and is unable to cleave
the similar stem-loop from Streptococcus thermophilus (Haurwitz et al., 2010).
107
Chapter 4. RNA sensors
A
miRNA / siRNA
Sensors through base pairing
B Sensors of shapes
Sensors of both shape and sequenceC
MCP, PCP Specific RNAses
         
  
   
 
   
 
                 
 
 
  
 
 
 
 
 
 
 
  
 
 
                
   
 
   
  
        
                                                   
                                                   
                        
                        
                      
                      
                        
                      
 
   
 
   
 
             
Processing, association 
with RISC
mRNA silencing or 
degradation in 
eukaryotes 
16S ribosomal 
subunit
                                                   
                                                   
                        
                        
                      
                      
                        
                      
Base pairing with Shine-
Dalgarno sequence
sRNAs
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
    
Hfq dependent or independent 
base pairing with target,
Silencing, degradation
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
1
87
User file #10
TLR3/TLR6/ RIG-I/MDA5
Sense dsRNA, 
uncapped RNA, 
non-self RNA
Activation of immune response
RNAses
         
  
   
 
   
 
                 
 
 
  
 
 
 
 
 
 
 
  
 
 
                
   
 
   
  
        
         
  
   
 
   
 
                 
 
 
  
 
 
 
 
 
 
 
  
 
 
                
   
 
   
  
                   
   
 
   
 
               
   
 
  
 
 
 
 
 
 
 
  
 
 
               
 
   
 
   
  
        
RNAse III:
dsRNA
RNAse H:
RNA/DNA 
duplexes
RNAse E:
A/U rich ssRNA
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
    
1 75
User file #11
Bind to MS2 
RNA, PP7 RNA
Cas9
Binds to Cas9 
handle
Chaperones – eg. Hfq
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
1
87
User file #10
Binds and 
chaperones sRNA via 
Hfq binding sites
Eg. Csy4 cuts specific 
RNA stem loop
Figure 4.1 – Types of natural RNA sensors. A: Natural RNA-based RNA sensors often
pair with their targets through base pairing. miRNAs and siRNAs, associate with
cellular co-factors such as the RISC complex during processing. They then base
pair with their targets, often mRNA, and downregulate it. Bacterial sRNAs also base
pair with their targets. The 16S ribosomal subunit interacts with ribosome binding
sites through the anti-SD sequence. B: Many sensors and RNases are specific to
RNA shapes or patters rather than sequence. TLRs and other human innate immune
response proteins recognise dsRNA and other types of non-self RNA. Several RNases
are specific, like RNase III, RNase H and RNase E. C: Some proteins are sequence
specific but recognise their target through secondary structure as well as sequence.
Examples include MS2 and similar phage coat proteins that bind to RNA loops, Cas9
and the Cas9 handle, or bacterial chaperones. Csy4 is a sequence specific RNase
targets a stem-loop.
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4.1.2 Synthetic RNA sensors
Synthetic RNA sensors have been engineered, and like natural sensors, they could be
divided into pattern-detectors and sequence-detectors. However, most attempts to
engineer RNA sensors have focused on the development of sequence specific devices
rather than pattern-sensing ones. One exception is the use of RNA binding proteins
such as the MS2 coat protein, that sense a fixed sequence, to target modified RNAs. To
do this, MS2 binding loops are cloned to the 3’ of the RNA of interest, and an MS2-GFP
fusion is co-expressed alongside the target mRNA in vivo. A similar approach can
be taken with PP7, Com, or other comparable RNA binding proteins. This allows the
visualisation of RNA expression and localisation in living cells (Bertrand et al., 1998).
By repeating this with the PP7 fused with mCherry, different RNAs can be targeted
simultaneously (Coulon et al., 2014). Other similar RNA binding proteins can also be
used for this purpose (e.g. Lange et al., 2008).
However, the use of these sequence specific sensors require the engineering of the
RNA of interest to introduce the MS2 and PP7 binding loops, limiting the use of this
strategy to artificial systems where the target sequence can be introduced. Most
unmodified sequences do not contain RNA binding protein sites, so this approach
is not generalisable. The re-engineering of sensing systems that detect their targets
through base pairing is therefore of great interest, as it could theoretically permit the
creation of a generic strategy for RNA sensor engineering. Past attempts at creating
such generalisable sensors are described below.
Trans-splicing ribozymes
Self-splicing group I intron ribozymes, such as the ones used to create circular riboreg-
ulators, can be split into two separate parts by removing the P6 loop, then expressing
them from different promoters (Galloway Salvo et al., 1990; Sullenger and Cech, 1994).
When transcribed, the two RNA parts still hybridise, and fold into a functional ri-
bozyme. The splicing reaction then ligates the exon sequences, as it does in the wild
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type system, resulting in an effective in vivo RNA ligation. The ribozyme splicing sites
also can be modified, so long as the secondary structure of the P1 and P10 stems,
where the splice targets are located, remain the same, and that the 5’ splice target is
a U base (Köhler et al., 1999). Trans-splicing ribozymes hybridise with their target
RNAs at their 5’ end – called the internal guide sequence (IGS) – and reform the P1
stem. Complementary changes at the 3’ end of the ribozyme allow the formation of
the P10 stem. The sequence downstream of the 3’ splice site is then ligated onto the
target RNA. Trans-splicing ribozymes can therefore be engineered to target a specific
RNA sequence, and replace its 3’ sequence with an arbitrary one placed on the trans-
splicing ribozymes. The specificity and activity of such trans-splicing ribozymes has
been improved by the addition of an external guide sequence (EGS), which consists of
a 100 nt antisense RNA that binds downstream of the target, bringing the ribozyme
and its target closer together (Köhler et al., 1999). Trans-splicers have been used
mostly with medical applications in mind, such as to target and repair mRNAs in vivo
(Sullenger and Cech, 1994; Lan et al., 1998; Nawtaisong et al., 2015). However, they
are programmed using the base-pairing rules of RNA, to splice onto their target in
a sequence specific way, and are therefore a form of sensor. Furthermore, the cargo
which is spliced onto the target could code for various protein outputs, which could
in turn activate other circuits.
Artificial ribozyme based RNA sensors
Hammerhead ribozymes (HHR) are self-cleaving ribozymes that were originally dis-
covered in plant viruses and viroids, and are widespread genetic elements found in
bacteria and eukaryotes (Hutchins et al., 1986; de la Peña and García-Robles, 2010).
Engineering of aptamer or sRNA binding regions into the loop of the HHR stem 3
has allowed the creation of sensor HHRs which are activated or repressed upon small
molecule addition (Yen et al., 2004; Klauser and Hartig, 2013). Depending on the
placement of the sensor region, the binding of the ligand stabilises or destabilises
the ribozyme core, permitting or blocking cleavage. Cleavage releases a cis-repressed
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mRNA at the ribozyme 3’, or in eukaryotes, encourages RNA degradation. Sensing of
the ligand is therefore linked to gene expression. Shen et al. (2015) added an extra layer
of complexity, with the "regazyme", a small molecule or sRNA inducible ribozyme
which releases another sRNA. This sensor acts as an RNA-based 2 component cir-
cuit, with the released sRNA able to activate downstream genes. One advantage of
this system is that it is transportable between organisms, as the HHR self-cleaves
in prokaryotes and eukaryotes (Klauser and Hartig, 2013). As with trans-splicing ri-
bozymes, the RNA base-pairing rules which govern the programming of such systems
are a key element as such devices could in theory be expanded to any organism and
to many RNAs.
Toehold switches for mRNA sensing
Toehold switches (Green et al., 2014), described in section 1.2.1, can be targeted to
mRNA sequences and act as sensors in E. coli. mRNA sensing toehold switches were
slightly modified relative to the synthetic trigger-sensing switches, with an increased
toehold length (from 12 or 15 nt to ≥ 24 nt), which aimed to decrease the sensitivity of
the sensors to mRNA secondary structure. The authors were able to create sensors
of a fluorescent protein mRNA (mCherry), of antibiotic resistance genes (cat and
aadA), and of a natural E. coli sRNA (rhyB). The sensors are designed automatically
using the NUPACK design suite, and the absence of sequence constraints makes them
theoretically adaptable to any target RNA. This adaptability might be constrained by
the secondary structure of the target sequence, which could render it inaccessible, or
by certain sequences which might disrupt the switch if they interacted with elements
such as the RBS. However, when sensing mRNAs, there is usually some flexibility in
the choice of the trigger sequence, as different parts of the mRNA can be targeted.
The toehold switch design has also been used in vitro, using cell free extract, and can
be freeze dried on paper to create portable RNA sensors (Pardee et al., 2014). The
combination of paper based toehold switches with an isothermal RNA amplification
method (NASBA, Nucleic acid sequence–based amplification) and with CRISPR-Cas9
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proteins targeting specific strains allowed the creation of femtomolar-sensitive, strain
specific sensors of Zikavirus (Pardee et al., 2016). Although toehold switches are
probably the most accomplished programmable RNA sensors, through their simple
mechanism, high sensitivity and flexible programmability, one important constraint
is that they are not portable across organisms. The riboregulator mechanism which
they are based on depends on the obstruction of the Shine-Dalgarno sequence and
the start codon of mRNAs, which is inherent to bacterial and archaeal mRNAs. In
eukaryotes, the riboregulator / toehold switch mechanism for control of translation
initiation cannot be directly transposed as initiation of translation is dependent on 5’
capping of mRNA (Shatkin, 1976). A second constraint is that their output is limited
to activation of protein production encoded by the switch RNA. Although this can
indirectly lead to other effects, toehold switches cannot directly regulate host gene
expression upon activation.
RNA-targeting CRISPR systems
Since the discovery of the CRISPR-Cas system as an RNA guided programmable de-
oxyribonuclease, several other CRISPR systems have been discovered. All involve
RNA-guided interference, usually directed at phage sequences. Type 1 systems do this
through a multi-protein complex, whereas type II use a single protein effector. Within
class 2, type II use the Cas9 protein to cleave its DNA target with its two RuvC and
HNH nuclease domains. Type V use a single nuclease domain containing protein (e.g.,
Cpf1, see Zetsche et al., 2015a). Although these systems target DNA, some CRISPR
classes can additionally target RNA, such as type III-A and type III-B (Zetsche et al.,
2015a; Jiang et al., 2016). The C2c2 protein used by Class 2 type VI systems has been
shown to be a single-component CRISPR system that only targets RNA (Abudayyeh
et al., 2016). These systems are not true sensors, as they can only downregulate their
RNA targets rather than activate genetic pathways upon their detection. However they
are RNA-programmable systems that recognise their targets through base pairing.
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4.1.3 CRISPR-Cas9
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a system for
adaptive immune response in bacteria (Barrangou et al., 2007). The CRISPR system
is composed of a protein ’effector’, the Cas9 protein, which contains two nuclease
domains that cleave each strand of the DNA after an RNA-programmed targeting.
The RNA sequence, called the guide RNA (gRNA), determines what sequence the
Cas9 protein binds to, through complementary base pairing with DNA. Differences
between gRNA expression in natural settings and engineered synthetic gRNA (sgRNA,
although synthetic versions are also referred to as gRNAs), are described in figure 4.3.
A generic gRNA is 100 to 105 nt long: 20-25 nt of targeting region, 42 nt of Cas9 handle,
and 38 nt S. pyogenes terminator (see fig. 4.2). The seed region has been shown to
be more important for binding than the 5’ end of the gRNA (Jiang et al., 2015). As
the gRNA is a small RNA part, its secondary structure and base pairing with DNA are
responsible for both the binding of the protein effector and for pairing with the target,
and as its sequence and structure are relatively simple, gRNAs are good parts to be
incorporated into synthetic RNA circuits.
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Figure 4.2 – 2D diagram of a sgRNA, with the cas9 protein location on the RNA shown
in orange. The blue region is complementary to the CRISPR target, with the ’seed’
region shown in a darker blue. The Cas9 handle is shown in red. the S. pyogenes
terminator used is shown in dark red.
113
Chapter 4. RNA sensors
4.1.4 Engineering of Cas9
After RNA-programmed targeting of Cas9 to a specific sequence, the two DNA strands
are cleaved by the RuvC and HNH nuclease domains (Jinek et al., 2012). Point mu-
tations deactivating either one of these nuclease domains or both have allowed the
creation of nickases (Cong et al., 2013; Ran et al., 2013), and of a catalytically inac-
tive ("dead") dCas9 (Qi et al., 2013). Nickases can be used to engineer eukaroyotic
genomes through the homology directed repair system (which is triggered by nicks in
the genome) rather than through the error-prone non-homologous end joining repair
system (triggered by double-stranded breaks). The catalytically inactive dCas9 was
first used by the authors to develop CRISPR interference (CRISPRi). They used dCas
and its gRNA to target E. coli promoter regions. As the nuclease sites are inactive, the
dCas9 remained bound to the DNA, blocking initiation of transcription and effectively
acting as an RNA-programmable repressor.
This transformation of dCas9 into an RNA-guided DNA binding protein opened up
the path to further innovations, by fusing the dCas9 with other effector domains. As
dCas9 had low activity in eukaryotic cells (Qi et al., 2013), the addition of repressor
domains permitted the improvement of CRISPRi in eukaryotes. This was achieved
with Krüppel-associated box (Cas9-KRAB) and mSin3 interaction domains (Cas9-
SID) in humans, or Max-interacting protein (Cas9-Mxi1) in yeast (Gilbert et al., 2013;
Konermann et al., 2013). Similarly, the fusion of dCas9 with an Ω subunit of RNAP
(in E. coli) or with a VP64 domain (in humans) allowed gRNA-targeted activation of
transcription, called CRISPR activation (CRISPRa, Bikard et al., 2013; Gilbert et al.,
2013).
Other modifications include the creation of a split and photoactivatable Cas9 (Zetsche
et al., 2015b; Hemphill et al., 2015), of fluorescent protein tagged Cas9 for imaging of
specific loci and the study of chromosome dynamics (Chen et al., 2013), as well as the
use of Cas9 proteins from other organisms with differing PAM requirements (Esvelt
et al., 2013). These diverse modifications of the Cas9 protein have greatly expanded
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the usefulness of CRISPR beyond that of a programmable nuclease, and transformed
it into an RNA-guided platform for carrying out many operations in living cells.
4.1.5 Engineering of CRISPR gRNAs
Asides from the aforementioned modifications to the Cas9 protein, the gRNA sequence
itself has also been engineered. The first change was the creation of the artificial guide
RNA (gRNA), also known as a synthetic gRNA (sgRNA). This was done by fusing the 3’
end of the crRNA and 5’ end of the tracrRNA through a short loop (Jinek et al., 2012).
The two RNAs present in the natural CRISPR system are thus replaced by a single
chimeric gRNA, reducing the number of required components to two (Cas9 + gRNA)
and removing the requirement for in vivo RNA processing (see fig. 4.3). The sgRNA
was then modified by extending both stem loops and flipping an A-U base, which
seems to increase Cas9 activity in human cells, possibly by stabilising the gRNA (Chen
et al., 2013). Further modifications of the gRNA led to the observation that cleavage
was reduced if shorter gRNA targeting regions are used. At targeting region lengths
between 12 and 16 nt depending on the target, this is due to a lack of cleavage by Cas9,
despite the protein binding the DNA correctly (Kiani et al., 2015). This allowed the
authors to simultaneously cleave certain sites and activate transcription at others, by
using a single Cas9-VPR protein fusion and varying full length and truncated gRNAs.
Sites targeted by full length gRNAs get cleaved, whereas those targeted by truncated
RNAs are transcriptionally activated by the VPR subunit. The targeting efficiency of
truncated gRNAs was also tested using CRISPRi by Qi et al. (2013), who found that
repression efficiency dropped to about 15-20% of maximum efficiency using a 12 to
18 nt gRNA, and then was completely abolished with targeting region of 11 nt or less.
Although they did create new gRNA structures, Thyme et al. (2016) showed that the
formation of secondary structure in the targeting region reduces or abolishes gRNA
activity. The authors tested the ability of several gRNAs to cleave DNA sequences in
vitro and in vivo. gRNAs that contained hairpin sequences in the targeting regions
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were inactive, and could be repaired by substituting bases to remove the secondary
structure. At least some of these inactive gRNAs were also found to successfully bind
to the Cas9 protein in vitro and could be used to sequester Cas9 proteins away from
active gRNAs, suggesting that the inhibition of the reaction by secondary structure
happens at the level of the DNA targeting. Thyme et al. (2016) also found that in
cases where the targeting region forms secondary structure with the Cas9 handle
of the gRNA, the Cas9 handle can be engineered to remove such interaction. Base
pairs of the handle that do not interact with the Cas9 protein (according to the crystal
structure) were substituted with another base pair, such that the secondary structure
of the Cas9 handle was maintained, but the interaction with the targeting region was
removed. This greatly increased gRNA activity, showing both that the gRNA structure
affects its activity, and that the Cas9 handle can tolerate modifications. Lee et al.
(2016) exploited this property of the gRNA and showed that they could modulate RNA
activity by engineering the Cas9 scaffold and introducing secondary structure, this
time from an artificial antisense sRNA targeted at the gRNA. The asRNAs had regions
complementary either to the gRNA targeting region, or to artificial additions within
the Cas9 scaffold, further confirming the flexible nature of the gRNA scaffold, and
the possibilities offered by modulation of its secondary structure. Another recent
development is that of small-molecule responsive gRNAs, created by incorporating a
riboswitch module at the 3’ of the gRNA (Liu et al., 2016). This module contains an
antisense stem that base pairs with the gRNA targeting region, and an aptamer. In the
absence of the small molecule trigger, the binding of the antisense stem with the tar-
geting region inactivates the gRNA. Upon small molecule binding to the aptamer, the
antisense stem is displaced, freeing the targeting region. The gRNA is then reactivated
and can cleave, repress or activate its target depending on the Cas9 variant used.
The authors built various aptamer-containing gRNAs, allowing the detection of small
molecules like tetracycline and theophylline, as well as of cancer-linked proteins such
as p53, HSF1 and NF-κB. Since aptamers can be generated in vitro by Systematic evo-
lution of ligands by exponential enrichment (SELEX, Tuerk and Gold, 1990; Ellington
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and Szostak, 1990), any molecule for which an aptamer can be succesfully created
could theoretically be used as an input. As an output, the method offers the same
advantages as those of CRISPR, and any DNA sequence could be cleaved, repressed or
activated through CRISPR, CRISPRi or CRISPRa.
The Cas9 handle has also been engineered to incorporate MS2 and PP7 protein binding
sites in order to permit the engineering of more complex "transcriptional programs"
(Zalatan et al., 2015). These stem loops are added to the 3’ of the gRNA, sticking out
of the Cas9-gRNA complex. A series of fusion proteins were built, containing on one
hand an RNA binding protein such as the MS2 coat protein (MCP), PP7 coat protein
(PCP) or Com, and on the other hand a transcriptional repressor or activator domain
such as KRAB or VP64, respectively. The authors showed that an MS2 gRNA combined
with an MCP-VP64 fusion could activate gene expression, and a com-containing gRNA
used in conjunction with a Com-KRAB could repress gene expression. This approach
encodes the repressing/activating activity in the gRNA rather than in the protein.
Using Cas9-VP64 or Cas9-KRAB, the activator or repressor domain would be targeted
to any gRNA target present. With this system, one gene can be activated while another
is simultaneously repressed, without cross-activation.
Finally, gRNAs have been combined with ribozymes or RNase targeting sites, both to
remove upstream and downstream transcribed sequences, and for the multiplexing
of multiple gRNAs within a single sequence. Methods have included the use of auto-
catalytic ribozymes such as the Hammerhead ribozyme (HHR) or the Hepatitis Delta
Ribozyme (HDV), the addition of Csy4 targeting loops to either side of the gRNA, or
the addition of flanking tRNAs, which get cleaved by the endogenous RNase P and
RNase Z tRNA processing ribozymes (Nissim et al., 2014; Tsai et al., 2014; Xie et al.,
2015).
To determine whether sensors could be created using CRISPR-Cas9 based outputs, we
designed and tested two strategies for creating sensors. The first strategy is derived
from the regazyme system, where a small molecule or a sRNA activates cleavage of an
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aptazyme. We hypothesised that gRNAs would be inactive unless released from the
aptazyme, and therefore that sensors with a gRNA output could be created if gRNA
release was dependent on small-molecule or sRNA induced cleavage of the ribozyme.
gRNAs were found to function even without the removal of the 5’ elements, which
led to a second strategy whereby RNA-binding regulatory elements were placed at
the 5’ of the targeting region. The hypothesis that artificial 5’ elements could block
gRNA function by secondary structure was tested, and used to create computationally
designed CRISPR gRNA based sensors of RNA sequences.
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Figure 4.3 – gRNA engineering strategies. A: i)Processed wild type gRNA, with a crRNA
(cyan) and tracrRNA (Red), and terminator (dark red). ii) Synthetic one-piece gRNA,
joined by a loop (black). iii) Extended gRNA with extended stems. Some base pairs
can also be replaced. iv) Truncated gRNAs between 12 and 16 bases allow Cas9
binding but not cleavage. B: i) Addition of a stem such as MS2 allows the targeting
of MCP fused proteins to the gRNA. ii) asRNAs can block gRNAs, by targeting the 5’
or an artificial linker. iii) Riboswitch gRNAs can be built by adding small molecule
or protein binding aptamers in the gRNA, along with a sequence complementary to
the targeting region. The complementary sequence blocks the trigger region, but is
displaced by the stabilisation of the stem caused by small molecule addition. C. i)
gRNA flanked by HHR and HDV ribozymes, which self-cleave and remove surrounding
sequences. ii) Csy4 flanked gRNAs are processed by the Csy4 RNase, and can be used
for gRNA multiplexing. iii) tRNAs can be used the same purpose, but are processed by
endogenous RNase P and RNase Z.
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4.2 Results
4.2.1 Design of the ’Crisprzyme’
Shen et al. (2015) previously described the ’regazyme’, small molecule or sRNA-
activated ribozymes which releases a riboregulator when cut. Regazymes can be
responsive to small molecules, such as theoHHAzRAJ11 which is theophylline acti-
vated, or sRNA activated, such as breakHHRzRAJ12. Both self-cleave after binding
their target. To create sensors of small molecules and RNAs that create an output
using the Cas9 protein as an effector, the theoHHAzRAJ11 regazyme was used as a
starting point. The aim was to create an aptamer-ribozyme fusion ("aptazyme") that
would cleave upon theophylline binding, and release a functional gRNA after cleavage.
This provided a simple system to test the compatibility of gRNAs with regazymes, and
one that could theoretically be extended to RNA-activated regazymes.
To maintain the structure of the regazyme, the first 25 bases of theoHHAzRAJ11 were
kept unchanged. Bases beyond 25 were removed and replaced with the Cas9 handle
and S. pyogenes terminator (see fig. 4.4A). These changes did not affect the predicted
secondary structure of the ribozyme core, which was verified using the NUPACK
software. The crisprzyme was thus designed to self-cleave upon theophylline binding,
releasing a functional gRNA. An artificial promoter region, composed of the J23119
promoter and the reverse complement of the 25 bases of theoHHAzRAJ11 was cloned
upstream of the B0034 RBS and the superfolder GFP gene (see fig. 4.4B). This artificial
promoter allowed the core of the crisprzyme to remain unchanged, identical to that
of the theoHHAzRAJ11 regazyme, reducing the chance that the modifications would
disrupt activity of the regazyme.
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GAAATTAGTTGTGCCACCTTAGGTC
TGACAGCTAGCTCAGTCCTAGGTATAATGCTAGCCTCTTTAATCAACACGGTGGAATCCAGAAAGAGGAGAAATACTAG
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Figure 4.4 – A. Design of the CRISPRzyme, based on theoHHAzRAJ11 regazyme (Shen
et al., 2015). The core sequence of the regazyme was kept unchanged, whereas the
downstream sequence was replaced with the Cas9 handle and S. pyogenes terminator.
Partially adapted from (Shen et al., 2015). B. Promoter reverse engineered to be
targeted by the gRNA released by the crisprzyme. The gRNA sequence is shown in red,
the Cas9 protein in orange.
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A plasmid containing the crisprzyme expressed from a PL-Lac promoter and an sfGFP
gene (Pédelacq et al., 2006) expressed from the synthetic promoter was constructed.
This was co-transformed with a second plasmid coding for the dCas9 protein (Qi
et al., 2013; Bikard et al., 2013). The circuit was designed to express the crisprzyme
RNA upon IPTG induction, and to only cleave upon theophylline addition. A working
circuit would repress sfGFP in the presence of both molecules only (see fig. 4.5A). The
crisprzyme device was transformed into MG1655-Z1 E. coli cells, with or without the
dCas9 plasmid. The fluorescence of cells grown in the presence or absence of IPTG (to
induce crisprzyme transcription) and theophylline (to induce cleavage) was measured
(see fig. 4.5B). A slight reduction of GFP fluorescence (~25 %) was observed when the
crisprzyme gRNA was co-expressed with a CRISPRi protein, compared to when the
RNA was not expressed. This reduction was not observed in the absence of CRISPRi,
suggesting that the gRNA was indeed repressing the transcription of GFP. However,
the addition of theophylline to the system when the gRNA was expressed did not
change the fluorescence levels. This suggested two possibilities that this assay could
not differentiate: Either the ribozyme can cleave without any need for theophylline,
or the uncleaved gRNA could repress transcription via CRISPRi, despite the presence
of the 79 base pair ribozyme at its 5’ end. The reduction in fluorescence levels was
also very low, although whether this was due to a weak promoter, an inefficient gRNA
target, or to the structure of the RNA cannot be determined by this experiment.
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Figure 4.5 – A. Circuit used for crisprzyme characterisation. B. Fluorescence of E.
coli cells containing the crisprzyme and reporter system, with or without a CRISPRi
expressing plasmid co-transformed.
4.2.2 Uncleaved crisprzymes repress transcription
Two modifications were then made to the crisprzyme. First, the sequence was modi-
fied to target a chromosomal pLacIq promoter that controls lacI transcription from
the E. coli chromosome, in order to create an amplifying circuit. Second, an HDV
ribozyme was added to the 3’ of the crisprzyme to ensure any terminator readthrough
sequence was removed (see fig. 4.6A). To establish whether the crisprzymes were
cleaving properly and whether they could repress transcription without cleaving, a
crisprzyme system was expressed in vitro along with a splicing deficient mutant G12A
(Ruffner et al., 1990), and cleavage upon theophylline addition was followed over time
(See fig. 4.6B). The cleavage products were observed on a gel, which showed that
whilst the crisprzyme cleaves upon addition of theophylline, the G12A mutant does
not. This confirmed the mutant as an effective non-splicing control. The crisprzyme
circuit was then placed under the control of a constitutive promoter, on the same
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plasmid as an sfGFP gene under the control of a PL-LacO1 promoter. The construct was
co-transformed with the dCas9 plasmid into E. coli MG1655-Z1 cells, which expresses
the LacI repressor from a pLacIq promoter (fig. 4.6C), and the fluorescence of cells
expressing this circuit measured (See fig. 4.6D). As the new circuit represses LacI
expression, which in turn represses GFP, functional CRISPRi repression results in an
increase in GFP. While the pLacIq was found to have low fluorescence consistent with
repression of GFP by LacI, both the crisprzyme and the G12A mutant were found to
have high fluorescence, in the absence of theophylline. The G12A mutant, which does
not self-cleave, had similar levels of fluorescence as the cleaving Crisprzyme. These
results indicated that the uncleaved RNA can still function as a CRISPR gRNA despite
the presence of the ribozyme at its 5’.
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Figure 4.6 – A: Modified Crisprzyme with an HDV self-cleaving ribozyme at its 3’. B:
Cleavage of HHR crisprzyme over time after theophylline addition. In vitro transcribed
crisprzyme on the left, G12A mutant on the right. L: Riboruler low range ladder. 0, 5,
10: Minutes after theophylline addition. C: Modified crisprzyme circuits. The gRNA,
in complex with Cas9, represses the pLacIq promoter on the E. coli genome. LacI
represses sfGFP. D: Fluorescence of E. coli cells expressing the pLacIq crisprzyme, the
G12A mutant, or a pLacIq targeting mutant.
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4.2.3 Base pairing in targeting region inhibits gRNA activity
Although the crisprzyme design did not behave as desired, the observation that a long
5’ element upstream of the gRNA targeting region does not inhibit gRNA function led
to the hypothesis that artificial cis-regulatory elements could be placed at the 5’ of an
engineered gRNA. For example, if a 5’ overhang could be used to inhibit gRNA activity
by base pairing, the use of a second regulatory element controls this base pairing by a
strand-displacement mechanism (Hochrein et al., 2013; Šulc et al., 2015; Rostain et al.,
2015) could be envisioned. To evaluate this idea, the hypothesis that gRNA function
could be inhibited by an artificial 5’ cis-regulatory structure was tested. A series of
gRNAs were constructed with a 5’ overhang that was predicted to fold back onto the
targeting region (see fig. 4.7). The targeting region of the gRNA is the same as used in
section 4.2.2, targeting the pLacIq promoter. The 5’ overhang contains a 15 nt loop
region, and a clamp region with varying lengths, from 7 to 15 nt.
gRNA Targeting region
15bp loop
Clamp
(7 to 15 bp)
3’
5’
Cas9 
handle
S. pyogenes
terminator
Figure 4.7 – Predicted secondary structure of the self-repressing gRNAs. The 20 nt
targeting region (light and dark blue) is repressed by a clamp region (violet), to which it
is complementary. A 15 nt loop region (Cyan) separates the two. The clamp was varied
from 7 to 15 nt. The Cas9 handle and terminator (red and dark red) are unmodified.
The 15 base pair loop was picked such that it was complementary to an unstructured
region of the mKate2 mRNA, and that it did not disrupt the formation of the target
structure. To find a sequence that respected these constraints, a custom NUPACK
design script was made (Zadeh et al., 2011; Wolfe and Pierce, 2014). The script first
folds the mKate2 RNA in a windowed fashion to find unstructured 15 nt regions, then
designs a sequence that satisfies the described constraints (see appendix E).
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This script was used to design a gRNA with a clamp length of 13 nt. 8 more variants
were then built by adding or removing bases complementary to the trigger, represent-
ing all 9 gRNAs with clamp lengths from 7 to 15 base pairs. The variants were then
re-analysed with NUPACK secondary structure analysis software (Dirks and Pierce,
2003; Dirks et al., 2004, 2007) to ensure correct folding.
The various switch plasmids were co-transformed with a dCas9 containing plasmid
into MG1655-Z1 E. coli cells. This created a similar circuit to that used in section
4.2.2. An active gRNA-dCas9 complex represses LacI production, and LacI represses
GFP production. Thus, active gRNA-dCas9 indirectly induces GFP production (see
fig. 4.8A). The fluorescence of cells containing modified gRNAs with different clamp
lengths was measured during exponential growth. Negative controls containing only
the gRNA or the dCas9 plasmid, and a positive control containing 2 mM IPTG (to
inhibit the LacI repressor) were grown alongside. Cells containing shorter clamps
had higher fluorescence, showing the dCas9-gRNA complex was repressing the LacI
protein. As the clamp got longer, fluorescence decreased, showing a reduction in
gRNA-dCas9 repression efficiency (see fig. 4.8B). The highest fluorescence was seen
with a 8 nt clamp (around 70 A.U.), higher than the 7 nt (about 40 A.U.). Otherwise,
fluorescence was gradually lower as clamp length got longer. The 12 nt clamp had
the lowest fluorescence (10 A.U.), and samples with 13-15 nt clamps also had low
values (< 13 A.U.). Cells induced with IPTG had high fluorescence (70 A.U.), and
cells containing only part of the gRNA-dCas9 complex had very low fluorescence
(< 5 A.U.), showing that LacI was repressing GFP production and that its inhibition
restores fluorescence. These results indicated that the gRNAs effectiveness at targeting
the dCas9 protein could be inhibited by the addition of a cis-repressing regulatory
sequence at its 5’ end.
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Figure 4.8 – A. Circuit used for cis-repressed gRNAswitch characterisation. B. GFP
fluorescence of MG1655-Z1 cells co-transformed with switches with varying clamp
lengths. ’No Cas9’ cells contain only the GFP and gRNAswitch plasmid. ’No gRNA’
cells contain only the dCas9 plasmid. Sample noted IPTG was grown with 2 mM
IPTG. Error bars represent standard deviation between three biological replicates.
The fluorescence of samples noted IPTG, No gRNA or No dCas9 are averages of two
biological replicates.
The fluorescence of the same circuits was then measured at the single cell level using
flow cytometry (see fig. 4.9). The same cells were grown to mid exponential phase
and measured for GFP fluorescence. Similarly, the cells were found to have low fluo-
rescence with long clamps, and higher fluorescence with short clamps. Interestingly,
cells with medium length clamps had one population with low fluorescence and a
tail of cells with higher fluorescence. The declining fluorescence of cells with higher
clamp lengths seen in figure 4.8 seems to be due to a mixed population of OFF and
partially ON cells rather than to a linear change in GFP expression.
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Figure 4.9 – Flow cytometry measurements of GFP fluorescence of MG1655-Z1 cells
co-transformed with varying clamp lengths, as described in fig. 4.7. ’GFP’ cells (yellow)
contain only the GFP and gRNAswitch plasmid, and are grown with or without 2 mM
IPTG. ’Cas9 only’ cells contain only the dCas9 plasmid.
4.2.4 Design of an RNA activated gRNA
The next step was to determine whether a gRNA with a regulatory self-repressing
5’ region (called the "gRNAswitch") could be engineered such that it switches back
on after hybridisation with a target RNA (the "trigger" RNA). The gRNAswitch, was
designed with a classic gRNA plus a 5’ region composed of three elements: The 15 nt
loop, a 13 nt clamp, and a 15 nt toehold (see fig. 4.10A and B). The loop and clamp
are designed as described above. The 15 nt toehold, like the loop, is complementary
to the target RNA. The loop and toehold complement regions on the target RNA are
separated by a spacer (fig. 4.10C).
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The sequences were designed with a NUPACK script that optimised these structures
when the gRNAswitch was alone, but so that the targeting region be unpaired when the
gRNAswitch and target are folded together. The co-folded constraints are described
in fig. 4.10D. The target RNA is in complex with the loop and toehold region of the
gRNAswitch. The clamp region (which is complementary to the targeting region) is
not in complex, and forms a bulge with the spacer region of the trigger on the other
strand. This binding results in the freeing of the targeting region of the gRNA.
The gRNAswitch 3A was created with this NUPACK script, which accomodates two
inputs: An RNA trigger, and a 20 nt CRISPR target. The script then:
1. Creates a trigger and creates complementary toehold and loop regions for the
gRNAswitch
2. Creates a clamp of the desired length, complementary to the gRNA targeting
region
3. Adds the dCas9 handle and S. pyogenes terminator
4. Folds the resulting sequence in NUPACK to analyse their predicted structure
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Figure 4.10 – A. gRNA secondary structure. B. Constraints of gRNAswitch alone.
Toehold and loop are single stranded. The clamp region is bound to the targeting
region. C. The target RNA was chosen to have low secondary structure. D. gRNAswitch
+ target complex design constraints. Toehold and loop regions are bound to the 3’ and
5’ of the target, respectively. The clamp and targeting region are unpaired.
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4.2.5 Trigger 3A can activate switch 3A
The NUPACK script was used to design a gRNAswitch, with a fraction of the mCherry
mRNA used as a trigger RNA, and the pLacIq promoter used as a target for CRISPR.
The gRNAswitch, called switch 3A, was then tested for its ability to detect a sRNA
containing its complement trigger sequence, trigger 3A. A plasmid containing dCas9
and the trigger 3A was constructed (dCas9-trig3A). The switch 3A was co-transformed
into E. coli MG1655-Z1 cells with either dCas9 (which contains only the dCas9 protein)
or dCas9-trig3A (which contains both dCas9 and the trigger). A negative control
containing only dCas9, and a positive control containing dCas9 and the trigger3A-
switch3A fusion, were also plated. Figure 4.11 shows these cells plated on LB and
visualised on a blue light box. Cells containing only the dCas9 and the gRNAswitch
were not visibly fluorescent, just as the cells transformed with dCas9 only. Cells
containing the gRNAswitch alongside the trigger, however, had high fluorescence, as
were cells containing the gRNAswitch-trigger fusion. These results indicate that the
trigger can activate the gRNA activity of switch 3A, which is otherwise inactive.
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Figure 4.11 – A. Circuit used. dCas9 and gRNAswitch are activated by the trigger RNA.
When active, they repress lacI, which represses GFP. Functional Cas9 therefore leads
to GFP expression. dCas9 has no trigger, nor gRNAswitch/GFP plasmid. dCas9 +
Switch has no trigger. dCas9 + switch + trigger has the whole circuit. dCas9 + fused
switch-trigger has no trigger RNA, but uses a modified switch where the trigger region
is added onto the switch RNA. B. Fluorescence of E. coli MG1655-Z1 cells transformed
with (clockwise from bottom left): dCas9 only, dCas9 and Switch 3A, dCas9, trigger 3A
and Switch 3A, dCas9 and fused trigger-switch 3A.
4.2.6 Sensing of full length mRNA
The NUPACK script was then expanded to allow the use of an RNA of any length. In
this case the script performs the following, using an RNA of any length and a CRISPR
target as inputs.
1. Searches the RNA sequence for unstructured regions to pick trigger regions.
2. Creates a gRNAswitch with toehold and loop regions complementary to trigger.
3. Adds targeting and clamp regions, as well as Cas9 handle and terminator.
4. Simulates folding of the created switches.
5. Picks results that satisfy the constraints best.
132
4.2. Results
This script was used to create two more gRNAswitches targeted to portions of the
mKate2 mRNA. Switch 3A-2 and 3A-3 were cloned in place of switch 3A. Two trigger
plasmids, dCas9-mKate2 and dCas9-mKate2ΔRBS were made, placing the full length
mKate2 mRNA in place of trigger 3A. Switches 3A-2 and 3A-3 were co-transformed
with either dCas9, dCas9-mKate2 or dCas9-mKate2ΔRBS in MG1655-Z1 cells. They
were grown and their GFP and mKate2 fluorescence was measured in exponential
phase (see fig. 4.12). For both gRNAswitches, red fluorescence was high (about 50
A.U.) when mKate2 was present. Deletion of the RBS or removal of the mKate2 gene
drastically reduced fluorescence in the red channel (to approx. 5 A.U. or 1.5 A.U.,
respectively). Switch 3A-2 (fig. 4.12B) had a 2 fold increased fluorescence in the
presence of mKate2 mRNA than in its absence (~28 A.U. vs 14 A.U.), regardless of
whether an RBS was present upstream of mKate2. With switch 3A-3 (fig. 4.12C), there
was no detectable increase in fluorescence in the presence of the mKate2 mRNA. A
small increase (from ~9.7 A.U. to 14.3 A.U.) was visible when the mRNA was absent.
Switch 3A-2 was activated by the mKate2 mRNA, increasing GFP fluorescence, al-
though with a small activation fold. Switch 3A-3 however was not functional. The
activation of switch 3A by a small RNA and of switch 3A-2 by a full length mRNA
showed that the gRNAswitch design can be used as synthetic RNA sensors with a
CRISPR-Cas9 protein output.
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Figure 4.12 – A. Circuit used for gRNAswitch characterisation, which should indi-
rectly activate GFP production in presence of the trigger RNA. Here, the trigger is
mKate2 mRNA. GFP (green) and mKate2 (red) fluorescence of MG1655-Z1 cells co-
transformed with B. switch 3A-2 or C. switch 3A-3, and dCas9, dCas9-mKate2 or
dCas9-mKate2ΔRBS. Error bars represent standard deviation between three biologi-
cal replicates. The circuit used is identical to that presented in fig. 4.8, but the Cas9
plasmid also contains mKate2 when appropriate.
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4.3 Discussion
4.3.1 Crisprzyme activity without induction
The crisprzyme circuit showed a small reduction in gene expression when it was
expressed, regardless of the addition of theophylline. It is possible that the crisprzyme
might self-cleave even without stabilisation of the theophyline aptamer. Such leaki-
ness has been shown to take place with hammerhead ribozyme (HHR) based theo-
phylline aptazymes (de Silva and Walter, 2009), which both the theoHHAzRAJ11
regazyme and the crisprzyme are. However, the testing of the circuit with the non-
cleaving G12A mutant showed that the crisprzyme could repress its target regardless
of the removal of the HHR moiety. This defeated the strategy of creating a self-cleaving
crisprzyme, as the main assumption it was built on – that the gRNA would not work
unless the large RNA sequence at its 5’ was removed – was disproved. However, it
opened up the new strategy of adding regulatory 5’ regions on the gRNA sequences,
allowing their integration into strand-displacement based RNA circuits. gRNAs have
been modified in their Cas9 handle stem loops (Thyme et al., 2016), between the
handle and the S. pyogenes terminator (Liu et al., 2016; Lee et al., 2016) and after the
terminator in species where it is inactive (Zalatan et al., 2015), but regulatory elements
have never been used at the gRNA 5’. These results show that the 5’ is also a possible
location for adding regulatory RNA structures.
In addition, the use of a ribozyme sequence created a level of unnecessary complexity,
with the requirement for correct formation of the ribozyme structure and of cleavage.
Finally, the recent development of CRISPR "flow conductors" by Liu et al. (2016)
showed that aptamers could be directly incorporated into the gRNAs, solving this
problem for small molecules.
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4.3.2 gRNA activity is inhibited by 5’ cis-repression
The creation of self-repressed gRNAs show that simple 5’ motifs complementary to
the gRNA targeting region could inhibit a gRNA. The self-inhibition of these gRNAs
is coherent with other reports that show that secondary structure formation within
gRNAs can interfere with Cas9 mediated cleavage (Thyme et al., 2016), and with the
use of trans-acting antisense RNAs that can block CRISPR gRNAs (Lee et al., 2016). Of
the gRNAs tested, there was a decrease of CRISPRi activity as clamp length increased,
with the exception of the 8 nt clamp which had a higher fluorescence than the 7 nt
clamp, close to that of the positive control. This might be due to the 8 nt clamp forming
an alternative secondary structure. As these RNAs were constructed by shrinking the
clamp region of switch 3A, they were optimised for a 13 nt clamp, which could explain
misfolding of shorter clamp lengths. However, the reduction in CRISPRi activity with
clamp length shows that artificial secondary structure is an effective way of regulating
gRNA activity. Interestingly, there is sharp reduction in activity with clamp lengths
of 9 nt or more, which leaves 11 nt or less of the gRNA targeting region accessible.
This mirrors the minimum length for CRISPR gRNAs trigger lengths found by Qi et al.
(2013), who noted a loss of dCas9 repression when using gRNAs trigger lengths of 11
nt or shorter.
4.3.3 Single cell measurements suggest stochastic changes
The flow cytometry single cell measurements of gRNAs with varying off clamps corrob-
orate the results found in population measurements: fluorescence values are reduced
with longer clamp lengths. Single cell measurements did not show differences between
the 7 nt clamp and 8 nt clamp, which warrants further exploration. However, a shift to-
wards lower fluorescence was clear as clamp lengths increased. Clamp lengths of 9, 10,
11 and 13 nt all showed a low fluorescence population, as well as a spread of cells with
higher fluorescence. This may indicate that the gradual reduction in fluorescence seen
in population measurements is due to a mix of GFP producing and non-producing
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cells rather than a uniform reduction of fluorescence across the population. The
structure of the circuit may explain some of this behaviour. The dCas9 protein and
sgRNAswitch are expressed from plasmids with p15a and pSC101-RepAE93K, which
have a copy number of 15 and 27, respectively (Hiszczyn´ska-Sawicka and Kur, 1997;
Peterson and Phillips, 2008). On the other hand, the CRISPRi target (LacI) is present
in a single copy on the E. coli chromosome. In exponential growth in LB, E. coli can
contain up to 12 replicating chromosomes (Stokke et al., 2012; du Lac et al., 2016),
some of which are partially synthesised. Therefore a maximum of 12 CRISPRi target
sites can be repressed, or not, by an active Cas9/gRNA complex. The small numbers
involved increase the chances of stochastic effects. 12 active gRNAs per cell should
theoretically be enough to repress all copies of LacI, and having between 1 and 12
active gRNAs per cell could lead to the intermediate levels seen in some cells.
4.3.4 gRNAswitches can sense RNAs
Cells expressing the GFP circuit and switch 3A were not fluorescent unless trigger
3A was present, showing that gRNAswitches can function as RNA sensors. Switch 3A
showed a clear, large increase in fluorescence visible on agar plates. For switch 3A-2,
the fluorescence increase was more modest, around 2 fold when measured in a plate
reader, but nonetheless this showed that gRNAswitches can sense full length mRNAs
as well as small RNAs. Switch 3A-3, designed like switch 3A-2 but targeting a different
area of the mKate2 sequence, did not work as an RNA sensor. To determine whether
switch 3A-2 and 3A-3 could function as well as switch 3A, they should be tested against
sRNA triggers containing their target sequence. However, one possibility for their
lower activity is the secondary structure of the mKate2 mRNA. mRNAs are known
to have secondary structure in vivo (Del Campo et al., 2015), and this could disrupt
their correct function. This secondary structure has been an impediment to the
development of trans-splicing ribozymes, which also interact with full length mRNAs
(Byun et al., 2003; Fiskaa and Birgisdottir, 2010a). To tackle this problem, developers of
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trans-splicers have either resorted to a "trans-tagging" assay which uses a randomised
trans-splicing library to attempt to identify all possible binding sites (Jones et al.,
1996) or have resorted to computational methods (Meluzzi et al., 2012). Here, rather
than experimental evidence for lack of secondary structure, the NUPACK design
package was used to predict sites with a high probability of being unpaired. However,
computational prediction of RNA is known to be imprecise with large sequences,
and the possibility that the trigger sites on the mRNA were inaccessible cannot be
discarded. The testing of a battery of gRNAswitches against a target mRNA would
likely be a better way of finding effective trigger sites.
Aside from secondary structure, the translation of the mRNA by ribosomes could be
expected to disrupt trigger-switch interaction. However, for switch 3A-2, the only one
to detect mKate2 RNA, deletion of the RBS does not change the GFP output, although
red fluorescence greatly decreases.
4.3.5 gRNAswitch characteristics
The gRNAswitch architecture contains 5 non-overlapping modules (Cas9 handle, tar-
geting region, loop, clamp and toehold). It is therefore theoretically adaptable to the
detection of any RNA sequence that is long enough to bind, and does not contain
strong secondary structure that would block interaction with the gRNAswitch. Se-
quences that are identical or complementary to the trigger region, or complementary
to the Cas9 handle, would also be incompatible with the gRNAswitch architecture.
Triggers that interact with the targeting region would not allow the correct unfolding
of the clamp, whereas sequences that interact with the Cas9 handle may disrupt Cas9
binding. However, both problems should be rare, and could be solved in some cases by
modifications of the switch. If the interaction with the targeting region region is only
partial, the gRNA targeting sequence could be modified slightly. gRNAs are known to
tolerate a certain number of mismatches, especially in the RNA 5’, and changing those
bases might remove the unwanted interaction with the trigger, without disrupting
138
4.3. Discussion
the targeting of the gRNA-Cas9 complex to the DNA. For trigger regions that disrupt
the Cas9 handle, then modifications of the Cas9 handle may remove the unwanted
interaction. Chen et al. (2013) and Thyme et al. (2016) were able to certain bases of
the stem without disrupting Cas9 binding, so long as the secondary structure of the
RNA was maintained. Such mutations could abolish unwanted interactions without
blocking Cas9 binding. Furthermore, such changes in the Cas9 handle might even be
beneficial to the sensing properties of the gRNAswitch. For all tested switches, the
Cas9 handle was kept identical to the original single-component sgRNA (Jinek et al.,
2012). However, since some base pairs of the stem that do not directly interact with the
Cas9 protein can be replaced, these could be designed automatically for optimising
the gRNA energetics, rather than being constrained to the original handle sequence.
4.3.6 Potential uses of gRNAswitches
gRNAswitches can detect RNA sequences, using dCas9 as an effector to repress tran-
scription. As the Cas9 handle is not involved in the sensing process, it should be
possible to use other variants of the Cas9 protein as effectors upon RNA sensing. DNA
cleavage, nickase, CRISPRi and CRISPRa should all be possible outputs after RNA
sensing by gRNAswitches. This would enhance their flexibility. These various uses of
wild type and engineered Cas9 are known to function in eukaryotic cells, including
plants and humans, as well as in E. coli. gRNAswitches, however, were only tested
in the latter. Their putative mechanism is however generalisable. The base pairing
rules that govern RNA secondary structure are the same regardless of the organism,
and the mechanism of DNA targeting by Cas9 is also presumed to be identical. If
gRNAswitches were functional RNA sensors in yeast and human cells, they could
rapidly be used as a research tool, for reporting gene expression or causing cell death
upon transcription of a particular RNA.
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4.3.7 Improvement of gRNAswitch design
The two functional gRNAswitches designed use 13 nt clamps. However, the clamped
gRNAs tested without a toehold showed slightly lower florescence with clamp lengths
of 12 or 14 nt. Whether this would also be the case with the toehold-containing
gRNAswitches is unknown, and this is in fact likely to vary with the targeting region
and with the trigger RNA, which will both modify the structure and the equilibrium
free energies of the gRNAswitch. The length of the spacer region, which does not
necessarily need to be equal to the clamp length, would also have an effect. To improve
the design of the switch, it would be interesting to vary the length of the clamp region
in presence of the toehold, as well as to change the lengths of the toehold and loop
regions, testing the fluorescence output of the circuit in all cases. The design of
gRNAswitches that repress different DNA targets would also be important to prove
the flexibility and generalisability of the gRNAswitch design. Flexibility that exists in
the Cas9 handle stem could also be exploited, by optimising non-constrained base
pairs to create more stable gRNAswitches.
The creation of a library of gRNAswitches with varying clamp, toehold and loop
lengths, for several RNA triggers and DNA targets, could allow the identification of the
optimal design for these parts. This work has shown that a clamp length of around 12
bases is likely a minimum. As varying all 4 length parameters over large ranges would
rapidly lead to untractable numbers, a similar screening should be done for the three
remaining parameters of the loop, toehold and spacer lengths to shrink down the
space of possible combinations, before a round of screening combining the different
possibilities. Although there might be an optimal set of lengths for one gRNAswitch,
this is likely to vary when designing switches with different triggers and targets. It
would be interesting to study the predicted free energy parameters of the best gR-
NAswitches, to determine whether there are generalisable design rules pertaining
to the length or to the free energy of the different elements of the gRNAswitch, in a
similar way to what was done for asRNAs by Hoynes-O’Connor and Moon (2016).
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4.3.8 gRNAswitch mechanism
The mechanism by which the gRNAswitch unfolds, although artificial, is not known.
The sequences were designed under the assumption that a strand-displacement mech-
anism could drive such conformational changes and act as a switch. However, it is also
possible that active switches are folded into this conformation co-transcriptionally, as
shown for riboswitches by Borujeni et al. (2015), rather than re-folded through strand
displacement. A second unknown is also whether inactive gRNAswitches are bound to
the Cas9 protein, unable to bind their DNA target due to obstruction by the clamp, or
whether the clamped gRNA is unable to bind Cas9 altogether. In the context tested, in
E. coli, these considerations do not affect the behaviour of the switch. However, they
might significantly affect the speed with which the sensor could work if used in a dif-
ferent setting. A system which must be switched on co-transcriptionally but can also
bind the Cas9 protein in its inactive form would sequester away the available cellular
effectors, without acting as a sensor. A trigger RNA could then only be sensed by newly
transcribed switch binding to yet unloaded Cas9 protein. However, if gRNAswitches
can be reactivated through strand-displacement and bind the Cas9 protein when in
their inactive form, they might react faster as they would be pre-loaded and ready
to act as an output. Further characterisation is required to better understand the
mechanism of gRNAswitches. In vitro testing of switch circuits would be particularly
useful, as adding the different elements (gRNAswitch, trigger RNA and Cas9 protein) in
different orders and observing the output might shed some light on this mechanism.
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4.3.9 Conclusion
Two types of CRISPR gRNAs with artificial regulatory elements at their 5’ end were
tested in E. coli using a CRISPRi circuit with a fluorescent protein as an output. The
first, called the crisprzyme, contains an aptazyme at its 5’ end, which only self-cleaves
and only releases the gRNA in presence of theophylline. Although cleavage was
conditional to small molecule addition, the unprocessed gRNA could also repress
its target even though the 79 nt ribozyme was not removed. This disqualified the
crisprzyme design but shows that relatively large regulatory elements can be added to
gRNAs in cis. This was exploited to design gRNAswitches, cis-repressed gRNAs that
are switched off by a clamp region that base pairs with the gRNA targeting region.
The gRNAswitch is switched off when using a clamp of 12 nt or more, but is switched
back on in presence of its cognate RNA trigger, which is complementary to two other
regions of the gRNAswitch, the toehold and the loop.
The gRNAswitch thus functions as a programmable RNA sensor. Although only tested
in E. coli, the gRNAswitch has no theoretical limitations that would hinder its function
in other organisms, including eukaryotes. Furthermore, several paths exist for gR-
NAswitch improvement, and the many outputs that can be used with CRISPR derived
systems should be suited to gRNAswitch outputs, including repression and activation
of transcription, DNA cleavage and DNA tagging. gRNAswitches are a new example of
the flexibility of the CRISPR-Cas9 system for synthetic biology applications, and shows
promise as it combines the programability of RNA circuits with the robust efficiency
of a protein based output.
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4.4 Materials and Methods
4.4.1 Strains used
All characterisation was carried out in MG1655-Z1 E. coli cells. Cloning was performed
in TOP10 E. coli cells. Strains genotypes are described in detail in section 5.1.
4.4.2 Cloning
Cloning was carried out using Goldengate or Gibson assembly with either PCR prod-
ucts or Gblocks synthesised by IDT DNA. Detailed protocols for assembly methods
are described in section 5.3. Primer and part sequences are available in appendix D.
Crisprzyme plasmids
The crisprzyme Gblock was synthesised by IDT DNA and cloned into pSC101-sfGFP-
DB by goldengate, resulting in the crisprzyme plasmid (pSC101 origin, KanR). The
second crisprzyme plasmid was constructed by PCR and goldengate self-ligation to
exchange the promoters.
Cas9 and Cas9 + trigger plasmids
The dCas9 plasmid (ChlorR, p15A origin of replication) was obtained from Bikard et al.
(2013). Trigger 3A, mKate2 and mKate2ΔRBS were obtained from Dr. John Duncan.
They were constructed by adding the trigger 3A, mKate2 or mKate2ΔRBS onto the
dCas9 plasmid by Gibson assembly.
Switch plasmids
Switch 3A was synthesised as a Gblock by IDT DNA and inserted by goldengate into
pSC101-sfGFP-DB. It was then used as a template to construct the 9 switch plasmids
with varying clamp lengths, as well as switch 3A-2 and 3A3. Switch 3A was amplified
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by PCR (Phusion polymerase, NEB) using primer GR21 (as a common reverse primer)
and one of GR22 to GR30 (as forward primers) to construct switch3A_OFFclamp_7 to
switch3A_OFFclamp_15, respectively; or using primers GR3A-2_fw / rv and GR3A-3_fw
/ rv to construct Switch 3A-2 and 3A-3, respectively. PCR conditions were according
to manufacturer’s instructions with 3 % added DMSO. Cycling conditions: 95°, 30sec.
30 cycles: 95°, 15sec; 58°, 20sec; 72°C, 3min. Final extension: 72°C, 10 minutes, hold:
4°. PCR products were then purified with a PCR extraction kit (Thermo Fisher), self-
ligated by goldengate and transformed. Correct clones were checked by restriction
digestion and sequencing.
4.4.3 Population fluorescence measurements
Population fluorescence measurements of circuits (figures 4.5B, 4.7B, 4.12) were car-
ried out as described in section 2.4.4. Briefly, cells were grown overnight, refreshed 6
hours in M9 medium (1:200 dilution) with inducers as appropriate (aTc: 100ng/µL ,
theophylline: 2 mM, IPTG: 250 nM), then inoculated into 96 well plates for measure-
ment in a TECAN plate reader. For mKate2 mRNA sensing described in figure 4.12, the
protocol was identical save for the GFP gain setting (set to 30), and the additional RFP
fluorescence measurement step: Excitation: 580 nm/20 nm, Emission: 635 nm/35 nm,
gain: 45). Bar charts plot fluorescence over ODλ= 600 at the closest point to ODλ= 600 0.3,
in mid exponential phase. Error bars represent standard deviations of three biological
replicates.
4.4.4 Single cell fluorescence measurements
Single cell fluorescence measurements were performed using a BD LSRFortessa flow
cytometer (BD Biosciences). Cells were grown in LB with antibiotics – Kanamycin
(17.5 µg/mL), spectinomycin (50 µg/mL), and chloramphenicol (17.5 µg/mL) – and
IPTG (1 mM), as appropriate. After overnight growth, cells were refreshed in a 96
well plate (5 µL in 195 µL ), grown (4 hours, 37°C, 200 rpm), then refreshed again the
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same way. When O.D. reached ~0.3, 10 µL of cells were diluted in 190 µL of pre-chilled
filtered (0.2 µMfilter, Sartorius) Phosphate Buffered Saline (PBS), supplemented with
2 mM kanamycin to block further protein synthesis. Cells were then kept at 4°C and
fluorescence of single cells was measured. Flow cytometer voltage settings were:
Forward Scatter (FSC): 632; Side Scatter (SSC): 237; GFP fluorescence (B485-530/30):
509. FCS data was gated to remove cell debris and fluorescence histograms plotted
with Flow Cytometry GUI for Matlab (Steinberg, 2012)).
4.4.5 Streak plate fluorescence
A single colony of E. coli containing either dCas9, dCas9 and switch3A, dCas9-trigger3A
and switch3A, or dCas9 and switch3A-trigger3A was plated. Cells were grown at 37°C
on LB agar with appropriate antibiotics and aTc (100 ng/µL ) 16 hours then imaged on
a blue light box.
4.4.6 RNA gel
The crisprzyme and the G12A mutant were amplified with primers oJD46f and oJD46r,
adding a pT7 promoter upstream of each. The PCR product was used to transcribe RNA
(Transcriptaid T7 High-Yield, ThermoFisher), purified in acidic phenol chloroform
(pH 4.5, Ambion), ethanol precipitated and quantified with a Nanodrop. 10 µg of each
RNA was incubated with 2 mM theophylline (buffer: 10 mM Tris HCl, 2 mM MgCl2).
1 µL of RNA was taken at each timepoint and denatured in 2X RNA loading buffer
(65°C, 10 min), then loaded on a polyacrylamide gel (8%) and run at 100 V. The gel was
stained with ethidium bromide and imaged with a gel-dock.
4.4.7 Crisprzyme and synthetic promoter design
The crisprzyme sequence was based on the sequence of theoHHAzRAJ11 (Shen et al.,
2015). The hammerhead based theophylline aptazyme sequence, as well as the first
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25 bases after the cleavage site were kept intact. The bases after that were removed
and replaced with a Cas9 handle and S. pyogenes terminator (Jinek et al., 2012).
The synthetic promoter was constructed as described, adding the gRNA target site
downstream of the J23119 promoter sequence (http://partsregistry.org/Part:BBa_J23119).
The resulting UTR sequence was checked for secondary structure around the RBS
and ATG and for alternate predicted ribosome binding sites. No strong secondary
structure around the RBS or ATG sites was predicted by NUPACK. No alternative ribo-
some binding sites were predicted by the Salis RBS calculator (Salis et al., 2009). The
correct RBS had a predicted TIR of 1998, and the next best initiation site had a TIR of
76 according to the RBS calculator.
4.4.8 Automatic design of gRNAswitches
gRNAswitch sequence 3A was automatically designed using a custom NUPACK script.
The script used a clamp length of 13 nt, a toehold and loop length of 15 nt, and a spacer
length of 9 nt. The full NUPACK code for design of switch 3A is available in appendix
E. For design of switch 3A-2 and 3A-3, the rfp_window.accessible[%] = [50,100] option
was enabled, which constrains the choice of the trigger region of the RNA to regions
predicted to be at least 50% unstructured.
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5.1 Strains used
The strains used in several chapters are described here, whereas more specialised
strains are described in the Materials and Methods sections of the relevant chapters.
TOP10 and DH5α were used for cloning. TOP10 genotype: F- mcrA Δ(mrr-hsdRMS-
mcrBC) Φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 galE15 galK16
rpsL(StrR) endA1 λ-. DH5α genotype: F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR
nupG purB20 φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK–mK+), λ–. MG1655
(Genotype: K-12 F– λ– ilvG– rfb-50 rph-1) was used for phage recombineering. For
inducible system testing, MG1655-Z1 or DH5α-Z1 were used. They are identical to
MG1655 and DH5α, respectively, but with a Z1 cassette insertion, which overexpresses
LacI, TetR and confers spectinomycin resistance (Lutz and Bujard, 1997).
5.2 Chemicals and reagents
Unless otherwise specified, all chemicals were obtained from Sigma Aldrich (St Louis,
USA), all enzymes were obtained from Thermo Fisher Scientific (Waltham, USA), all
primers and synthetic DNA – Gblocks and minigenes – were obtained from Integrated
DNA technologies (Coralville, USA).
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5.3 Cloning
Cloning was performed in DH5α or TOP10 E. coli. Plasmids were assembled by
standard digestion-ligation, Gibson assembly or Goldengate assembly as described in
Materials and Methods sections 2.4, 4.4 and 3.4, with protocols described below. All
cloning products were verified by colony PCR or restriction digestion, and by Sanger
sequencing (GATC Biotech AG., Constance, Germany).
DNA purification
All DNA miniprep, PCR purification or gel extraction procedures were carried out
using either Qiagen or Thermo Fisher purification kits. DNA was eluted in Elution
Buffer (EB; 10 mM Tris-Cl, pH 8.5).
Restriction digestion
All restriction digestions were carried out with FastDigest restriction enzymes (Thermo
Fisher Scientific) according to manufacturer’s instructions. Parts cloned into standard
goldengate cloning plasmids and other biobrick compatible plasmids were verified
with EcoRI and PstI. Buffers used were FD-green for plasmid verification, standard FD
buffer followed by PCR purification when DNA was needed for cloning.
Agarose gels
DNA was visualised in 1% agarose gels in a UV lightbox or for gel extractions, in a
blue light box. Gel were stained with Ethidium Bromide or SYBR Safe DNA gel stain
(Thermo Fisher).
Standard ligation
Standard ligations were carried out with T4 ligase according to manufacturer’s instruc-
tions. 3 µL of ligation reaction was electroporated for transformations.
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Goldengate cloning
Goldengate cloning (Engler et al., 2008) was carried out using 1µL BsaI (New England
Biolabs, Ipswitch, USA), 1 µL T4 Ligase (NEB), 2 µL T4 ligase buffer and 100 fmol of each
DNA fragment used (PCR product, Gblock, plasmid or annealed oligos), topped up to
20 µL . Reaction was then cycled in a thermocycler. 30 cycles: 37°C, 2 minutes; 16°C, 5
minutes then 10 minutes, 50°C; 10 minutes, 80°C; 4°, hold. Oligos for goldengate were
annealed by diluting them to 0.1 µM in EB, heating them to 96°C for 5 minutes in a heat
block, switching it off and letting them cool to room temperature. 3 µL of goldengate
reaction were electroporated. Four standard biobrick-compatible goldengate cloning
plasmids were built and used for generic goldengate clonong (see section 5.3.1).
Gibson Assembly
1.5X Gibson assembly master mix was prepared with 320 µL 5X ISO buffer, 0.64 µL T5
exonuclease, 20 µL Phusion polymerase, 160 µL Taq ligase (all enzymes from NEB), and
600 µL H2O and kept at -20°C until use. 5X ISO buffer preparation: 3 mL Tris-HCl pH
7.5 (1M); 150 µL MgCl2 (2M); 240 µL dNTP mix (25mM each dGTP, dCTP, dATP, dTTP) ;
300 µL DTT (1M) ; 1.5 g PEG-8000; 300 µL NAD (100 mM) and 2 mL H2O. Assembly
was carried out with 100 fmol of each fragment (5 µL added in 15 µL mastermix) and
incubated at 50°C for 1 hour. 2 µL of reaction were electroporated.
Transformations
Appropriate cells were rendered competent using standard protocols. Briefly, an
overnight culture was refreshed and grown to ODλ= 600 0.4. Cells were spun down and
washed twice in 4°C water, and once in 10% glycerol, resuspended in 10% glycerol and
kept at -80°C. For transformations, 40 µL of cells were incubated with the DNA mix 15
min on ice, and electroporated in 2 mm wide ice-cold electroporation cuvettes with a
BioRad MicroPulse Cell Electroporator on the Ec2 setting (2.50 kV, 1 pulse), diluted in
950 µL SOC medium and incubated 45 min at 37°C before plating.
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5.3.1 Standard goldengate cloning plasmids
4 biobrick compatible goldengate cloning plasmids were used for easy construction
of parts. pSB1C3-DB, pSC101-DB, pSC101-sfGFP-DB and pLitmus-chlor-RFP. All
three plasmids contain an RFP gene (Biobrick part BBa_J04450) between a modified
biobrick prefix and suffix containing EcoRI-BsaI and BsaI-PstI, respectively. This
permits insertion of one or multiple genes using goldengate cloning and red/white
selection. Plasmid maps and goldengte cloning sites are described in appendix A.1.
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6.1 Standardisation of RNA part design
The aim of synthetic biology, and even its definition, has not been clearly agreed on
by synthetic biologists themselves (Kitney and Freemont, 2012). Some definitions
focus on the functional aspects of building artificial organisms with novel properties,
while others focus on the multidisciplinary aspect of a field combining information
technology, biotechnology and nanotechnology, or on the role of DNA synthesis
(de Vriend, 2006). However, most definitions agree on the fundamental influence
of engineering practices like standardisation, and concepts such as decoupling and
abstraction hierarchy, on the development of a new approach to genetic modification
(Endy, 2005; Müller and Arndt, 2012; Cameron et al., 2014). This was inspired by
the incorporation of such practices into manufacturing processes throughout the
19th century, and has led to claims that synthetic biology will be the next industrial
revolution (Hellsten and Nerlich, 2011). However, it is still unclear whether such
practices can really be applied to biology, and if so, how they can be applied (Kitney
and Freemont, 2012). The work presented in this thesis uses three different approaches
for engineering RNA parts. The construction of circular riboregulators, described
in chapter 2, uses a standardised approach, always using the same PIE sequence
for RNA circularisation. The directed evolution presented in chapter 3 is a method
151
Chapter 6. General discussion
which does not rely on precise understanding of mechanism for action, but requires
working parts as a starting point, and a "selection gene" through which evolution
can be directed. Finally, the strategy used for the engineering of gRNAswitches in
chapter 4 is based upon a rationally designed mechanism of action, but with the use
of computational models to predict RNA folding and choose some part elements.
These three approaches are complementary, and have been used to varying degrees
by researchers in the field of synthetic biology.
6.1.1 ’Plug and play’ RNA parts
The goal to achieve standardisation of ’plug and play’ parts has been pursued by some
synthetic biologists (Müller and Arndt, 2012), most notably by the Registry of Standard
Biological parts (http://parts.igem.org) who have encouraged the spread of the RFC
10 standard for cloning compatibility for biological parts. In the Registry, each part
is presented, at least in theory, as an independent, characterised unit. Published
literature also includes standardised plasmid collections (Shetty et al., 2008), as well as
standardised and characterised promoter and RBS libraries (Kelly et al., 2009; Ander-
son et al., 2010b). This ’plug and play’ approach is not straightforward to implement,
as many sequences that are sometimes defined as ’parts’ are known to in fact behave
differently depending on the context they are used in. This is the case for promoters
and RBS sequences (Ellinger et al., 1994), and the pertinence of the standardised,
modular approach has been questioned (Kittleson et al., 2012; Kosuri et al., 2013).
In this work, the PIE ribozyme method used for generating circular RNA was used
as is, without further changes to adapt it to its context. Despite this, it maintained
its ability to circularise different riboregulators, suggesting PIE circularisation is a
robust method for circRNA generation. This robustness is also backed up by its uses
in other studies in S. cerevisiae and E. coli (Ford and Ares, 1994), to circularise mRNAs
or aptamers (Perriman and Ares, 1998; Umekage and Kikuchi, 2009). It is also easy to
implement, and so far seems to be a suitable ’plug and play’ circular RNA generator.
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Although this view of biological parts as isolated units should probably be taken with
some skepticism, the other uses of ribozymes throughout the literature indicate that
they might be relatively well suited to this ’plug and play’ approach. Along with the
circRNA generators, the crisprzymes and gRNAswitches presented in chapter 4 also
contained ribozymes. The former were derived from a Hammerhead ribozyme with a
modified stem, and both systems were transcribed with an HDV ribozyme at their 3’
end to ensure that the correct length gRNAs were produced in vivo. The ability of these
ribozymes to retain their activity in these different contexts, as well as in various other
applications Fiskaa and Birgisdottir (2010b); Serganov and Patel (2007); Gao and Zhao
(2014), might be due to the fact that ribozymes are stabilised by tertiary interactions
(Batey et al., 1999; Woodson, 2015). This contrasts with parts such as RBSs which have
low structure, and might therefore be more easily disrupted. The effect of context on
the ribozymes should however be measured, as this might reveal context dependent
reduction of the splicing efficiency for example, when the techniques used here are
not quantitative. Some factors such as those discussed in section 2.3.2 could upset
view of PIE ribozymes as ’plug and play’ RNA parts, which will need to be confirmed
by further use of PIE ribozymes.
6.1.2 Prediction-based design of RNA parts
The ’plug and play’ approach has been contrasted with prediction-based design
and library screening/selection methods (Kosuri et al., 2013). In this work, we used
prediction-based design for the creation of new cr-mRNAs, and for making gRNAswitch
RNA sensors. The reverse engineering of the Nusl3 and Nusl6 5’ UTRs presented in
chapter 2, that are activated by the linear riboregulator taRAJ31min, validates the
design goals developed by Green et al. (2014) for designing new cr-mRNAs. The gR-
NAswitch RNA sensors presented in chapter 4 are a new example of this approach,
where design goals for a modified CRISPR gRNA are fixed, and software is used to
pick a fragment of a target mRNA which satisfies these constraints. Like toehold
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switches, the gRNAswitch design goals are modular, with non-overlapping regions
with determined functions. The clamp and targeting regions are dependent on the
Cas9 target, whereas the loop and toehold regions are picked by the NUPACK software
such that they are both part of a target RNA sequence and fit the desired constraints.
The design goals of gRNAswitches also have some similarities with those of toehold
switches. Most notably, both use long single-stranded toehold regions (15 nt). This
contrasts with the 6 nucleotides used by Rodrigo et al. (2012), and by many natural
systems containing YUNR motifs. One difference between the architecture of gR-
NAswitches compared to toehold switches or other previously designed RNA parts
is that gRNAswitches contain two separate target binding regions. One is situated in
the 5’ toehold and the other in the loop. These are separated by the ’clamp’ region
which is bound to the targeting region in the OFF state, and trapped in a bulge in the
ON state. This separation of the hybridisation domains of RNA parts into two or more
distinct regions might be useful in offering more flexibility when designing other RNA
parts.
The limits of the prediction-based design used here are highlighted by the low ac-
tivation of the Switch 3A-2 when sensing a full length mRNA, and by the failure or
lower activity of circular riboregulators. For low activation of switch 3A-2, low mRNA
accessibility might be responsible, although only three switches were tested, which
is too limited a sample to make definitive conclusions. As mRNAs are longer than
the sRNAs otherwise considered, their structure is less well predicted by secondary
structure prediction software and picking target sequences based on these software is
less reliable. The inability of the current algorithms to predict interactions between
circular RNA and their targets is another downside of prediction-based design of RNA
parts, which cannot efficiently predict pseudoknotted structures.
Despite these limitations, the field of RNA engineering is one that lends itself well to
the application of these concepts of prediction-based design. This is permitted by
computational models of RNA folding which, even though they are simplified, allow
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the design of RNA parts with a desired structure. Combined with rationally designed
RNA structure objectives, such as those of previously described riboregulators and
toehold switches (Rodrigo et al., 2012; Green et al., 2014), or those of the gRNAswitches
described in this work, functional RNA parts can be designed computationally. So far,
this approach has only been used for relatively short RNAs, generally not exceeding
100 nt in length, and which do not contain pseudoknots. As RNA-structure predic-
tion models improve, they might allow improved design of pseudoknot-containing
circuits such as those involving circular RNAs, or allow reliable prediction of mRNA
unstructured regions. Secondary structure prediction software can also be used in
combination with experimental methods for RNA structure determination such as
SHAPE-Seq (Watters et al., 2016). These methods can be used to determine the real
structure of working RNA parts, which can in turn help to improve the design prin-
ciples used to construct RNA parts (Takahashi et al., 2016). Eventually, biophysical
models which predict the tertiary structure of both proteins and RNA may replace sec-
ondary structure models. In the meantime, the combination of secondary structure
modelling with design rules will remain a useful method for creating new RNA parts.
6.1.3 Evolution of RNA parts
To improve upon parts whose structure is not predictable computationally, we tested
a system for directed evolution using continuous culture of T7 phages. Although the
phage system allowed the accumulation of mutations in the circRNA, and there was
evidence of positive selection on the trxA gene inserted onto the phage, there was no
sign of positive selection for functional circRAJ31 production. In fact, all the mutations
deactivated circRAJ31 functionality. This highlights the difficulty in creating good
selection systems in a continuous evolution setup, and the possibility for the organism
to evolve towards different objectives than the system was designed for.
Overall, this failure to evolve circRAJ31 in a continuous T7 evolution setup highlights
issues with this particular directed evolution setup rather than inform us about the
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incorporation of directed evolution methods in RNA part design. The basic idea that
creation of computationally designed parts could serve as a starting point for directed
evolution could still hold, although a system where testing of the part in the context of
the evolution system is more straightforward should be used. These lessons apply to
all directed evolution systems, regardless of whether using RNA or proteins.
6.2 Combination of RNA circuits with protein based out-
puts
The development of gRNAswitches presented in chapter 4 shows that RNA circuits can
be combined with a protein based output platform. These results join the list of previ-
ously published systems where dCas9 is used with engineered gRNAs. Zalatan et al.
(2015) constructed gRNAs containing an MS2 stem loop or similar elements, which
allows the recruitment of activators or repressors, whereas Liu et al. (2016) developed
gRNA based small molecule sensors. This approach has the advantage of harnessing
the programmability and predictability of small RNA parts, with the robustness of the
protein outputs. Other RNA-protein complexes have also been used, for example by
Sakai et al. (2014) who added Hfq binding sites on riboregulators. However, Hfq only
chaperoned the sRNAs, helping the riboregulator activity, but not carrying out the
programmed task. Delebecque et al. (2011) also made use of RNA-protein complexes,
using RNA as a three-dimensional scaffold for the spatial organisation of hydrogen
producing enzymes. In this case, proteins carried out the programmed task (hydrogen
production), but RNA was limited to its role as a scaffold and did not interact with
other RNAs, or switch states. In the gRNAswitch system, we use RNA for the tasks
it is most suited for: interacting with the trigger RNA and with the DNA target in a
programmable fashion, and switching states. The output is then carried out by the
Cas9 protein, which can also be chosen to act as a nuclease, repressor or activator,
depending on the variant chosen. This combination of RNA based computation and
protein based actuation might be a good option which combines the programmability
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of RNA with the strong activity of proteins. To make these more reliable, it might be
useful to measure the parameters of RNA folding in presence of the Cas9 protein. As-
sociation rates of CRISPR gRNA with DNA have been measured and modelled (Farasat
and Salis, 2016), and if combined with refined models of the folding of gRNA 5’ regions,
ease the development of CRISPR based RNA sensors.
6.3 Uses of RNA circuits
6.3.1 Medical uses of RNA circuits
RNA circuits, and CRISPR-based RNA sensors in particular, could have interesting
medical applications. Similar small molecule responsive gRNAs have already been
shown to work in human cells (Liu et al., 2016), and RNA-sensing gRNAswitches
could be used to construct ’smart drugs’ responsive to the presence of specific RNAs.
Although programmable RNA sensors exist for bacteria (Green et al., 2014), there
are none available in eukaryotes. The simple and programmable mechanism of
gRNAswitches, combined with the different output platforms based on the Cas9
protein, could form the basis of RNA-based ’smart drugs’. Programmable inputs could
be the presence of viral RNAs, or if associated with small-molecule sensing gRNAs
developed by Liu et al. (2016), combinations of RNAs and metabolites associated with
cancer Xie et al. (e.g. 2011). Conditionally activated outputs could be associated with
circuits that cause cell death (Nissim and Bar-Ziv, 2010), express immunostimulatory
compounds, or downregulate immune evasion genes (Dannull et al., 2007), by taking
advantage of the different Cas9 variants that cleave, upregulate or downregulate the
target. gRNAswitches, alone or as part of RNA circuits, could improve RNA vaccines
(that were proposed by Andries et al., 2015), and could be combined with other RNA
based drugs that are being developed (Burnett and Rossi, 2012; Sahin et al., 2014).
This would require reliable methods for in-vivo delivery of RNAs, for which various
viral and non-viral means are being explored (Kauffman et al., 2015).
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Another issue that needs to be addressed for RNA parts to be used in medical appli-
cations is that foreign RNA is inflammatory in human cells, due to its recognition by
the antiviral immune response pathway described in the introduction of chapter 4
(section 4.1.1). To avoid inflammatory side effects, non-natural amino acids such as
pseudouridine can be incorporated into the sequences (Karikó et al., 2008; Anderson
et al., 2010a). This also has the advantage of enhancing RNA stability (Karikó et al.,
2008). However, these modifications are known to have different thermodynamic
properties than ordinary bases (Serra et al., 2004), but have not been studied in de-
tail (Mathews and Turner, 2006) and are not incorporated in secondary structure
prediction software. New biochemical studies of the thermodynamic properties of
RNAs containing modified bases that have relevant medical uses could facilitate the
creation of RNA circuits for medical uses. In the case of gRNAswitches with modified
nucleotides, their ability to bind the Cas9 protein would also need to be tested.
6.4 Concluding remarks
The versatility and programmability of RNA has permitted the development of many
RNA-based parts and circuits. This work contributes to the expansion of this catalog
through the development of design rules for two new types of RNA parts: Circular
riboregulators and RNA-sensing CRISPR gRNAswitches. PIE ribozymes are demon-
strated to be a flexible method for generating circular RNAs, simply by pasting the
cargo sequence between the ribozyme exons. This can generate active, circular ri-
boregulators in E. coli, although in this context they are generally less active than
their counterparts. They nonetheless interact with their target through base-pairing
interactions and are generated in sufficient quantities to control transcription from
cis-repressed messenger RNAs. A method for improving riboregulators through di-
rected evolution based on continuous growth of T7 bacteriophage was also tested.
Although this did not yield improved RNA parts, we showed that recombination could
take place between a phage and a transduced phagemid, which could allow the use of
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library based methods to increase the genetic diversity during continuous evolution.
Finally, a new type of RNA sensor was developed, based on engineered CRISPR-Cas9
gRNAs. We show that gRNAs can be repressed by the addition of a cis-regulating
element which blocks the gRNA targeting region through base pairing. Further ad-
dition of toehold and loop regions which hybridise to a second trigger RNA allow
these switches to conditionally target the Cas9 protein to its DNA target upon RNA
trigger addition. These new RNA parts could find applications such as control ele-
ments in RNA circuits, which could be used within in vitro circuits, in programmable
bacterial or eukaryotic cells, or for producing RNA-based drugs. Future testing of
synthetic circRNA regulators in different contexts might reveal applications where
circularity brings a significant advantage, whereas refinement of the design rules of
gRNAswitches, and testing with a larger number of mRNA trigger sites could permit
the improvement of their sensitivity, which would make them an attractive choice as
synthetic RNA sensors in eukaryotic cells.
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A.0.1 Supplemented M9 minimal medium
Ingredient Concentration
CaCl2 100 µM
MgSO4 2 mM
FeSO4 10 µM
M9 Salts 1x
Casein amino acids 0.2% w/v
Glycerol 0.8% v/v
Thiamine 1 µg/mL
Uracil 20 µg/mL
Leucine 30 µg/mL
NaOH Adjust to pH 7.4
Table A.1 – Composition of enriched M9 medium.
A.1 Generic goldengate cloning plasmids
A.1.1 Multiple cloning sites
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A
GAATTCGAAGACGCTTGAGACC
CTTAAGCTTCTGCGAACTCTGG
GGTCTCCAGCCTCTTCCTGCAG
CCAGAGGTCGGAGAAGGACGTCRFP
EcoRI
Overhang Overhang
BsaI
Red/white selection
BsaI PstI
pSB1C3-DB MCS
B
GAATTCGCTGAGAGACC
CTTAAGCGACTCTCTGG
GGTCTCCTGGCCTGCAG
CCAGAGGACCGGACGTCRFP
EcoRI
Overhang Overhang
BsaI
Red/white selection
BsaI PstI
pLitmus-GG MCS
C
GAATTCGCTGAGAGACC
CTTAAGCGACTCTCTGG
GGTCTCCTGGCCTGCAG
CCAGAGGTCGGGACGTCRFP
EcoRI
Overhang Overhang
BsaI
Red/white selection
BsaI PstI
pSC101-DB MCS
D
GAATTCGCTGAGAGACC
CTTAAGCGACTCTCTGG
GGTCTCGATGCGTAAAGGC...
CCAGAGGTACGCATTTCCG...RFP
EcoRI
Overhang Overhang
BsaI
Red/white selection
BsaI sfGFP CDS
pSC101-sfGFP-DB MCS
Figure A.1 – Multiple cloning sites used in generic biobrick compatible goldengate
plasmids. A, B, C: Cloning sites for the pSB1C3, pLitmus-GG and pSC101-DB plasmids,
respectively. EcoRI and PstI sites surround the divergent BsaI insertion sites. Parts
can be inserted by goldengate, and the RFP cassette allows red/white selection. D.
The pSC101-sfGFP-DB plasmid has a similar upstream site and RFP cassette, but the
downstream BsaI site overhang is the start codon of sfGFP, allowing easy insertion of
promoters or 5’ UTR sequences.
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A.1. Generic goldengate cloning plasmids
A.1.2 Plasmid maps
A B
C D
pSC101-DB pSC101-sfGFP-DB
pSB1C3-DB pLitmus-GG-chlor-RFP
Figure A.2 – Plasmid maps of generic goldengate cloning plasmids. the RFP cassette
is the J04450 biobrick part. pSC101-DB and pSC101-sfGFP-DB are derived from the
pSB4K5 biobrick plasmid, pSB1C3-DB is derived from pSB1C3, and pLitmus-GG-
chlor-RFP is derived from pLitmus28.
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Part Sequence
PIE ribozyme 
(Cargo = NNNN)
TCTAGAGGTTCTACATAAATGCCTAACGACTATCCCTTTGGGGAGTAGGG
TCAAGTGACTCGAAACGATAGACAACTTGCTTTAACAAGTTGGAGATATA
GTCTGCTCTGCATGGTGACATGCAGCTGGATATAATTCCGGGGTAAGATT
AACGACCTTATCTGAACATAATGCTACCGTTTAATATTNNNNATGTTTTCTT
GGGTTAATTGAGGCCTGAGTATAAGGTGACTTATACTTGTAATCTATCTAA
ACGGGGAACCTCTCTAGTAGACAATCCCGTGCTAAATTGTAGGACTCAAT
TGATCCTTAGCGAAAGCTAAGGATTTTTTTT
PIE ribozyme 
C873U
TCTAGAGGTTCTACATAAATGCCTAACGATTATCCCTTTGGGGAGTAGGG
TCAAGTGACTCGAAACGATAGACAACTTGCTTTAACAAGTTGGAGATATA
GTCTGCTCTGCATGGTGACATGCAGCTGGATATAATTCCGGGGTAAGATT
AACGACCTTATCTGAACATAATGCTACCGTTTAATATTNNNNATGTTTTCTT
GGGTTAATTGAGGCCTGAGTATAAGGTGACTTATACTTGTAATCTATCTAA
ACGGGGAACCTCTCTAGTAGACAATCCCGTGCTAAATTGTAGGACTCAAT
TGATCCTTAGCGAAAGCTAAGGATTTTTTTT
circRAJ31 
(insert)
CCTAGGGGATCAATATTAAGCTTTACCGTCGTCTCATCCGCAATTAAGTC
CCTATCCGCTGTCACTGTATTGGTCTGCTAGC
circRAJ31Toe CCTAGGGGATCAATATTAAGCTTTACCGACACCCCATCCGCAATTAAGTC
CCTATCCGCTGTCACTGTATTGGTCTGCTAGC
Nusl3 GGATAGGGACTTAATTGCGGATGAGACGACGGTAAATTATTAATTAACTT
AAGGAGGTAATAAATGACCGTCGTCTGGGCCACTGGGCGTCATACAATG
ACTAGC
Nusl6 GGGACTTAATTGCGGATGAGACGACGGTAAGCGTTAATTAACTTAAGGAG
GTAACGCATGCCGTCGTCTCAAGGCTTTAGCCGTCACTTTATGACTAGC
taRAJ31min GGATCAATATTAAGCTTTACCGTCGTCTCATCCGCAATTAAGTCCCTATCC
GCTGTCACTGTATTGGTCTATCCTTAGCGAAAGCTAAGGATTTTTTTT
circRAG1v1 CCTAGGGCAGGGATAAACGAGATAGATAAGATAAGATAGCCTAGG
circRAG1v2 CCTAGGGCCGGCAGGGATAAACGAGATAGATAAGATAAGATAGCGGCCC
TAGG
linRAG1 GGGACTGACTATTCTGTGCAATAGTCAGTAAAGCAGGGATAAACGAGATA
GATAAGATAAGATAGATCCTTAGCGAAAGCTAAGGATTTTTTTT
cisRAG1 GGGTCTTATCTTATCTATCTCGTTTATCCCTGCATACAGAAACAGAGGAGA
TATGCAATGATAAACGAGAACCTGGCGGCAGCGCAAAAG
circRAG2v2
CCTAGGGCCGCACTAAACTAAACGACAATGTAATCAAACTCGGCCCTAGG
linRAG2 GGGACAGATCCACTGAGGCGTGGATCTGTGAACACTAAACTAAACGACAATGTAATCAAACTAACATCCTTAGCGAAAGCTAAGGATTTTTTTT
cisRAG2 GGGAGTTTGATTACATTGTCGTTTAGTTTAGTGATACATAAACAGAGGAGA
TATCACATGACTAAACGAAACCTGGCGGCAGCGCAAAAG
circRAG5v1 GAAACTAACAGAAGCCAAATCAATTACATAC
Table B.1 – List of sequences used in chapter 2.
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Part Sequence
PIE ribozyme 
(Cargo = NNNN)
TCTAGAGGTTCTACATAAATGCCTAACGACTATCCCTTTGGGGAGTAGGG
TCAAGTGACTCGAAACGATAGACAACTTGCTTTAACAAGTTGGAGATATA
GTCTGCTCTGCATGGTGACATGCAGCTGGATATAATTCCGGGGTAAGATT
AACGACCTTATCTGAACATAATGCTACCGTTTAATATTNNNNATGTTTTCTT
GGGTTAATTGAGGCCTGAGTATAAGGTGACTTATACTTGTAATCTATCTAA
ACGGGGAACCTCTCTAGTAGACAATCCCGTGCTAAATTGTAGGACTCAAT
TGATCCTTAGCGAAAGCTAAGGATTTTTTTT
PIE ribozyme 
C873U
TCTAGAGGTTCTACATAAATGCCTAACGATTATCCCTTTGGGGAGTAGGG
TCAAGTGACTCGAAACGATAGACAACTTGCTTTAACAAGTTGGAGATATA
GTCTGCTCTGCATGGTGACATGCAGCTGGATATAATTCCGGGGTAAGATT
AACGACCTTATCTGAACATAATGCTACCGTTTAATATTNNNNATGTTTTCTT
GGGTTAATTGAGGCCTGAGTATAAGGTGACTTATACTTGTAATCTATCTAA
ACGGGGAACCTCTCTAGTAGACAATCCCGTGCTAAATTGTAGGACTCAAT
TGATCCTTAGCGAAAGCTAAGGATTTTTTTT
circRAJ31 
(insert)
CCTAGGGGATCAATATTAAGCTTTACCGTCGTCTCATCCGCAATTAAGTC
CCTATCCGCTGTCACTGTATTGGTCTGCTAGC
circRAJ31Toe CCTAGGGGATCAATATTAAGCTTTACCGACACCCCATCCGCAATTAAGTC
CCTATCCGCTGTCACTGTATTGGTCTGCTAGC
Nusl3 GGATAGGGACTTAATTGCGGATGAGACGACGGTAAATTATTAATTAACTT
AAGGAGGTAATAAATGACCGTCGTCTGGGCCACTGGGCGTCATACAATG
ACTAGC
Nusl6 GGGACTTAATTGCGGATGAGACGACGGTAAGCGTTAATTAACTTAAGGAG
GTAACGCATGCCGTCGTCTCAAGGCTTTAGCCGTCACTTTATGACTAGC
taRAJ31min GGATCAATATTAAGCTTTACCGTCGTCTCATCCGCAATTAAGTCCCTATCC
GCTGTCACTGTATTGGTCTATCCTTAGCGAAAGCTAAGGATTTTTTTT
circRAG1v1 CCTAGGGCAGGGATAAACGAGATAGATAAGATAAGATAGCCTAGG
circRAG1v2 CCTAGGGCCGGCAGGGATAAACGAGATAGATAAGATAAGATAGCGGCCC
TAGG
linRAG1 GGGACTGACTATTCTGTGCAATAGTCAGTAAAGCAGGGATAAACGAGATA
GATAAGATAAGATAGATCCTTAGCGAAAGCTAAGGATTTTTTTT
cisRAG1 GGGTCTTATCTTATCTATCTCGTTTATCCCTGCATACAGAAACAGAGGAGA
TATGCAATGATAAACGAGAACCTGGCGGCAGCGCAAAAG
circRAG2v2
CCTAGGGCCGCACTAAACTAAACGACAATGTAATCAAACTCGGCCCTAGG
linRAG2 GGGACAGATCCACTGAGGCGTGGATCTGTGAACACTAAACTAAACGACAATGTAATCAAACTAACATCCTTAGCGAAAGCTAAGGATTTTTTTT
cisRAG2 GGGAGTTTGATTACATTGTCGTTTAGTTTAGTGATACATAAACAGAGGAGA
TATCACATGACTAAACGAAACCTGGCGGCAGCGCAAAAG
circRAG5v1 GAAACTAACAGAAGCCAAATCAATTACATAC
Table B.2 – List of sequences used in chapter 2 (continued).
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Primer Sequence
circRT-fw GCAATTAAGTCCCTATCCGCTG
circRT-rv GGATGAGACGACGGTAAAGC
tdC873U_sense CTACATAAATGCCTAACGATTATCCCTTTGGGGAGTAGG
tdC873U_antisense CCTACTCCCCAAAGGGATAATCGTTAGGCATTTATGTAG
wr_cr83 CACCGAATTCTCCCTATCAGTGATAGAGATTGACATCCCTATCAGT
GATAGAGATACTGAGCACGGATCAATATTAAGCTTTACCGTCGTCT
C
wr_cr84 GTCGATCCCTGCAGAAAAAAAATCCTTAGCTTTCGCTAAGGATAGA
CCAATACAGTGACAGCGGATAGAGACCAATACAGTGACAGCGGAT
AG
CircRT-Lin GACATGCAGCTGGATATAATTCC 
CircRaj_toe_sense TGGTCTCTACCGACACCCCATCCGCAATTAAGTCCCTATCCGCTGT
GAGACCTT
CircRaj_toe_asense AAGGTCTCACAGCGGATAGGGACTTAATTGCGGATGGGGTGTCGG
TAGAGACCA
GFP_AddLAA_fw TGGTCTCTCAGCGTGATGATACTAGTAGCGGCCGC
GFP_AddLAA_Rv AGGTCTCTTAGCTTTGTACAGTTCATCCATACCATGCG
LAA_anneal_Fw TGGTCTCTGCTAGCGCAGCGAACGACGAAAATTACGCCCTTGCAG
CAGAGACCT
LAA_anneal_Rv AGGTCTCTGCTGCAAGGGCGTAATTTTCGTCGTTCGCTGCGCTAGC
AGAGACCA
GG-CAT-Fw TGGTCTCTATGGAGAAAAAAATCACTGGATATACCAC
GG-CAT-rv AGGTCTCATTATTACGCCCCGCCCTGCC
cisR31-Fw TGGTCTCTATAATACTAGTAGCGGCCGCTGC
cisR31-Rv AGGTCTCACCATATTATGTTTCTCCTCTTTATGTCGTCTC
circRAG1v1S TAGGGCAGGGATAAACGAGATAGATAAGATAAGATAGCCTAGG
circRAG1v1AS ACATCCTAGGCTATCTTATCTTATCTATCTCGTTTATCCCTGC
circRAG4v1S TAGGGACAGTAAACGGAGCTCTAATCCATAATCGCCTAGG
circRAG4v1AS ACATCCTAGGCGATTATGGATTAGAGCTCCGTTTACTGTC
circRAG5v1S TAGGGAAACTAACAGAAGCCAAATCAATTACATACCTAGG
circRAG5v1AS ACATCCTAGGTATGTAATTGATTTGGCTTCTGTTAGTTTC
circRAG1v2S TAGGGCCGGCAGGGATAAACGAGATAGATAAGATAAGATAGCGGC
CCTAGG
circRAG1v2AS ACATCCTAGGGCCGCTATCTTATCTTATCTATCTCGTTTATCCCTGC
CGGC
circRAG2v2S TAGGGCCGCACTAAACTAAACGACAATGTAATCAAACTCGGCCCTA
GG
circRAG2v2AS ACATCCTAGGGCCGAGTTTGATTACATTGTCGTTTAGTTTAGTGCG
GC
Table B.3 – List of primers used in chapter 2.
169

C Appendix to chapter 3
C.1 Sequences
Primer Sequence
pT7-RBS TAATACGACTCACTATAGGGAGTCGTCAATAGAACACATTAAGGAGGTAGA
GA
SL GGCGCCGTCGTCAT
UTR1 GGATAGGGACTTAATTGCGGATGAGACGACGGTAAAGCGTATGCAGAACA
GAGGAGAATACGCATGACCGTCGTCTATCGCTTCAGCGGTCAGAGTATGAC
CGCAATTGCACCGGTAATTACGATC
UTR2 GGATAGGGACTTAATTGCGGATGAGACGACGGTAAAGCCTATGTGAAACAG
AGGAGAATAGGCATGACCGTCGTCTATCGCCTTCGCGGTCACACTATGACC
GCAATTGCACCGGTAATTACGATC
cmk_5'_30bp ATGACCGCAATTGCACCGGTAATTACGATC
Table C.1 – List of sequences used in chapter 3.
C.2 Primers
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Primer Sequence
G5F_new GGTCGCGTCAATGAAGCTATGG
G5R_new AAAGAGAGCATCAAGGAACTCAAAG
CiE20 CCAGTGGTCTCCAACCCAGC
PR2 TTGGTCTCTGCCAGGTAATAGACAGTGTACCCAGC
PR1 TTGGTCTCTGCTGTGTTACTCCACGCGGTGC
pT7_anneal_sense GTAATAATACGACTCACTATAGGGAGTCGTCAATAGAACACATTAAGGA
GGTAGAGA
pT7_anneal_asense TCATTCTCTACCTCCTTAATGTGTTCTATTGACGACTCCCTATAGTGAGT
CGTATTA
SL_anneal_sense GTAAGGCGCCGTCGTCAT
SL_anneal_asense TCATATGACGACGGCGCC
Table C.2 – List of primers used in chapter 3.
C.3 Bioreactor construction
The bioreactors were built by Mr. Fabio Polesel using customised glass bottles and
caps (see figure C.1. Detailed instructions for bioreactor construction are available on
the Evoprog consortium website: http://evoprog.eu/ (Polesel et al., 2016).
A B
Customised bottle cap and syringes Bioreactor
Figure C.1 – A. Caps and syringes used for input and output of media, cells and air. B.
Assembled bottle.
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Part Sequence
J23119 TTGACAGCTAGCTCAGTCCTAGGTATAATGCTAGC
HDV ribozyme GGCCGGCATGGTCCCAGCCTCCTCGCTGGCGCCGGCTGGGCAACATGC
TTCGGCATGGCGAATGGGAC
Switch 3A GCGACTTCATGCTGTAAAGGTTTTGCACGTTTCTTTGTCTGCCGTGCAAA
ACCTTTCGCGGTAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTA
GTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 7bp
TTTGCACGTTTCTTTGTCTGCCGTGCAAAACCTTTCGCGGTAGTTTTAGAG
CTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGT
GGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 8bp
GTGCAAAACCTTTCGCGGTAGTTTTAGAGCTAGAAATAGCAAGTTAAAATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 9bp
GTGCAAAACCTTTCGCGGTAGTTTTAGAGCTAGAAATAGCAAGTTAAAATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 10bp
GTGCAAAACCTTTCGCGGTAGTTTTAGAGCTAGAAATAGCAAGTTAAAATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 11bp
GTGCAAAACCTTTCGCGGTAGTTTTAGAGCTAGAAATAGCAAGTTAAAATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 12bp
AAGGTTTTGCACGTTTCTTTGTCTGCCGTGCAAAACCTTTCGCGGTAGTTT
TAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAA
AAAGTGGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 13bp
AAAGGTTTTGCACGTTTCTTTGTCTGCCGTGCAAAACCTTTCGCGGTAGTT
TTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCG
Switch 3A No 
Toehold, 14bp
GAAAGGTTTTGCACGTTTCTTTGTCTGCCGTGCAAAACCTTTCGCGGTAG
TTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTT
GAAAAAGTGGCACCGAGTCGGTGCTTTT
Switch 3A No 
Toehold, 15bp
CGAAAGGTTTTGCACGTTTCTTTGTCTGCCGTGCAAAACCTTTCGCGGTA
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TGAAAAAGTGGCACCGAGTCGGTGCTTTT
Crisprzyme 1
TCTTTCCCGGGTACATCC CTGATGAGTCCCAAATAGGACGAAATACATACCAGCCGAAAGGCCCTTGGCAGGTGTCCTGGATTCCACCGTGTTGATTAAAGGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT
crisprzyme 2
TTTTGCACCTGATGAGCCTGGATACCAGCCGAAAGGCCCTTGGCAGTTA
GACGAAACGGTGAAAGCCGTAGTGCAAAACCTTTCGCGGTAGTTTTAGA
GCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAG
TGGCACCGAGTCGGTGCTTTTGGCCGGCATGGTCCCAGCCTCCTCGCTG
GCGCCGGCTGGGCAACATGCTTCGGCATGGCGAATGGGAC
G12A crisprzyme
TTTTG AC ATG G C GA ACCAGCC AA GGCCCTTGGCAGTTA
GACAAAACGGTGAAAGCCGTAGTGCAAAACCTTTCGCGGTAGTTTTAGAG
CTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGT
GGCACCGAGTCGGTGCTTTT
Table D.1 – List of sequences used in chapter 4.
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D.2 Primers used
Primer Sequence
GR21 TTTTGGTCTCGGCTAGCATTATACCTAGGACTGAGCTAGC 
GR22 TTTTGGTCTCTTAGCTTTGCACGTTTCTTTGTCTGCCG
GR23 TTTTGGTCTCTTAGCTTTTGCACGTTTCTTTGTCTGCCG
GR24 TTTTGGTCTCTTAGCGTTTTGCACGTTTCTTTGTCTGCCG
GR25 TTTTGGTCTCTTAGCGGTTTTGCACGTTTCTTTGTCTGCC
GR26 TTTTGGTCTCTTAGCAGGTTTTGCACGTTTCTTTGTCTGC
GR27 TTTTGGTCTCTTAGCAAGGTTTTGCACGTTTCTTTGTCTGC
GR28 TTTTGGTCTCTTAGCAAAGGTTTTGCACGTTTCTTTGTCTGC
GR29 TTTTGGTCTCTTAGCGAAAGGTTTTGCACGTTTCTTTGTCTGC
GR30 TTTTGGTCTCTTAGCCGAAAGGTTTTGCACGTTTCTTTGTCTGC
GR3A-2_rv TATGGTCTCTGGTTTTGCACGTAATAGACGCCAGGGTGCAAAACCTTTCGC
GGTAGTTTTAG
GR3A-2_fw TATGGTCTCTAACCTTTCGTCTGGAACGTATCGCTAGCATTATACCTAGGAC
TGAGCTAGC
GR3A-3_rv TATGGTCTCTAACCTTTCGCGCAAAACTTTCAGCTAGCATTATACCTAGGAC
TGAGCTAGC
GR3A-3_fw TATGGTCTCTGGTTTTGCACGACGTCGCCAGGATGTGTGCAAAACCTTTCG
CGGTAGTTTTAG
oJD46f TAATACGACTCACTATAGGGTTTTGCACCTGATGAGCCTGGATACC
oJD46r GTCCCATTCGCCATGCCGAAGC
Table D.2 – List of primers used in chapter 4.
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E Appendix: NUPACK code
E.1 Design code for new RAJ31 activated UTRs
NUPACK design code for designing cis-repressed UTRs on a sfGFP gene, used to
design Nusl3. The Nusl6 part is similar, but with a toehold shrank to 15 bases, as
described in figure 2.13.
1
2 # NUPACK code for designing a cis -repressed UTR activated by circRAJ 31
3 # William Rostain , U. of Warwick , 2016
4 #
5 # design material , temperature , and trials
6 # see NUPACK User Guide for valid options
7 # material , sodium , magnesium , and dangles
8 #
9 material = rna # Use RNA
10 temperature[C] = 37.0 # optional units: C (default) or K
11 trials = 10 # The results will then be analysed manually
12 sodium[M] = 1.0 # optional units: M (default), mM, uM, nM, pM
13 dangles = some
14 #
15 # target structure using DU+ notation. See NUPACK website for info on notation.
16 structure cisrepressedUTR = U6U17D10(U3D6(U15)U3)U2D3(U4)D4(U5)U4
17 #
18 # sequence domains
19 #
20 # a = toehold and stem
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21 # b = weak top stem
22 # c = loop region
23 # RBS = RBS
24 #
25 #Domains , they will be annotated on the NUPACK output
26 domain a = ggatagggacttaattgcggatgagacgacggtaaa
27 domain b = N6
28 domain c = N4
29 domain RBS = AACAGAGGAGA
30 domain d = ATAN3
31 domain ATG = ATG
32 domain e = N10
33 domain f = N12
34 domain g = N8
35 domain gfp = ATGactagc
36 #
37 # thread sequence domains onto target structures
38 #
39 cisrepressedUTR.seq = a b c RBS d ATG e f g gfp
40 #
41 # specify stop conditions for normalized ensemble defect
42 # default: 1.0 (percent) for each target structure
43 #
44 cisrepressedUTR.stop = 1.0
45
46 #
47 # prevent sequence patterns
48 #
49 prevent = AAAA , CCCC , GGGG , UUUU
50 prevent = KKKKKK , MMMMMM , RRRRRR , SSSSSS , WWWWWW , YYYYYY
E.2 Design code for mKate2 sensing gRNAswitches
Design code for gRNAswitches that use a full length RNA as an input.
1
2 # NUPACK code for designing a gRNAswitch , aka griboswitch
3 # Griboswitch initial design was conceived by the brilliant minds of Dr. J.
Duncan and W. Rostain
4 # Code by William Rostain , U. of Warwick , 2016
5 #################################################
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E.2. Design code for mKate2 sensing gRNAswitches
6 #
7 # design material , temperature , and trials
8 # see NUPACK User Guide for valid options
9 # material , sodium , magnesium , and dangles
10 #
11 material = rna
12 temperature[C] = 37.0 # optional units: C (default) or K
13 trials = 10 # 10 sequences designed
14 sodium[M] = 1.0# optional units: M (default), mM , uM , nM , pM
15 dangles = some
16 #magnesium[M] = 0.05
17 #################################################
18 #
19 structure signal1 = U15U9U15 #This is the trigger RNA
20 structure griboRNA = U15 D13 (U15) U7U1D6(U1D4(U4)U3)U3D2(U5)U7D4(U4)U1D6(U3)U7 #
This is the structure of the gRNAswitch alone
21 structure compl = D15(U9D15 + U13 ) U13 U7 U1D6(U1D4(U4)U3)U3D2(U5)U7D4(U4)U1D6(U
3)U7 # This is the structure of the gRNAswitch in complex with the trigger
22 #
23 #
24 # The trigger is broken into three domains (5prime , spacer , 3prime)
25 domain sig1 = N15
26 domain sig2 = N9
27 domain sig3 = N15
28 #
29 # The switch is broken down into toehold , clamp (free), loop , OFFclamp (the 5
prime part of targeting region that gets blocked), and Cas9 (which includes
terminator)
30 domain toehold = N15 #The 15 bases toehold that is complementary to target
31 domain free = N13 #12 bases of the heteroduplexed loop
32 domain loop = N15 #15 bases of the loop , complementary to target
33 domain OFFclamp = N13 #12 bases that are occluded in the off state and become
free. Normally at gRNA 5’
34 domain rest = N7 #8 free bases that are not in the loop , just before the cas9
handle
35 domain free2 = N13
36 domain cas9 =
GTTTTAGAGCTAGAAATAGCAAGnTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT
37 #
38 # Source can be any RNA
39 source RFP =
atggcttcctccgaagacgttatcaaagagttcatgcgtttcaaagttcgtatggaaggttccgttaacggtcacgagttcga
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aatcgaaggtgaaggtgaaggtcgtccgtacgaaggtacccagaccgctaaactgaaagttaccaaaggtggtccgctgccgt
tcgcttgggacatcctgtccccgcagtccagtacggttccaaagcttacgttaaacacccggctgacatcccggactacctga
aactgtcc
40 #
41 #
42 window rfp_window = sig1 sig2 sig3
43 rfp_window.source = RFP
44 rfp_window.accessible[%] = [50 ,100] # optional units: % (default) or frac.
Input accessibility here [lower limit , upper limit]
45 #
46 #
47 #
48 strand griboRNAstrand = toehold free2 loop OFFclamp rest cas9
49 strand signal = sig1 sig2 sig3
50 griboRNA.seq = griboRNAstrand
51 signal 1.seq = signal
52 compl.seq = signal griboRNAstrand
53 signal 1.stop[%] = 25.0 # optional units: % or frac
54 ## Illegal sequence , relaxed
55 prevent = AAAA , CCC
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